1	A	a	DT	_	2	NMOD
2	model	model	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	tripeptidyl	tripeptidyl	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	peptidase	peptidase	NN	_	9	NMOD
7	I	i	CD	_	6	NMOD
8	(	(	-LRB-	_	9	P
9	CLN2	cln0	NN	_	17	NMOD
10	)	)	-RRB-	_	17	P
11	,	,	,	_	17	P
12	a	a	DT	_	17	NMOD
13	ubiquitous	ubiquitous	JJ	_	17	NMOD
14	and	and	CC	_	13	COORD
15	highly	highly	RB	_	16	AMOD
16	conserved	conserve	VBN	_	14	CONJ
17	member	member	NN	_	3	PMOD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	sedolisin	sedolisin	NN	_	21	NMOD
21	family	family	NN	_	18	PMOD
22	of	of	IN	_	21	NMOD
23	serine	serine	NN	_	25	NMOD
24	-	-	HYPH	_	23	P
25	carboxyl	carboxyl	NN	_	26	NMOD
26	peptidases	peptidase	NNS	_	22	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	Background	background	NN	_	0	ROOT

1	Tripeptidyl	tripeptidyl	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	peptidase	peptidase	NN	_	11	SBJ
4	I	i	CD	_	3	NMOD
5	,	,	,	_	3	P
6	also	also	RB	_	7	ADV
7	known	know	VBN	_	3	NMOD
8	as	as	IN	_	7	ADV
9	CLN2	cln0	NN	_	8	PMOD
10	,	,	,	_	11	P
11	is	be	VBZ	_	0	ROOT
12	a	a	DT	_	13	NMOD
13	member	member	NN	_	11	PRD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	16	NMOD
16	family	family	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	sedolisins	sedolisins	NNS	_	23	NMOD
19	(	(	-LRB-	_	23	P
20	serine	serine	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	carboxyl	carboxyl	NN	_	23	NMOD
23	peptidases	peptidase	NNS	_	17	PMOD
24	)	)	-RRB-	_	11	P
25	.	.	.	_	11	P

1	In	in	IN	_	10	LOC
2	humans	human	NNS	_	1	PMOD
3	,	,	,	_	10	P
4	defects	defect	VBZ	_	10	SBJ
5	in	in	IN	_	4	NMOD
6	expression	expression	NN	_	5	PMOD
7	of	of	IN	_	6	NMOD
8	this	this	DT	_	9	NMOD
9	enzyme	enzyme	NN	_	7	PMOD
10	lead	lead	VBP	_	0	ROOT
11	to	to	IN	_	10	ADV
12	a	a	DT	_	15	NMOD
13	fatal	fatal	JJ	_	15	NMOD
14	neurodegenerative	neurodegenerative	JJ	_	15	NMOD
15	disease	disease	NN	_	11	PMOD
16	,	,	,	_	15	P
17	classical	classical	JJ	_	23	NMOD
18	late	late	JJ	_	20	AMOD
19	-	-	HYPH	_	18	P
20	infantile	infantile	JJ	_	23	NMOD
21	neuronal	neuronal	JJ	_	23	NMOD
22	ceroid	ceroid	JJ	_	23	NMOD
23	lipofuscinosis	lipofuscinosis	NN	_	15	APPO
24	.	.	.	_	10	P

1	Similar	similar	JJ	_	2	NMOD
2	enzymes	enzyme	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	been	be	VBN	_	3	VC
5	found	find	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	the	the	DT	_	9	NMOD
8	genomic	genomic	JJ	_	9	NMOD
9	sequences	sequence	NNS	_	6	PMOD
10	of	of	IN	_	9	NMOD
11	several	several	JJ	_	12	NMOD
12	species	specie	NNS	_	10	PMOD
13	,	,	,	_	3	P
14	but	but	CC	_	3	COORD
15	neither	neither	CC	_	17	COORD
16	systematic	systematic	JJ	_	17	NMOD
17	analyses	analysis	NNS	_	26	SBJ
18	of	of	IN	_	17	NMOD
19	their	their	PRP$	_	20	NMOD
20	distribution	distribution	NN	_	18	PMOD
21	nor	nor	CC	_	17	COORD
22	modeling	modeling	NN	_	21	CONJ
23	of	of	IN	_	22	NMOD
24	their	their	PRP$	_	25	NMOD
25	structures	structure	NNS	_	23	PMOD
26	have	have	VBP	_	14	CONJ
27	been	be	VBN	_	26	VC
28	previously	previously	RB	_	27	TMP
29	attempted	attempt	VBN	_	27	VC
30	.	.	.	_	3	P

1	Results	result	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	analyzed	analyze	VBN	_	2	VC
4	the	the	DT	_	5	NMOD
5	presence	presence	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	orthologs	orthologs	NNS	_	6	PMOD
8	of	of	IN	_	7	NMOD
9	human	human	JJ	_	10	NMOD
10	CLN2	cln0	NN	_	8	PMOD
11	in	in	IN	_	3	LOC
12	the	the	DT	_	14	NMOD
13	genomic	genomic	JJ	_	14	NMOD
14	sequences	sequence	NNS	_	11	PMOD
15	of	of	IN	_	14	NMOD
16	a	a	DT	_	17	NMOD
17	number	number	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	eukaryotic	eukaryotic	JJ	_	20	NMOD
20	species	specie	NNS	_	18	PMOD
21	.	.	.	_	2	P

1	Enzymes	enzyme	NNS	_	9	SBJ
2	with	with	IN	_	1	NMOD
3	sequences	sequence	NNS	_	2	PMOD
4	sharing	share	VBG	_	3	NMOD
5	over	over	IN	_	6	QMOD
6	80	0	CD	_	7	NMOD
7	%	%	NN	_	8	NMOD
8	identity	identity	NN	_	4	OBJ
9	have	have	VBP	_	0	ROOT
10	been	be	VBN	_	9	VC
11	found	find	VBN	_	10	VC
12	in	in	IN	_	11	LOC
13	the	the	DT	_	14	NMOD
14	genomes	genome	NNS	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	macaque	macaque	NN	_	15	PMOD
17	,	,	,	_	16	P
18	mouse	mouse	NN	_	16	CONJ
19	,	,	,	_	18	P
20	rat	rat	NN	_	18	CONJ
21	,	,	,	_	20	P
22	dog	dog	NN	_	20	CONJ
23	,	,	,	_	22	P
24	and	and	CC	_	22	COORD
25	cow	cow	NN	_	24	CONJ
26	.	.	.	_	9	P

1	Closely	closely	RB	_	2	AMOD
2	related	relate	VBN	_	8	NMOD
3	,	,	,	_	4	P
4	although	although	IN	_	2	PRN
5	clearly	clearly	RB	_	6	AMOD
6	distinct	distinct	JJ	_	4	SUB
7	,	,	,	_	4	P
8	enzymes	enzyme	NNS	_	9	SBJ
9	are	be	VBP	_	0	ROOT
10	present	present	JJ	_	9	PRD
11	in	in	IN	_	9	LOC
12	fish	fish	NN	_	14	NMOD
13	(	(	-LRB-	_	14	P
14	fugu	fugu	NN	_	11	PMOD
15	and	and	CC	_	14	COORD
16	zebra	zebra	NN	_	15	CONJ
17	)	)	-RRB-	_	11	P
18	,	,	,	_	11	P
19	as	as	RB	_	21	ADV
20	well	well	RB	_	21	ADV
21	as	as	IN	_	11	COORD
22	in	in	IN	_	21	CONJ
23	frogs	frog	NNS	_	26	NMOD
24	(	(	-LRB-	_	26	P
25	Xenopus	xenopus	NNP	_	26	NMOD
26	tropicalis	tropicalis	NNP	_	22	PMOD
27	)	)	-RRB-	_	9	P
28	.	.	.	_	9	P

1	A	a	DT	_	5	NMOD
2	three	three	CD	_	4	AMOD
3	-	-	HYPH	_	2	P
4	dimensional	dimensional	JJ	_	5	NMOD
5	model	model	NN	_	9	SBJ
6	of	of	IN	_	5	NMOD
7	human	human	JJ	_	8	NMOD
8	CLN2	cln0	NN	_	6	PMOD
9	was	be	VBD	_	0	ROOT
10	built	build	VBN	_	9	VC
11	based	base	VBN	_	10	ADV
12	mainly	mainly	RB	_	13	PMOD
13	on	on	IN	_	11	PMOD
14	the	the	DT	_	15	NMOD
15	homology	homology	NN	_	13	PMOD
16	with	with	IN	_	15	NMOD
17	Pseudomonas	pseudomonas	NNP	_	18	NMOD
18	sp	sp	NNP	_	16	PMOD
19	.	.	.	_	9	P

1	101	0	CD	_	2	NMOD
2	sedolisin	sedolisin	NN	_	0	ROOT
3	.	.	.	_	2	P

1	Conclusion	conclusion	NN	_	0	ROOT

1	CLN2	cln0	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	very	very	RB	_	4	AMOD
4	highly	highly	RB	_	5	ADV
5	conserved	conserve	VBN	_	2	VC
6	and	and	CC	_	5	COORD
7	widely	widely	RB	_	8	ADV
8	distributed	distribute	VBN	_	6	CONJ
9	among	among	IN	_	5	ADV
10	higher	high	JJR	_	11	NMOD
11	organisms	organism	NNS	_	9	PMOD
12	and	and	CC	_	2	COORD
13	may	may	MD	_	12	CONJ
14	play	play	VB	_	13	VC
15	an	an	DT	_	17	NMOD
16	important	important	JJ	_	17	NMOD
17	role	role	NN	_	14	OBJ
18	in	in	IN	_	14	ADV
19	their	their	PRP$	_	21	NMOD
20	life	life	NN	_	21	NMOD
21	cycles	cycle	NNS	_	18	PMOD
22	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	model	model	NN	_	5	SBJ
3	presented	present	VBN	_	2	NMOD
4	here	here	RB	_	3	ADV
5	indicates	indicate	VBZ	_	0	ROOT
6	a	a	DT	_	12	NMOD
7	very	very	RB	_	8	AMOD
8	open	open	JJ	_	12	NMOD
9	and	and	CC	_	8	COORD
10	accessible	accessible	JJ	_	9	CONJ
11	active	active	JJ	_	12	NMOD
12	site	site	NN	_	5	OBJ
13	that	that	WDT	_	14	SBJ
14	is	be	VBZ	_	12	NMOD
15	almost	almost	RB	_	16	AMOD
16	completely	completely	RB	_	14	ADV
17	conserved	conserve	VBN	_	14	VC
18	among	among	IN	_	17	ADV
19	all	all	DT	_	22	NMOD
20	known	know	VBN	_	22	NMOD
21	CLN2	cln0	NN	_	22	NMOD
22	enzymes	enzyme	NNS	_	18	PMOD
23	.	.	.	_	5	P

1	This	this	DT	_	2	NMOD
2	result	result	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	somehow	somehow	RB	_	3	ADV
5	surprising	surprising	JJ	_	3	PRD
6	for	for	IN	_	3	ADV
7	a	a	DT	_	8	NMOD
8	tripeptidase	tripeptidase	NN	_	6	PMOD
9	where	where	WRB	_	19	LOC
10	the	the	DT	_	11	NMOD
11	presence	presence	NN	_	18	SBJ
12	of	of	IN	_	11	NMOD
13	a	a	DT	_	17	NMOD
14	more	more	RBR	_	15	AMOD
15	constrained	constrained	JJ	_	17	NMOD
16	binding	binding	NN	_	17	NMOD
17	pocket	pocket	NN	_	12	PMOD
18	was	be	VBD	_	8	NMOD
19	anticipated	anticipate	VBN	_	18	VC
20	.	.	.	_	3	P

1	This	this	DT	_	3	NMOD
2	structural	structural	JJ	_	3	NMOD
3	model	model	NN	_	4	SBJ
4	should	should	MD	_	0	ROOT
5	be	be	VB	_	4	VC
6	useful	useful	JJ	_	5	PRD
7	in	in	IN	_	5	ADV
8	the	the	DT	_	9	NMOD
9	search	search	NN	_	7	PMOD
10	for	for	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	physiological	physiological	JJ	_	13	NMOD
13	substrates	substrate	NNS	_	10	PMOD
14	of	of	IN	_	13	NMOD
15	these	these	DT	_	16	NMOD
16	enzymes	enzyme	NNS	_	14	PMOD
17	and	and	CC	_	7	COORD
18	in	in	IN	_	17	CONJ
19	the	the	DT	_	20	NMOD
20	design	design	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	more	more	JJR	_	24	NMOD
23	specific	specific	JJ	_	24	NMOD
24	inhibitors	inhibitor	NNS	_	21	PMOD
25	of	of	IN	_	24	NMOD
26	CLN2	cln0	NN	_	25	PMOD
27	.	.	.	_	4	P

1	Background	background	NN	_	0	ROOT

1	Although	although	IN	_	33	ADV
2	the	the	DT	_	3	NMOD
3	existence	existence	NN	_	14	SBJ
4	of	of	IN	_	3	NMOD
5	tripeptidyl	tripeptidyl	NN	_	7	NMOD
6	-	-	HYPH	_	5	P
7	peptidase	peptidase	NN	_	10	NMOD
8	I	i	CD	_	7	NMOD
9	(	(	-LRB-	_	10	P
10	TPP	tpp	NN	_	4	PMOD
11	-	-	HYPH	_	10	P
12	I	i	CD	_	10	NMOD
13	)	)	-RRB-	_	14	P
14	was	be	VBD	_	1	SUB
15	first	$#ORD#$	RB	_	14	TMP
16	noted	note	VBN	_	14	VC
17	over	over	IN	_	20	AMOD
18	40	0	CD	_	19	NMOD
19	years	year	NNS	_	20	AMOD
20	ago	ago	RB	_	16	TMP
21	[	[	-LRB-	_	22	P
22	1	0	CD	_	16	PRN
23	]	]	-RRB-	_	22	P
24	,	,	,	_	33	P
25	the	the	DT	_	29	NMOD
26	structural	structural	JJ	_	29	NMOD
27	and	and	CC	_	26	COORD
28	mechanistic	mechanistic	JJ	_	27	CONJ
29	basis	base	NN	_	33	SBJ
30	of	of	IN	_	29	NMOD
31	its	its	PRP$	_	32	NMOD
32	activity	activity	NN	_	30	PMOD
33	has	have	VBZ	_	0	ROOT
34	been	be	VBN	_	33	VC
35	largely	largely	RB	_	34	ADV
36	misunderstood	misunderstand	VBN	_	34	VC
37	until	until	IN	_	36	TMP
38	quite	quite	RB	_	39	AMOD
39	recently	recently	RB	_	37	PMOD
40	.	.	.	_	33	P

1	The	the	DT	_	2	NMOD
2	situation	situation	NN	_	3	SBJ
3	changed	change	VBD	_	0	ROOT
4	after	after	IN	_	3	TMP
5	it	it	PRP	_	6	SBJ
6	was	be	VBD	_	4	SUB
7	shown	show	VBN	_	6	VC
8	that	that	IN	_	7	OBJ
9	TPP	tpp	NN	_	12	SBJ
10	-	-	HYPH	_	9	P
11	I	i	CD	_	9	NMOD
12	is	be	VBZ	_	8	SUB
13	identical	identical	JJ	_	12	PRD
14	to	to	IN	_	13	AMOD
15	an	an	DT	_	18	NMOD
16	independently	independently	RB	_	17	AMOD
17	characterized	characterize	VBN	_	18	NMOD
18	enzyme	enzyme	NN	_	14	PMOD
19	named	name	VBN	_	18	NMOD
20	CLN2	cln0	NN	_	19	OPRD
21	.	.	.	_	3	P

1	It	it	PRP	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	also	also	RB	_	2	ADV
4	demonstrated	demonstrate	VBN	_	2	VC
5	that	that	IN	_	4	OBJ
6	mutations	mutation	NNS	_	16	SBJ
7	leading	lead	VBG	_	6	NMOD
8	to	to	IN	_	7	ADV
9	abolishment	abolishment	NN	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	enzymatic	enzymatic	JJ	_	13	NMOD
13	activity	activity	NN	_	10	PMOD
14	of	of	IN	_	13	NMOD
15	CLN2	cln0	NN	_	14	PMOD
16	were	be	VBD	_	5	SUB
17	the	the	DT	_	19	NMOD
18	direct	direct	JJ	_	19	NMOD
19	cause	cause	NN	_	16	PRD
20	of	of	IN	_	19	NMOD
21	a	a	DT	_	25	NMOD
22	fatal	fatal	JJ	_	25	NMOD
23	inherited	inherit	VBN	_	25	NMOD
24	neurodegenerative	neurodegenerative	JJ	_	25	NMOD
25	disease	disease	NN	_	20	PMOD
26	,	,	,	_	25	P
27	classical	classical	JJ	_	33	NMOD
28	late	late	JJ	_	30	AMOD
29	-	-	HYPH	_	28	P
30	infantile	infantile	JJ	_	33	NMOD
31	neuronal	neuronal	JJ	_	33	NMOD
32	ceroid	ceroid	NN	_	33	NMOD
33	lipofuscinosis	lipofuscinosis	NN	_	25	APPO
34	[	[	-LRB-	_	35	P
35	2	0	CD	_	4	PRN
36	]	]	-RRB-	_	35	P
37	.	.	.	_	2	P

1	This	this	DT	_	3	NMOD
2	important	important	JJ	_	3	NMOD
3	observation	observation	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	followed	follow	VBN	_	4	VC
6	by	by	IN	_	5	LGS
7	the	the	DT	_	8	NMOD
8	identification	identification	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	CLN2	cln0	NN	_	9	PMOD
11	as	as	IN	_	8	NMOD
12	a	a	DT	_	14	NMOD
13	serine	serine	NN	_	14	NMOD
14	peptidase	peptidase	NN	_	11	PMOD
15	[	[	-LRB-	_	18	P
16	3	0	CD	_	18	NMOD
17	,	,	,	_	18	P
18	4	0	CD	_	8	PRN
19	]	]	-RRB-	_	18	P
20	,	,	,	_	5	P
21	without	without	IN	_	5	MNR
22	,	,	,	_	21	P
23	however	however	RB	_	25	ADV
24	,	,	,	_	25	P
25	specifying	specify	VBG	_	21	PMOD
26	its	its	PRP$	_	27	NMOD
27	structural	structural	JJ	_	25	OBJ
28	fold	fold	RB	_	27	NMOD
29	and	and	CC	_	27	COORD
30	the	the	DT	_	31	NMOD
31	details	detail	NNS	_	29	CONJ
32	of	of	IN	_	31	NMOD
33	the	the	DT	_	35	NMOD
34	catalytic	catalytic	JJ	_	35	NMOD
35	site	site	NN	_	32	PMOD
36	.	.	.	_	4	P

1	More	more	RBR	_	2	AMOD
2	accurate	accurate	JJ	_	3	NMOD
3	placement	placement	NN	_	15	SBJ
4	of	of	IN	_	3	NMOD
5	CLN2	cln0	NN	_	4	PMOD
6	within	within	IN	_	3	NMOD
7	the	the	DT	_	8	NMOD
8	context	context	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	a	a	DT	_	11	NMOD
11	family	family	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	related	related	JJ	_	14	NMOD
14	enzymes	enzyme	NNS	_	12	PMOD
15	became	become	VBD	_	0	ROOT
16	possible	possible	JJ	_	15	PRD
17	only	only	RB	_	18	ADV
18	after	after	IN	_	15	TMP
19	high	high	JJ	_	21	NMOD
20	-	-	HYPH	_	19	P
21	resolution	resolution	NN	_	23	NMOD
22	crystal	crystal	JJ	_	23	NMOD
23	structures	structure	NNS	_	40	SBJ
24	of	of	IN	_	23	NMOD
25	two	two	CD	_	27	NMOD
26	bacterial	bacterial	JJ	_	27	NMOD
27	enzymes	enzyme	NNS	_	24	PMOD
28	with	with	IN	_	27	NMOD
29	a	a	DT	_	32	NMOD
30	limited	limit	VBN	_	32	NMOD
31	sequence	sequence	NN	_	32	NMOD
32	similarity	similarity	NN	_	28	PMOD
33	to	to	IN	_	32	NMOD
34	CLN2	cln0	NN	_	33	PMOD
35	,	,	,	_	34	P
36	sedolisin	sedolisin	NN	_	34	CONJ
37	and	and	CC	_	36	COORD
38	kumamolisin	kumamolisin	NN	_	37	CONJ
39	,	,	,	_	40	P
40	became	become	VBD	_	18	SUB
41	available	available	JJ	_	40	PRD
42	[	[	-LRB-	_	43	P
43	5	0	CD	_	15	PRN
44	-	-	SYM	_	45	P
45	7	0	CD	_	43	NMOD
46	]	]	-RRB-	_	43	P
47	.	.	.	_	15	P

1	These	these	DT	_	2	NMOD
2	structures	structure	NNS	_	3	SBJ
3	defined	define	VBD	_	0	ROOT
4	a	a	DT	_	6	NMOD
5	novel	novel	JJ	_	6	NMOD
6	family	family	NN	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	enzymes	enzyme	NNS	_	7	PMOD
9	,	,	,	_	6	P
10	now	now	RB	_	11	TMP
11	called	call	VBN	_	6	NMOD
12	sedolisins	sedolisins	NNS	_	11	OPRD
13	or	or	CC	_	12	COORD
14	serine	serine	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	carboxyl	carboxyl	NN	_	17	NMOD
17	peptidases	peptidase	NNS	_	13	CONJ
18	,	,	,	_	6	P
19	that	that	WDT	_	20	SBJ
20	is	be	VBZ	_	6	NMOD
21	characterized	characterize	VBN	_	20	VC
22	by	by	IN	_	21	ADV
23	the	the	DT	_	24	NMOD
24	utilization	utilization	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	a	a	DT	_	30	NMOD
27	fully	fully	RB	_	28	AMOD
28	conserved	conserve	VBN	_	30	NMOD
29	catalytic	catalytic	JJ	_	30	NMOD
30	triad	triad	NN	_	36	NMOD
31	(	(	-LRB-	_	36	P
32	Ser	ser	NN	_	36	NMOD
33	,	,	,	_	36	P
34	Glu	glu	NN	_	36	NMOD
35	,	,	,	_	36	P
36	Asp	asp	NN	_	25	PMOD
37	)	)	-RRB-	_	22	P
38	and	and	CC	_	22	COORD
39	by	by	IN	_	38	CONJ
40	the	the	DT	_	41	NMOD
41	presence	presence	NN	_	39	PMOD
42	of	of	IN	_	41	NMOD
43	an	an	DT	_	44	NMOD
44	Asp	asp	NN	_	42	PMOD
45	in	in	IN	_	41	LOC
46	the	the	DT	_	48	NMOD
47	oxyanion	oxyanion	NN	_	48	NMOD
48	hole	hole	NN	_	45	PMOD
49	[	[	-LRB-	_	50	P
50	8	0	CD	_	3	PRN
51	]	]	-RRB-	_	50	P
52	.	.	.	_	3	P

1	Sedolisin	sedolisin	NN	_	22	SBJ
2	and	and	CC	_	1	COORD
3	its	its	PRP$	_	5	NMOD
4	several	several	JJ	_	5	NMOD
5	variants	variant	NNS	_	9	NMOD
6	(	(	-LRB-	_	9	P
7	e.g.	e.g.	FW	_	9	NMOD
8	,	,	,	_	9	P
9	kumamolisin	kumamolisin	NN	_	2	CONJ
10	,	,	,	_	9	P
11	aorsin	aorsin	NN	_	9	CONJ
12	[	[	-LRB-	_	13	P
13	9	0	CD	_	11	PRN
14	]	]	-RRB-	_	13	P
15	,	,	,	_	11	P
16	and	and	CC	_	11	COORD
17	physarolisin	physarolisin	NN	_	16	CONJ
18	[	[	-LRB-	_	19	P
19	10	0	CD	_	9	PRN
20	]	]	-RRB-	_	19	P
21	)	)	-RRB-	_	22	P
22	have	have	VBP	_	0	ROOT
23	now	now	RB	_	22	TMP
24	been	be	VBN	_	22	VC
25	found	find	VBN	_	24	VC
26	in	in	IN	_	25	LOC
27	archaea	archaea	NN	_	26	PMOD
28	,	,	,	_	27	P
29	bacteria	bacteria	NNS	_	27	CONJ
30	,	,	,	_	29	P
31	fungi	fungus	NNS	_	29	CONJ
32	and	and	CC	_	31	COORD
33	amoebae	amoeba	NNS	_	32	CONJ
34	,	,	,	_	25	P
35	whereas	whereas	IN	_	25	ADV
36	the	the	DT	_	38	NMOD
37	higher	high	JJR	_	38	NMOD
38	organisms	organism	NNS	_	39	SBJ
39	seem	seem	VBP	_	35	SUB
40	to	to	TO	_	39	OPRD
41	contain	contain	VB	_	40	IM
42	only	only	RB	_	43	NMOD
43	variants	variant	NNS	_	41	OBJ
44	of	of	IN	_	43	NMOD
45	CLN2	cln0	NN	_	44	PMOD
46	[	[	-LRB-	_	47	P
47	8	0	CD	_	25	PRN
48	]	]	-RRB-	_	47	P
49	.	.	.	_	22	P

1	The	the	DT	_	3	NMOD
2	physiological	physiological	JJ	_	3	NMOD
3	role	role	NN	_	10	SBJ
4	of	of	IN	_	3	NMOD
5	sedolisins	sedolisins	NNS	_	4	PMOD
6	in	in	IN	_	3	NMOD
7	the	the	DT	_	9	NMOD
8	lower	low	JJR	_	9	NMOD
9	organisms	organism	NNS	_	6	PMOD
10	has	have	VBZ	_	0	ROOT
11	not	not	RB	_	10	ADV
12	yet	yet	RB	_	10	TMP
13	been	be	VBN	_	10	VC
14	elucidated	elucidate	VBN	_	13	VC
15	.	.	.	_	10	P

1	Despite	despite	IN	_	19	ADV
2	the	the	DT	_	5	NMOD
3	potential	potential	JJ	_	5	NMOD
4	medical	medical	JJ	_	5	NMOD
5	importance	importance	NN	_	1	PMOD
6	of	of	IN	_	5	NMOD
7	CLN2	cln0	NN	_	6	PMOD
8	and	and	CC	_	7	COORD
9	related	related	JJ	_	10	NMOD
10	enzymes	enzyme	NNS	_	8	CONJ
11	,	,	,	_	19	P
12	no	no	DT	_	14	NMOD
13	systematic	systematic	JJ	_	14	NMOD
14	studies	study	NNS	_	19	SBJ
15	of	of	IN	_	14	NMOD
16	their	their	PRP$	_	18	NMOD
17	genomic	genomic	JJ	_	18	NMOD
18	distribution	distribution	NN	_	15	PMOD
19	have	have	VBP	_	0	ROOT
20	been	be	VBN	_	19	VC
21	published	publish	VBN	_	20	VC
22	to	to	IN	_	21	TMP
23	date	date	NN	_	22	PMOD
24	.	.	.	_	19	P

1	There	there	EX	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	also	also	RB	_	2	ADV
4	no	no	RB	_	6	NMOD
5	published	publish	VBN	_	6	NMOD
6	reports	report	NNS	_	2	PRD
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	9	NMOD
9	crystallization	crystallization	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	this	this	DT	_	12	NMOD
12	enzyme	enzyme	NN	_	10	PMOD
13	.	.	.	_	2	P

1	In	in	IN	_	14	ADV
2	the	the	DT	_	3	NMOD
3	absence	absence	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	an	an	DT	_	7	NMOD
6	experimental	experimental	JJ	_	7	NMOD
7	structure	structure	NN	_	4	PMOD
8	obtained	obtain	VBN	_	7	NMOD
9	by	by	IN	_	8	MNR
10	crystallography	crystallography	NN	_	9	PMOD
11	or	or	CC	_	10	COORD
12	NMR	nmr	NN	_	11	CONJ
13	it	it	PRP	_	14	SBJ
14	is	be	VBZ	_	0	ROOT
15	sometimes	sometimes	RB	_	14	TMP
16	necessary	necessary	JJ	_	14	PRD
17	to	to	TO	_	14	OPRD
18	resort	resort	VB	_	17	IM
19	to	to	IN	_	18	ADV
20	molecular	molecular	JJ	_	21	NMOD
21	modeling	modeling	NN	_	19	PMOD
22	in	in	IN	_	18	ADV
23	order	order	NN	_	22	PMOD
24	to	to	TO	_	23	NMOD
25	provide	provide	VB	_	24	IM
26	a	a	DT	_	28	NMOD
27	structural	structural	JJ	_	28	NMOD
28	basis	base	NN	_	25	OBJ
29	for	for	IN	_	28	NMOD
30	the	the	DT	_	31	NMOD
31	explanation	explanation	NN	_	29	PMOD
32	of	of	IN	_	31	NMOD
33	the	the	DT	_	35	NMOD
34	biological	biological	JJ	_	35	NMOD
35	properties	property	NNS	_	32	PMOD
36	of	of	IN	_	35	NMOD
37	an	an	DT	_	38	NMOD
38	enzyme	enzyme	NN	_	36	PMOD
39	,	,	,	_	25	P
40	and	and	CC	_	25	COORD
41	,	,	,	_	40	P
42	in	in	IN	_	45	ADV
43	particular	particular	JJ	_	42	PMOD
44	,	,	,	_	45	P
45	to	to	TO	_	40	CONJ
46	initiate	initiate	VB	_	45	IM
47	design	design	NN	_	46	OBJ
48	of	of	IN	_	47	NMOD
49	its	its	PRP$	_	50	NMOD
50	inhibitors	inhibitor	NNS	_	48	PMOD
51	.	.	.	_	14	P

1	Examples	example	NNS	_	10	SBJ
2	of	of	IN	_	1	NMOD
3	such	such	JJ	_	9	NMOD
4	very	very	RB	_	5	AMOD
5	successful	successful	JJ	_	9	NMOD
6	and	and	CC	_	5	COORD
7	useful	useful	JJ	_	6	CONJ
8	modeling	modeling	NN	_	9	NMOD
9	efforts	effort	NNS	_	2	PMOD
10	are	be	VBP	_	0	ROOT
11	provided	provide	VBN	_	10	VC
12	by	by	IN	_	11	ADV
13	HIV	hiv	NN	_	14	NMOD
14	protease	protease	NN	_	12	PMOD
15	[	[	-LRB-	_	16	P
16	11	0	CD	_	14	PRN
17	]	]	-RRB-	_	16	P
18	,	,	,	_	12	P
19	or	or	CC	_	12	COORD
20	very	very	RB	_	21	AMOD
21	recently	recently	RB	_	22	TMP
22	by	by	IN	_	19	CONJ
23	the	the	DT	_	24	NMOD
24	peptidase	peptidase	NN	_	22	PMOD
25	from	from	IN	_	24	NMOD
26	a	a	DT	_	27	NMOD
27	coronavirus	coronavirus	NN	_	25	PMOD
28	involved	involve	VBN	_	27	NMOD
29	in	in	IN	_	28	ADV
30	the	the	DT	_	34	NMOD
31	severe	severe	JJ	_	34	NMOD
32	acute	acute	JJ	_	34	NMOD
33	respiratory	respiratory	JJ	_	34	NMOD
34	syndrome	syndrome	NN	_	29	PMOD
35	[	[	-LRB-	_	36	P
36	12	0	CD	_	24	PRN
37	]	]	-RRB-	_	36	P
38	,	,	,	_	11	P
39	among	among	IN	_	11	ADV
40	others	others	NNS	_	39	PMOD
41	.	.	.	_	10	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	now	now	RB	_	2	TMP
4	applied	apply	VBN	_	2	VC
5	the	the	DT	_	6	NMOD
6	tools	tool	NNS	_	4	OBJ
7	of	of	IN	_	6	NMOD
8	molecular	molecular	JJ	_	10	NMOD
9	homology	homology	NN	_	10	NMOD
10	modeling	modeling	NN	_	7	PMOD
11	to	to	IN	_	4	ADV
12	predicting	predict	VBG	_	11	PMOD
13	a	a	DT	_	14	NMOD
14	structure	structure	NN	_	12	OBJ
15	of	of	IN	_	14	NMOD
16	CLN2	cln0	NN	_	15	PMOD
17	that	that	WDT	_	18	SBJ
18	could	could	MD	_	14	NMOD
19	be	be	VB	_	18	VC
20	used	use	VBN	_	19	VC
21	as	as	IN	_	20	PRP
22	a	a	DT	_	23	NMOD
23	basis	base	NN	_	21	PMOD
24	for	for	IN	_	23	NMOD
25	a	a	DT	_	26	NMOD
26	search	search	NN	_	27	NMOD
27	for	for	IN	_	24	PMOD
28	the	the	DT	_	30	NMOD
29	biological	biological	JJ	_	30	NMOD
30	substrates	substrate	NNS	_	27	PMOD
31	of	of	IN	_	30	NMOD
32	this	this	DT	_	33	NMOD
33	family	family	NN	_	31	PMOD
34	of	of	IN	_	33	NMOD
35	enzymes	enzyme	NNS	_	34	PMOD
36	and	and	CC	_	27	COORD
37	for	for	IN	_	36	CONJ
38	the	the	DT	_	39	NMOD
39	design	design	NN	_	37	PMOD
40	of	of	IN	_	39	NMOD
41	specific	specific	JJ	_	42	NMOD
42	inhibitors	inhibitor	NNS	_	40	PMOD
43	.	.	.	_	2	P

1	Results	result	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	discussion	discussion	NN	_	2	CONJ

1	Sequence	sequence	NN	_	2	NMOD
2	comparisons	comparison	NNS	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	8	NMOD
5	CLN2	cln0	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	like	like	JJ	_	8	NMOD
8	enzymes	enzyme	NNS	_	3	PMOD

1	Mammalian	mammalian	JJ	_	2	NMOD
2	enzymes	enzyme	NNS	_	12	SBJ
3	homologous	homologous	JJ	_	2	NMOD
4	to	to	IN	_	3	AMOD
5	human	human	JJ	_	6	NMOD
6	CLN2	cln0	NN	_	4	PMOD
7	[	[	-LRB-	_	10	P
8	2	0	CD	_	10	NMOD
9	,	,	,	_	10	P
10	4	0	CD	_	2	PRN
11	]	]	-RRB-	_	10	P
12	form	form	VBP	_	0	ROOT
13	a	a	DT	_	14	NMOD
14	subfamily	subfamily	NN	_	12	OBJ
15	of	of	IN	_	14	NMOD
16	sedolisins	sedolisins	NNS	_	15	PMOD
17	with	with	IN	_	16	NMOD
18	highly	highly	RB	_	19	AMOD
19	conserved	conserve	VBN	_	20	NMOD
20	sequences	sequence	NNS	_	17	PMOD
21	(	(	-LRB-	_	22	P
22	Figure	figure	NN	_	12	PRN
23	1	0	CD	_	22	NMOD
24	)	)	-RRB-	_	22	P
25	.	.	.	_	12	P

1	These	these	DT	_	2	NMOD
2	enzymes	enzyme	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	expressed	express	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	a	a	DT	_	7	NMOD
7	prosegment	prosegment	NN	_	5	PMOD
8	consisting	consist	VBG	_	7	NMOD
9	of	of	IN	_	8	ADV
10	195	0	CD	_	11	NMOD
11	residues	residue	NNS	_	9	PMOD
12	that	that	WDT	_	13	SBJ
13	is	be	VBZ	_	7	NMOD
14	cleaved	cleave	VBN	_	13	VC
15	off	off	RP	_	14	PRT
16	during	during	IN	_	14	TMP
17	maturation	maturation	NN	_	16	PMOD
18	,	,	,	_	14	P
19	yielding	yield	VBG	_	14	ADV
20	the	the	DT	_	23	NMOD
21	active	active	JJ	_	23	NMOD
22	catalytic	catalytic	JJ	_	23	NMOD
23	domain	domain	NN	_	19	OBJ
24	.	.	.	_	3	P

1	Complete	complete	JJ	_	2	NMOD
2	sequences	sequence	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	available	available	JJ	_	3	PRD
5	for	for	IN	_	3	ADV
6	CLN2	cln0	NN	_	5	PMOD
7	from	from	IN	_	3	ADV
8	six	six	CD	_	9	NMOD
9	species	specie	NNS	_	21	NMOD
10	in	in	IN	_	15	ADV
11	which	which	WDT	_	10	PMOD
12	it	it	PRP	_	13	SBJ
13	has	have	VBZ	_	9	NMOD
14	been	be	VBN	_	13	VC
15	found	find	VBN	_	14	VC
16	so	so	RB	_	17	AMOD
17	far	far	RB	_	15	TMP
18	(	(	-LRB-	_	21	P
19	human	human	JJ	_	21	NMOD
20	,	,	,	_	21	P
21	macaque	macaque	NN	_	7	PMOD
22	,	,	,	_	21	P
23	dog	dog	NN	_	21	CONJ
24	,	,	,	_	23	P
25	mouse	mouse	NN	_	23	CONJ
26	,	,	,	_	25	P
27	rat	rat	NN	_	25	CONJ
28	,	,	,	_	27	P
29	and	and	CC	_	27	COORD
30	cow	cow	NN	_	29	CONJ
31	)	)	-RRB-	_	3	P
32	.	.	.	_	3	P

1	The	the	DT	_	5	NMOD
2	full	full	JJ	_	4	NMOD
3	-	-	HYPH	_	2	P
4	length	length	NN	_	5	NMOD
5	enzymes	enzyme	NNS	_	6	SBJ
6	consist	consist	VBP	_	0	ROOT
7	of	of	IN	_	6	ADV
8	563	0	CD	_	10	NMOD
9	amino	amino	NN	_	10	NMOD
10	acids	acid	NNS	_	7	PMOD
11	arranged	arrange	VBN	_	10	NMOD
12	in	in	IN	_	11	MNR
13	a	a	DT	_	16	NMOD
14	single	single	JJ	_	16	NMOD
15	polypeptide	polypeptide	NN	_	16	NMOD
16	chain	chain	NN	_	12	PMOD
17	containing	contain	VBG	_	16	NMOD
18	both	both	CC	_	24	COORD
19	the	the	DT	_	20	NMOD
20	prosegment	prosegment	NN	_	17	OBJ
21	and	and	CC	_	20	COORD
22	the	the	DT	_	23	NMOD
23	catalytic	catalytic	JJ	_	21	CONJ
24	domain	domain	NN	_	23	NMOD
25	,	,	,	_	16	P
26	with	with	IN	_	16	NMOD
27	the	the	DT	_	28	NMOD
28	exception	exception	NN	_	26	PMOD
29	of	of	IN	_	28	NMOD
30	mouse	mouse	NN	_	31	NMOD
31	CLN2	cln0	NN	_	29	PMOD
32	that	that	WDT	_	33	SBJ
33	has	have	VBZ	_	31	NMOD
34	a	a	DT	_	36	NMOD
35	single	single	JJ	_	36	NMOD
36	deletion	deletion	NN	_	33	OBJ
37	in	in	IN	_	33	LOC
38	the	the	DT	_	39	NMOD
39	prosegment	prosegment	NN	_	37	PMOD
40	.	.	.	_	6	P

1	The	the	DT	_	4	NMOD
2	overall	overall	JJ	_	4	NMOD
3	sequence	sequence	NN	_	4	NMOD
4	identity	identity	NN	_	8	SBJ
5	for	for	IN	_	4	NMOD
6	these	these	DT	_	7	NMOD
7	enzymes	enzyme	NNS	_	5	PMOD
8	is	be	VBZ	_	0	ROOT
9	81	0	CD	_	10	NMOD
10	%	%	NN	_	8	PRD
11	,	,	,	_	8	P
12	whereas	whereas	IN	_	8	ADV
13	the	the	DT	_	14	NMOD
14	similarity	similarity	NN	_	15	SBJ
15	is	be	VBZ	_	12	SUB
16	92	0	CD	_	17	NMOD
17	%	%	NN	_	15	PRD
18	.	.	.	_	8	P

1	A	a	DT	_	3	NMOD
2	pairwise	pairwise	JJ	_	3	NMOD
3	comparison	comparison	NN	_	10	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	9	NMOD
6	human	human	JJ	_	9	NMOD
7	and	and	CC	_	6	COORD
8	mouse	mouse	NN	_	7	CONJ
9	enzymes	enzyme	NNS	_	4	PMOD
10	yields	yield	VBZ	_	0	ROOT
11	88	0	CD	_	12	NMOD
12	%	%	NN	_	13	NMOD
13	identity	identity	NN	_	10	OBJ
14	and	and	CC	_	13	COORD
15	94	0	CD	_	16	NMOD
16	%	%	NN	_	17	NMOD
17	similarity	similarity	NN	_	14	CONJ
18	,	,	,	_	13	P
19	considerably	considerably	RB	_	20	AMOD
20	higher	high	JJR	_	13	NMOD
21	than	than	IN	_	20	AMOD
22	the	the	DT	_	26	NMOD
23	median	median	JJ	_	26	NMOD
24	78.5	0	CD	_	25	NMOD
25	%	%	NN	_	26	NMOD
26	identity	identity	NN	_	21	PMOD
27	reported	report	VBN	_	26	NMOD
28	for	for	IN	_	27	ADV
29	all	all	DT	_	34	NMOD
30	identified	identify	VBN	_	34	NMOD
31	mouse	mouse	NN	_	34	NMOD
32	-	-	HYPH	_	31	P
33	human	human	JJ	_	31	DEP
34	orthologs	orthologs	NNS	_	28	PMOD
35	[	[	-LRB-	_	36	P
36	13	0	CD	_	10	PRN
37	]	]	-RRB-	_	36	P
38	.	.	.	_	10	P

1	Thus	thus	RB	_	5	ADV
2	,	,	,	_	5	P
3	mammalian	mammalian	JJ	_	4	NMOD
4	CLN2	cln0	NN	_	5	SBJ
5	appears	appear	VBZ	_	0	ROOT
6	to	to	TO	_	5	OPRD
7	be	be	VB	_	6	IM
8	a	a	DT	_	11	NMOD
9	highly	highly	RB	_	10	AMOD
10	conserved	conserve	VBN	_	11	NMOD
11	enzyme	enzyme	NN	_	7	PRD
12	.	.	.	_	5	P

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Sequence	sequence	NN	_	2	NMOD
2	comparisons	comparison	NNS	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	mammalian	mammalian	JJ	_	8	NMOD
5	CLN2	cln0	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	like	like	JJ	_	8	NMOD
8	enzymes	enzyme	NN	_	3	PMOD
9	.	.	.	_	2	P

1	These	these	DT	_	2	NMOD
2	sequences	sequence	NNS	_	3	SBJ
3	correspond	correspond	VBP	_	0	ROOT
4	to	to	IN	_	3	ADV
5	the	the	DT	_	7	NMOD
6	complete	complete	JJ	_	7	NMOD
7	enzymes	enzyme	NNS	_	4	PMOD
8	,	,	,	_	7	P
9	including	include	VBG	_	7	NMOD
10	the	the	DT	_	11	NMOD
11	prosegment	prosegment	NN	_	9	PMOD
12	.	.	.	_	3	P

1	Residues	residue	NNS	_	6	SBJ
2	forming	form	VBG	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	active	active	JJ	_	5	NMOD
5	site	site	NN	_	2	OBJ
6	are	be	VBP	_	0	ROOT
7	shown	show	VBN	_	6	VC
8	in	in	IN	_	7	ADV
9	yellow	yellow	NN	_	8	PMOD
10	on	on	IN	_	7	ADV
11	red	red	JJ	_	12	NMOD
12	background	background	NN	_	10	PMOD
13	,	,	,	_	6	P
14	other	other	JJ	_	16	NMOD
15	conserved	conserve	VBN	_	16	NMOD
16	residues	residue	NNS	_	26	SBJ
17	identified	identify	VBN	_	16	NMOD
18	as	as	IN	_	17	ADV
19	important	important	JJ	_	18	PMOD
20	for	for	IN	_	19	AMOD
21	the	the	DT	_	22	NMOD
22	stability	stability	NN	_	20	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	25	NMOD
25	enzyme	enzyme	NN	_	23	PMOD
26	are	be	VBP	_	6	CONJ
27	marked	mark	VBN	_	26	VC
28	with	with	IN	_	27	ADV
29	yellow	yellow	JJ	_	30	NMOD
30	background	background	NN	_	28	PMOD
31	,	,	,	_	26	P
32	residues	residue	NNS	_	41	SBJ
33	identical	identical	JJ	_	32	NMOD
34	in	in	IN	_	33	LOC
35	at	at	RB	_	36	QMOD
36	least	least	RBS	_	37	QMOD
37	5	0	CD	_	34	PMOD
38	of	of	IN	_	37	NMOD
39	the	the	DT	_	40	NMOD
40	structures	structure	NNS	_	38	PMOD
41	are	be	VBP	_	26	CONJ
42	green	green	JJ	_	41	PRD
43	,	,	,	_	41	P
44	and	and	CC	_	41	COORD
45	residues	residue	NNS	_	50	SBJ
46	similar	similar	JJ	_	45	NMOD
47	in	in	IN	_	46	AMOD
48	their	their	PRP$	_	49	NMOD
49	character	character	NN	_	47	PMOD
50	are	be	VBP	_	44	CONJ
51	shown	show	VBN	_	50	VC
52	in	in	IN	_	51	ADV
53	magenta	magenta	NN	_	52	PMOD
54	.	.	.	_	6	P

1	The	the	DT	_	4	NMOD
2	maturation	maturation	NN	_	4	NMOD
3	cleavage	cleavage	NN	_	4	NMOD
4	point	point	NN	_	13	SBJ
5	generating	generate	VBG	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	N	n	NN	_	8	NMOD
8	terminus	terminus	NN	_	5	OBJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	active	active	JJ	_	12	NMOD
12	enzyme	enzyme	NN	_	9	PMOD
13	is	be	VBZ	_	0	ROOT
14	marked	mark	VBN	_	13	VC
15	with	with	IN	_	14	MNR
16	black	black	JJ	_	17	NMOD
17	triangles	triangle	NNS	_	15	PMOD
18	.	.	.	_	13	P

1	In	in	IN	_	11	ADV
2	addition	addition	NN	_	1	PMOD
3	to	to	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	mammals	mammal	NNS	_	3	PMOD
6	,	,	,	_	11	P
7	CLN2	cln0	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	like	like	JJ	_	10	NMOD
10	enzymes	enzyme	NNS	_	11	SBJ
11	are	be	VBP	_	0	ROOT
12	also	also	RB	_	11	ADV
13	found	find	VBN	_	11	VC
14	in	in	IN	_	13	LOC
15	fugu	fugu	NN	_	19	NMOD
16	(	(	-LRB-	_	19	P
17	puffer	puffer	NN	_	18	NMOD
18	fish	fish	NN	_	19	NMOD
19	–	–	NN	_	14	PMOD
20	unannotated	unannotated	JJ	_	22	NMOD
21	record	record	NN	_	22	NMOD
22	SINFRUP00000077297	sinfrup0	NN	_	19	PRN
23	in	in	IN	_	22	NMOD
24	the	the	DT	_	28	NMOD
25	NCBI	ncbi	NNP	_	28	NMOD
26	fugu	fugu	NN	_	27	NMOD
27	sequence	sequence	NN	_	28	NMOD
28	database	database	NN	_	23	PMOD
29	,	,	,	_	22	P
30	)	)	-RRB-	_	22	P
31	and	and	CC	_	19	COORD
32	zebrafish	zebrafish	NN	_	31	CONJ
33	(	(	-LRB-	_	35	P
34	contig	contig	NN	_	35	NMOD
35	wz4596.2	wz0	NN	_	32	PRN
36	in	in	IN	_	35	NMOD
37	the	the	DT	_	40	NMOD
38	zebrafish	zebrafish	NN	_	40	NMOD
39	EST	est	NN	_	40	NMOD
40	database	database	NN	_	36	PMOD
41	,	,	,	_	35	P
42	)	)	-RRB-	_	35	P
43	.	.	.	_	11	P

1	Only	only	RB	_	3	NMOD
2	a	a	DT	_	3	NMOD
3	fragment	fragment	NN	_	11	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	sequence	sequence	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	10	NMOD
9	latter	latter	JJ	_	10	NMOD
10	enzyme	enzyme	NN	_	7	PMOD
11	agreed	agree	VBD	_	0	ROOT
12	with	with	IN	_	11	ADV
13	the	the	DT	_	14	NMOD
14	former	former	JJ	_	12	PMOD
15	.	.	.	_	11	P

1	However	however	RB	_	8	ADV
2	,	,	,	_	8	P
3	a	a	DT	_	7	NMOD
4	few	few	JJ	_	7	NMOD
5	comparatively	comparatively	RB	_	6	AMOD
6	minor	minor	JJ	_	7	NMOD
7	modifications	modification	NNS	_	8	SBJ
8	can	can	MD	_	0	ROOT
9	bring	bring	VB	_	8	VC
10	the	the	DT	_	12	NMOD
11	zebrafish	zebrafish	NN	_	12	NMOD
12	sequence	sequence	NN	_	9	OBJ
13	into	into	IN	_	9	ADV
14	good	good	JJ	_	15	NMOD
15	agreement	agreement	NN	_	13	PMOD
16	with	with	IN	_	15	NMOD
17	that	that	DT	_	16	PMOD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	fugu	fugu	NN	_	21	NMOD
21	CLN2	cln0	NN	_	18	PMOD
22	.	.	.	_	8	P

1	These	these	DT	_	2	NMOD
2	modifications	modification	NNS	_	3	SBJ
3	include	include	VBP	_	0	ROOT
4	a	a	DT	_	5	NMOD
5	deletion	deletion	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	a	a	DT	_	9	NMOD
8	single	single	JJ	_	9	NMOD
9	nucleotide	nucleotide	NN	_	6	PMOD
10	from	from	IN	_	5	NMOD
11	a	a	DT	_	12	NMOD
12	run	run	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	three	three	CD	_	13	PMOD
15	,	,	,	_	5	P
16	as	as	RB	_	18	ADV
17	well	well	RB	_	18	ADV
18	as	as	IN	_	5	COORD
19	three	three	CD	_	20	NMOD
20	insertions	insertion	NNS	_	18	CONJ
21	of	of	IN	_	20	NMOD
22	repeated	repeat	VBN	_	24	NMOD
23	nucleotide	nucleotide	NN	_	24	NMOD
24	pairs	pair	NNS	_	21	PMOD
25	(	(	-LRB-	_	26	P
26	Figure	figure	NN	_	3	PRN
27	2	0	CD	_	26	NMOD
28	)	)	-RRB-	_	26	P
29	.	.	.	_	3	P

1	It	it	PRP	_	2	SBJ
2	must	must	MD	_	24	DEP
3	be	be	VB	_	2	VC
4	stressed	stress	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	these	these	DT	_	7	NMOD
7	modifications	modification	NNS	_	8	SBJ
8	are	be	VBP	_	5	SUB
9	speculative	speculative	JJ	_	8	PRD
10	and	and	CC	_	8	COORD
11	may	may	MD	_	10	CONJ
12	lead	lead	VB	_	11	VC
13	to	to	IN	_	12	ADV
14	prediction	prediction	NN	_	13	PMOD
15	of	of	IN	_	14	NMOD
16	several	several	JJ	_	19	NMOD
17	incorrect	incorrect	JJ	_	19	NMOD
18	amino	amino	NN	_	19	NMOD
19	acids	acid	NNS	_	15	PMOD
20	;	;	:	_	24	P
21	however	however	RB	_	24	ADV
22	,	,	,	_	24	P
23	they	they	PRP	_	24	SBJ
24	bring	bring	VBP	_	0	ROOT
25	the	the	DT	_	27	NMOD
26	two	two	CD	_	27	NMOD
27	sequences	sequence	NNS	_	24	OBJ
28	into	into	IN	_	24	ADV
29	good	good	JJ	_	31	NMOD
30	global	global	JJ	_	31	NMOD
31	agreement	agreement	NN	_	35	NMOD
32	(	(	-LRB-	_	35	P
33	69	0	CD	_	34	NMOD
34	%	%	NN	_	35	NMOD
35	identities	identity	NNS	_	28	PMOD
36	and	and	CC	_	35	COORD
37	83	0	CD	_	38	NMOD
38	%	%	NN	_	39	NMOD
39	similarities	similarity	NNS	_	36	CONJ
40	)	)	-RRB-	_	24	P
41	.	.	.	_	24	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Corrected	correct	VBN	_	3	NMOD
2	gene	gene	NN	_	3	NMOD
3	sequence	sequence	NN	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	7	NMOD
6	zebrafish	zebrafish	NN	_	7	NMOD
7	CLN2	cln0	NN	_	4	PMOD
8	.	.	.	_	3	P

1	This	this	DT	_	3	NMOD
2	putative	putative	JJ	_	3	NMOD
3	sequence	sequence	NN	_	4	SBJ
4	shows	show	VBZ	_	0	ROOT
5	the	the	DT	_	7	NMOD
6	manual	manual	JJ	_	7	NMOD
7	corrections	correction	NNS	_	4	OBJ
8	that	that	WDT	_	9	SBJ
9	bring	bring	VBP	_	7	NMOD
10	it	it	PRP	_	9	OBJ
11	into	into	IN	_	9	ADV
12	alignment	alignment	NN	_	11	PMOD
13	with	with	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	sequence	sequence	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	fugu	fugu	NN	_	19	NMOD
19	enzyme	enzyme	NN	_	16	PMOD
20	.	.	.	_	4	P

1	Inserted	insert	VBN	_	2	NMOD
2	nucleotides	nucleotide	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	marked	mark	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	green	green	JJ	_	5	PMOD
7	and	and	CC	_	4	COORD
8	a	a	DT	_	10	NMOD
9	deleted	delete	VBN	_	10	NMOD
10	one	one	NN	_	7	GAP-SBJ
11	in	in	IN	_	10	ADV
12	red	red	NN	_	11	PMOD
13	.	.	.	_	3	P

1	The	the	DT	_	5	NMOD
2	available	available	JJ	_	5	NMOD
3	amino	amino	NN	_	4	NMOD
4	acid	acid	NN	_	5	NMOD
5	sequence	sequence	NN	_	22	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	10	NMOD
8	fugu	fugu	NN	_	9	NMOD
9	CLN2	cln0	NN	_	10	NMOD
10	analog	analog	NN	_	6	PMOD
11	,	,	,	_	5	P
12	named	name	VBN	_	5	NMOD
13	by	by	IN	_	12	LGS
14	us	us	PRP	_	13	PMOD
15	sedolisin	sedolisin	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	TPP	tpp	NN	_	12	OPRD
18	[	[	-LRB-	_	19	P
19	8	0	CD	_	12	PRN
20	]	]	-RRB-	_	19	P
21	,	,	,	_	22	P
22	is	be	VBZ	_	0	ROOT
23	also	also	RB	_	22	ADV
24	in	in	IN	_	22	PRD
25	good	good	JJ	_	26	NMOD
26	agreement	agreement	NN	_	24	PMOD
27	with	with	IN	_	26	NMOD
28	the	the	DT	_	29	NMOD
29	sequences	sequence	NNS	_	27	PMOD
30	of	of	IN	_	29	NMOD
31	the	the	DT	_	33	NMOD
32	mammalian	mammalian	JJ	_	33	NMOD
33	orthologs	orthologs	NNS	_	30	PMOD
34	(	(	-LRB-	_	35	P
35	Figure	figure	NN	_	22	PRN
36	3	0	CD	_	35	NMOD
37	)	)	-RRB-	_	35	P
38	.	.	.	_	22	P

1	The	the	DT	_	4	NMOD
2	only	only	JJ	_	4	NMOD
3	major	major	JJ	_	4	NMOD
4	difference	difference	NN	_	18	SBJ
5	in	in	IN	_	4	LOC
6	the	the	DT	_	10	NMOD
7	translated	translate	VBN	_	10	NMOD
8	amino	amino	NN	_	9	NMOD
9	acid	acid	NN	_	10	NMOD
10	sequence	sequence	NN	_	5	PMOD
11	compared	compare	VBN	_	10	NMOD
12	to	to	IN	_	11	PMOD
13	the	the	DT	_	17	NMOD
14	mammalian	mammalian	JJ	_	17	NMOD
15	and	and	CC	_	14	COORD
16	zebrafish	zebrafish	JJ	_	15	CONJ
17	enzymes	enzyme	NNS	_	12	PMOD
18	is	be	VBZ	_	0	ROOT
19	in	in	IN	_	18	LOC
20	the	the	DT	_	22	NMOD
21	amino	amino	NN	_	22	NMOD
22	terminus	terminus	NN	_	19	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	26	NMOD
25	propeptide	propeptide	NN	_	26	NMOD
26	region	region	NN	_	23	PMOD
27	that	that	WDT	_	28	SBJ
28	is	be	VBZ	_	26	NMOD
29	shorter	short	JJR	_	28	PRD
30	by	by	IN	_	28	ADV
31	30	0	CD	_	33	NMOD
32	amino	amino	NN	_	33	NMOD
33	acids	acid	NNS	_	30	PMOD
34	(	(	-LRB-	_	36	P
35	not	not	RB	_	36	ADV
36	shown	show	VBN	_	22	PRN
37	)	)	-RRB-	_	36	P
38	.	.	.	_	18	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	very	very	RB	_	4	AMOD
4	likely	likely	JJ	_	2	PRD
5	that	that	IN	_	2	OBJ
6	this	this	DT	_	7	SBJ
7	represents	represent	VBZ	_	5	SUB
8	a	a	DT	_	9	NMOD
9	fault	fault	NN	_	7	OBJ
10	in	in	IN	_	9	LOC
11	the	the	DT	_	13	NMOD
12	assembled	assemble	VBN	_	13	NMOD
13	sequence	sequence	NN	_	10	PMOD
14	rather	rather	RB	_	15	PMOD
15	than	than	IN	_	9	NMOD
16	a	a	DT	_	18	NMOD
17	real	real	JJ	_	18	NMOD
18	variation	variation	NN	_	15	PMOD
19	,	,	,	_	7	P
20	since	since	IN	_	7	PRP
21	the	the	DT	_	24	NMOD
22	current	current	JJ	_	24	NMOD
23	coding	code	VBG	_	24	NMOD
24	frame	frame	NN	_	25	SBJ
25	is	be	VBZ	_	20	SUB
26	not	not	RB	_	25	ADV
27	initiated	initiate	VBN	_	25	VC
28	with	with	IN	_	27	MNR
29	a	a	DT	_	30	NMOD
30	methionine	methionine	NN	_	28	PMOD
31	,	,	,	_	25	P
32	and	and	CC	_	25	COORD
33	a	a	DT	_	36	NMOD
34	few	few	JJ	_	36	NMOD
35	extra	extra	JJ	_	36	NMOD
36	residues	residue	NNS	_	37	SBJ
37	are	be	VBP	_	32	CONJ
38	present	present	JJ	_	37	PRD
39	in	in	IN	_	37	LOC
40	the	the	DT	_	43	NMOD
41	full	full	JJ	_	43	NMOD
42	genomic	genomic	JJ	_	43	NMOD
43	sequence	sequence	NN	_	39	PMOD
44	available	available	JJ	_	43	NMOD
45	from	from	IN	_	44	AMOD
46	the	the	DT	_	49	NMOD
47	fugu	fugu	NN	_	48	NMOD
48	sequencing	sequencing	NN	_	49	NMOD
49	consortium	consortium	NN	_	45	PMOD
50	.	.	.	_	2	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Sequences	sequence	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	catalytic	catalytic	JJ	_	5	NMOD
5	domains	domain	NNS	_	2	PMOD
6	of	of	IN	_	5	NMOD
7	CLN2	cln0	NN	_	6	PMOD
8	.	.	.	_	1	P

1	Complete	complete	JJ	_	2	NMOD
2	sequences	sequence	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	shown	show	VBN	_	3	VC
5	for	for	IN	_	4	ADV
6	CLN2	cln0	NN	_	5	PMOD
7	from	from	IN	_	6	NMOD
8	human	human	JJ	_	10	NMOD
9	,	,	,	_	10	P
10	fugu	fugu	NN	_	7	PMOD
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	zebrafish	zebrafish	NN	_	12	CONJ
14	,	,	,	_	4	P
15	together	together	RB	_	16	PMOD
16	with	with	IN	_	4	ADV
17	the	the	DT	_	19	NMOD
18	partial	partial	JJ	_	19	NMOD
19	sequence	sequence	NN	_	16	PMOD
20	of	of	IN	_	19	NMOD
21	putative	putative	JJ	_	22	NMOD
22	CLN2	cln0	NN	_	20	PMOD
23	in	in	IN	_	19	LOC
24	Xenopus	xenopus	NNP	_	25	NMOD
25	tropicalis	tropicalis	NNP	_	23	PMOD
26	.	.	.	_	3	P

1	Residues	residue	NNS	_	7	SBJ
2	identical	identical	JJ	_	1	NMOD
3	in	in	IN	_	2	AMOD
4	all	all	DT	_	6	NMOD
5	four	four	CD	_	6	NMOD
6	enzymes	enzyme	NNS	_	3	PMOD
7	are	be	VBP	_	0	ROOT
8	colored	color	VBN	_	7	VC
9	green	green	NN	_	8	OPRD
10	and	and	CC	_	7	COORD
11	those	those	DT	_	12	NMOD
12	similar	similar	JJ	_	13	SBJ
13	are	be	VBP	_	10	CONJ
14	colored	color	VBN	_	13	VC
15	magenta	magenta	NN	_	14	OPRD
16	.	.	.	_	7	P

1	Active	active	JJ	_	3	NMOD
2	site	site	NN	_	3	NMOD
3	residues	residue	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	marked	mark	VBN	_	4	VC
6	as	as	IN	_	5	MNR
7	in	in	IN	_	6	PMOD
8	Figure	figure	NN	_	7	PMOD
9	1	0	CD	_	8	NMOD
10	.	.	.	_	4	P

1	CLN2	cln0	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	present	present	JJ	_	2	PRD
4	not	not	RB	_	6	COORD
5	only	only	RB	_	4	ADV
6	in	in	IN	_	2	LOC
7	fish	fish	NNS	_	6	PMOD
8	,	,	,	_	6	P
9	but	but	CC	_	6	COORD
10	also	also	RB	_	9	ADV
11	in	in	IN	_	9	CONJ
12	amphibians	amphibian	NNS	_	11	PMOD
13	,	,	,	_	11	P
14	in	in	IN	_	16	PMOD
15	particular	particular	JJ	_	14	PMOD
16	in	in	IN	_	11	PMOD
17	Xenopus	xenopus	NNP	_	18	NMOD
18	tropicalis	tropicalis	NNP	_	21	NMOD
19	(	(	-LRB-	_	21	P
20	a	a	DT	_	21	NMOD
21	species	specie	NN	_	16	PMOD
22	of	of	IN	_	21	NMOD
23	frog	frog	NN	_	22	PMOD
24	)	)	-RRB-	_	2	P
25	.	.	.	_	2	P

1	A	a	DT	_	3	NMOD
2	partial	partial	JJ	_	3	NMOD
3	sequence	sequence	NN	_	17	SBJ
4	of	of	IN	_	3	NMOD
5	its	its	PRP$	_	8	NMOD
6	sedolisin	sedolisin	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	TPP	tpp	NN	_	10	NMOD
9	(	(	-LRB-	_	10	P
10	AL594774	al0	NN	_	4	PMOD
11	)	)	-RRB-	_	3	P
12	found	find	VBN	_	3	NMOD
13	in	in	IN	_	12	ADV
14	the	the	DT	_	16	NMOD
15	EST	est	NN	_	16	NMOD
16	database	database	NN	_	13	PMOD
17	spans	span	VBZ	_	0	ROOT
18	the	the	DT	_	20	NMOD
19	middle	middle	JJ	_	20	NMOD
20	part	part	NN	_	17	OBJ
21	of	of	IN	_	20	NMOD
22	the	the	DT	_	24	NMOD
23	catalytic	catalytic	JJ	_	24	NMOD
24	domain	domain	NN	_	21	PMOD
25	,	,	,	_	17	P
26	without	without	IN	_	17	ADV
27	reaching	reach	VBG	_	26	PMOD
28	the	the	DT	_	29	NMOD
29	part	part	NN	_	27	OBJ
30	of	of	IN	_	29	NMOD
31	the	the	DT	_	33	NMOD
32	active	active	JJ	_	33	NMOD
33	site	site	NN	_	30	PMOD
34	closer	closer	RBR	_	35	AMOD
35	to	to	IN	_	29	NMOD
36	the	the	DT	_	38	NMOD
37	N	n	NN	_	38	NMOD
38	terminus	terminus	NN	_	35	PMOD
39	that	that	WDT	_	40	SBJ
40	contains	contain	VBZ	_	29	NMOD
41	the	the	DT	_	45	NMOD
42	aspartic	aspartic	JJ	_	45	NMOD
43	and	and	CC	_	42	COORD
44	glutamic	glutamic	JJ	_	43	CONJ
45	acids	acid	NNS	_	40	OBJ
46	that	that	WDT	_	47	SBJ
47	belong	belong	VBP	_	45	NMOD
48	to	to	IN	_	47	ADV
49	the	the	DT	_	51	NMOD
50	catalytic	catalytic	JJ	_	51	NMOD
51	triad	triad	NN	_	48	PMOD
52	.	.	.	_	17	P

1	However	however	RB	_	9	ADV
2	,	,	,	_	9	P
3	the	the	DT	_	5	NMOD
4	sequenced	sequence	VBN	_	5	NMOD
5	part	part	NN	_	9	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	enzyme	enzyme	NN	_	6	PMOD
9	shows	show	VBZ	_	0	ROOT
10	75	0	CD	_	11	NMOD
11	%	%	NN	_	12	NMOD
12	identity	identity	NN	_	9	OBJ
13	with	with	IN	_	12	NMOD
14	the	the	DT	_	18	NMOD
15	fugu	fugu	NN	_	18	NMOD
16	sedolisin	sedolisin	NN	_	18	NMOD
17	-	-	HYPH	_	16	P
18	TPP	tpp	NN	_	13	PMOD
19	,	,	,	_	12	P
20	and	and	CC	_	12	COORD
21	69	0	CD	_	22	NMOD
22	%	%	NN	_	23	NMOD
23	identity	identity	NN	_	20	CONJ
24	with	with	IN	_	23	NMOD
25	human	human	JJ	_	26	NMOD
26	CLN2	cln0	NN	_	24	PMOD
27	(	(	-LRB-	_	28	P
28	Figure	figure	NN	_	9	PRN
29	3	0	CD	_	28	NMOD
30	)	)	-RRB-	_	28	P
31	.	.	.	_	9	P

1	Sequence	sequence	NN	_	2	NMOD
2	similarity	similarity	NN	_	8	SBJ
3	to	to	IN	_	2	NMOD
4	bacterial	bacterial	JJ	_	7	NMOD
5	or	or	CC	_	4	COORD
6	fungal	fungal	JJ	_	5	CONJ
7	sedolisins	sedolisins	NNS	_	3	PMOD
8	is	be	VBZ	_	0	ROOT
9	much	much	RB	_	10	AMOD
10	lower	low	JJR	_	8	PRD
11	,	,	,	_	8	P
12	indicating	indicate	VBG	_	8	ADV
13	that	that	IN	_	12	OBJ
14	the	the	DT	_	15	NMOD
15	enzyme	enzyme	NN	_	19	SBJ
16	found	find	VBN	_	15	NMOD
17	in	in	IN	_	16	LOC
18	frogs	frog	NNS	_	17	PMOD
19	might	might	MD	_	13	SUB
20	also	also	RB	_	19	ADV
21	share	share	VB	_	19	VC
22	the	the	DT	_	24	NMOD
23	functional	functional	JJ	_	24	NMOD
24	properties	property	NNS	_	21	OBJ
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	28	NMOD
27	CLN2	cln0	NN	_	28	NMOD
28	subfamily	subfamily	NN	_	25	PMOD
29	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	discovery	discovery	NN	_	24	SBJ
3	of	of	IN	_	2	NMOD
4	highly	highly	RB	_	5	AMOD
5	conserved	conserve	VBN	_	9	NMOD
6	CLN2	cln0	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	like	like	JJ	_	9	NMOD
9	enzymes	enzyme	NNS	_	3	PMOD
10	not	not	RB	_	12	COORD
11	only	only	RB	_	10	ADV
12	in	in	IN	_	2	LOC
13	mammals	mammal	NNS	_	12	PMOD
14	but	but	CC	_	12	COORD
15	also	also	RB	_	14	ADV
16	in	in	IN	_	14	CONJ
17	two	two	CD	_	19	NMOD
18	fish	fish	NN	_	19	NMOD
19	species	specie	NNS	_	16	PMOD
20	and	and	CC	_	19	COORD
21	one	one	CD	_	20	CONJ
22	of	of	IN	_	21	NMOD
23	frogs	frog	NNS	_	22	PMOD
24	may	may	MD	_	0	ROOT
25	indicate	indicate	VB	_	24	VC
26	that	that	IN	_	25	OBJ
27	these	these	DT	_	28	NMOD
28	peptidases	peptidase	NNS	_	29	SBJ
29	are	be	VBP	_	26	SUB
30	universally	universally	RB	_	29	ADV
31	present	present	JJ	_	29	PRD
32	in	in	IN	_	29	LOC
33	the	the	DT	_	34	NMOD
34	vertebrates	vertebrate	NNS	_	32	PMOD
35	,	,	,	_	26	P
36	and	and	CC	_	26	COORD
37	that	that	IN	_	36	CONJ
38	their	their	PRP$	_	40	NMOD
39	important	important	JJ	_	40	NMOD
40	role	role	NN	_	52	SBJ
41	identified	identify	VBN	_	40	NMOD
42	in	in	IN	_	41	LOC
43	humans	human	NNS	_	42	PMOD
44	[	[	-LRB-	_	45	P
45	2	0	CD	_	43	PRN
46	]	]	-RRB-	_	45	P
47	and	and	CC	_	43	COORD
48	mice	mouse	NNS	_	47	CONJ
49	[	[	-LRB-	_	50	P
50	14	0	CD	_	48	PRN
51	]	]	-RRB-	_	50	P
52	might	might	MD	_	37	SUB
53	be	be	VB	_	52	VC
54	a	a	DT	_	57	NMOD
55	more	more	RBR	_	56	AMOD
56	general	general	JJ	_	57	NMOD
57	feature	feature	NN	_	53	PRD
58	.	.	.	_	24	P

1	Modeling	modeling	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	structure	structure	NN	_	2	PMOD
5	of	of	IN	_	4	NMOD
6	human	human	JJ	_	7	NMOD
7	CLN2	cln0	NN	_	5	PMOD

1	The	the	DT	_	3	NMOD
2	medical	medical	JJ	_	3	NMOD
3	importance	importance	NN	_	13	SBJ
4	of	of	IN	_	3	NMOD
5	CLN2	cln0	NN	_	4	PMOD
6	and	and	CC	_	3	COORD
7	the	the	DT	_	8	NMOD
8	lack	lack	NN	_	6	CONJ
9	of	of	IN	_	8	NMOD
10	a	a	DT	_	12	NMOD
11	crystal	crystal	JJ	_	12	NMOD
12	structure	structure	NN	_	9	PMOD
13	inspired	inspire	VBD	_	0	ROOT
14	attempts	attempt	NNS	_	13	OBJ
15	at	at	IN	_	14	NMOD
16	protein	protein	NN	_	17	NMOD
17	modeling	modeling	NN	_	15	PMOD
18	.	.	.	_	13	P

1	The	the	DT	_	4	NMOD
2	first	$#ORD#$	JJ	_	4	NMOD
3	such	such	JJ	_	4	NMOD
4	model	model	NN	_	5	SBJ
5	assumed	assume	VBD	_	0	ROOT
6	that	that	IN	_	5	OBJ
7	this	this	DT	_	8	NMOD
8	enzyme	enzyme	NN	_	9	SBJ
9	is	be	VBZ	_	6	SUB
10	membrane	membrane	NN	_	12	AMOD
11	-	-	HYPH	_	10	P
12	bound	bind	VBN	_	9	PRD
13	,	,	,	_	9	P
14	with	with	IN	_	9	ADV
15	the	the	DT	_	16	NMOD
16	sequence	sequence	NN	_	17	NMOD
17	271	0	CD	_	31	SBJ
18	–	–	SYM	_	19	P
19	294	0	CD	_	17	NMOD
20	(	(	-LRB-	_	28	P
21	numbering	numbering	NN	_	28	DEP
22	corresponding	correspond	VBG	_	21	NMOD
23	to	to	IN	_	22	ADV
24	the	the	DT	_	26	NMOD
25	mature	mature	JJ	_	26	NMOD
26	enzyme	enzyme	NN	_	23	PMOD
27	,	,	,	_	28	P
28	Figure	figure	NN	_	17	PRN
29	1	0	CD	_	28	NMOD
30	)	)	-RRB-	_	28	P
31	forming	form	VBG	_	14	PMOD
32	the	the	DT	_	35	NMOD
33	putative	putative	JJ	_	35	NMOD
34	transmembrane	transmembrane	JJ	_	35	NMOD
35	anchor	anchor	NN	_	31	OBJ
36	[	[	-LRB-	_	37	P
37	15	0	CD	_	9	PRN
38	]	]	-RRB-	_	37	P
39	.	.	.	_	5	P

1	However	however	RB	_	20	ADV
2	,	,	,	_	20	P
3	in	in	IN	_	20	ADV
4	view	view	NN	_	3	PMOD
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	9	NMOD
7	subsequently	subsequently	RB	_	8	AMOD
8	obtained	obtain	VBN	_	9	NMOD
9	structures	structure	NNS	_	5	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	16	NMOD
12	fully	fully	RB	_	16	NMOD
13	water	water	NN	_	15	AMOD
14	-	-	HYPH	_	13	P
15	soluble	soluble	JJ	_	16	NMOD
16	sedolisins	sedolisins	NNS	_	10	PMOD
17	,	,	,	_	20	P
18	this	this	DT	_	19	NMOD
19	model	model	NN	_	20	SBJ
20	was	be	VBD	_	0	ROOT
21	clearly	clearly	RB	_	20	ADV
22	incorrect	incorrect	JJ	_	20	PRD
23	.	.	.	_	20	P

1	Exploiting	exploit	VBG	_	18	ADV
2	the	the	DT	_	4	NMOD
3	sequence	sequence	NN	_	4	NMOD
4	similarity	similarity	NN	_	1	OBJ
5	between	between	IN	_	4	NMOD
6	CLN2	cln0	NN	_	5	PMOD
7	,	,	,	_	6	P
8	sedolisin	sedolisin	NN	_	6	CONJ
9	,	,	,	_	8	P
10	and	and	CC	_	8	COORD
11	kumamolisin	kumamolisin	NN	_	10	CONJ
12	(	(	-LRB-	_	13	P
13	Figure	figure	NN	_	1	PRN
14	4	0	CD	_	13	NMOD
15	)	)	-RRB-	_	13	P
16	,	,	,	_	18	P
17	we	we	PRP	_	18	SBJ
18	have	have	VBP	_	0	ROOT
19	now	now	RB	_	18	TMP
20	used	use	VBN	_	18	VC
21	the	the	DT	_	24	NMOD
22	experimentally	experimentally	RB	_	23	AMOD
23	obtained	obtain	VBN	_	24	NMOD
24	structures	structure	NNS	_	20	OBJ
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	29	NMOD
27	latter	latter	JJ	_	29	NMOD
28	two	two	CD	_	29	NMOD
29	enzymes	enzyme	NNS	_	25	PMOD
30	to	to	TO	_	20	PRP
31	form	form	VB	_	30	IM
32	a	a	DT	_	38	NMOD
33	new	new	JJ	_	38	NMOD
34	,	,	,	_	38	P
35	homology	homology	NN	_	37	AMOD
36	-	-	HYPH	_	35	P
37	derived	derive	VBN	_	38	NMOD
38	model	model	NN	_	31	OBJ
39	of	of	IN	_	38	NMOD
40	human	human	JJ	_	41	NMOD
41	CLN2	cln0	NN	_	39	PMOD
42	.	.	.	_	18	P

1	The	the	DT	_	3	NMOD
2	primary	primary	JJ	_	3	NMOD
3	basis	base	NN	_	8	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	7	NMOD
6	homology	homology	NN	_	7	NMOD
7	model	model	NN	_	4	PMOD
8	was	be	VBD	_	0	ROOT
9	the	the	DT	_	10	NMOD
10	structure	structure	NN	_	8	PRD
11	of	of	IN	_	10	NMOD
12	a	a	DT	_	13	NMOD
13	complex	complex	NN	_	11	PMOD
14	of	of	IN	_	13	NMOD
15	sedolisin	sedolisin	NN	_	14	PMOD
16	with	with	IN	_	15	NMOD
17	a	a	DT	_	21	NMOD
18	covalently	covalently	RB	_	20	AMOD
19	-	-	HYPH	_	18	P
20	bound	bound	JJ	_	21	NMOD
21	inhibitor	inhibitor	NN	_	16	PMOD
22	,	,	,	_	21	P
23	pseudo-iodotyrostatin	pseudo-iodotyrostatin	NN	_	21	APPO
24	.	.	.	_	8	P

1	Although	although	IN	_	30	ADV
2	it	it	PRP	_	3	SBJ
3	has	have	VBZ	_	1	SUB
4	not	not	RB	_	3	ADV
5	been	be	VBN	_	3	VC
6	directly	directly	RB	_	5	ADV
7	shown	show	VBN	_	5	VC
8	that	that	IN	_	7	OBJ
9	this	this	DT	_	10	NMOD
10	compound	compound	NN	_	11	SBJ
11	can	can	MD	_	8	SUB
12	inhibit	inhibit	VB	_	11	VC
13	human	human	JJ	_	14	NMOD
14	CLN2	cln0	NN	_	12	OBJ
15	,	,	,	_	30	P
16	other	other	JJ	_	18	NMOD
17	similar	similar	JJ	_	18	NMOD
18	peptides	peptide	NNS	_	30	SBJ
19	with	with	IN	_	18	NMOD
20	an	an	DT	_	22	NMOD
21	aldehyde	aldehyde	NN	_	22	NMOD
22	functionality	functionality	NN	_	19	PMOD
23	on	on	IN	_	22	NMOD
24	their	their	PRP$	_	28	NMOD
25	``	``	``	_	28	P
26	C	c	NNP	_	28	NMOD
27	-	-	HYPH	_	26	P
28	termini	terminus	NNP	_	23	PMOD
29	''	''	''	_	30	P
30	are	be	VBP	_	0	ROOT
31	weak	weak	JJ	_	36	NMOD
32	,	,	,	_	31	P
33	but	but	CC	_	31	COORD
34	detectable	detectable	JJ	_	33	CONJ
35	,	,	,	_	36	P
36	inhibitors	inhibitor	NNS	_	30	PRD
37	of	of	IN	_	36	NMOD
38	this	this	DT	_	39	NMOD
39	enzyme	enzyme	NN	_	37	PMOD
40	(	(	-LRB-	_	41	P
41	Oda	oda	NNP	_	30	CIT
42	,	,	,	_	41	P
43	unpublished	unpublished	JJ	_	41	DEP
44	)	)	-RRB-	_	41	P
45	.	.	.	_	30	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	thus	thus	RB	_	2	ADV
4	likely	likely	JJ	_	2	PRD
5	that	that	IN	_	2	OBJ
6	pseudo-iodotyrostatin	pseudo-iodotyrostatin	NN	_	11	SBJ
7	or	or	CC	_	6	COORD
8	a	a	DT	_	10	NMOD
9	similar	similar	JJ	_	10	NMOD
10	inhibitor	inhibitor	NN	_	7	CONJ
11	might	might	MD	_	5	SUB
12	work	work	VB	_	11	VC
13	for	for	IN	_	12	ADV
14	CLN2	cln0	NN	_	13	PMOD
15	as	as	RB	_	16	AMOD
16	well	well	RB	_	12	ADV
17	,	,	,	_	12	P
18	although	although	IN	_	12	ADV
19	the	the	DT	_	21	NMOD
20	actual	actual	JJ	_	21	NMOD
21	contacts	contact	NNS	_	34	SBJ
22	between	between	IN	_	21	NMOD
23	the	the	DT	_	24	NMOD
24	inhibitor	inhibitor	NN	_	22	PMOD
25	and	and	CC	_	24	COORD
26	the	the	DT	_	27	NMOD
27	enzyme	enzyme	NN	_	25	CONJ
28	that	that	WDT	_	29	SBJ
29	are	be	VBP	_	21	NMOD
30	seen	see	VBN	_	29	VC
31	in	in	IN	_	30	ADV
32	the	the	DT	_	33	NMOD
33	model	model	NN	_	31	PMOD
34	have	have	VB	_	18	SUB
35	to	to	TO	_	34	OPRD
36	be	be	VB	_	35	IM
37	treated	treat	VBN	_	36	VC
38	with	with	IN	_	37	MNR
39	caution	caution	NN	_	38	PMOD
40	.	.	.	_	2	P

1	Another	another	DT	_	2	NMOD
2	reason	reason	NN	_	10	SBJ
3	for	for	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	modeling	modeling	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	a	a	DT	_	9	NMOD
8	pseudo-iodotyrostatin	pseudo-iodotyrostatin	NN	_	9	NMOD
9	complex	complex	NN	_	6	PMOD
10	is	be	VBZ	_	0	ROOT
11	that	that	IN	_	10	PRD
12	CLN2	cln0	NN	_	13	SBJ
13	is	be	VBZ	_	11	SUB
14	a	a	DT	_	15	NMOD
15	tripeptidase	tripeptidase	NN	_	13	PRD
16	,	,	,	_	11	P
17	and	and	CC	_	11	COORD
18	that	that	IN	_	17	CONJ
19	this	this	DT	_	20	NMOD
20	inhibitor	inhibitor	NN	_	18	SUB
21	it	it	PRP	_	22	SBJ
22	represents	represent	VBZ	_	20	NMOD
23	the	the	DT	_	26	NMOD
24	only	only	RB	_	26	NMOD
25	experimental	experimental	JJ	_	26	NMOD
26	structure	structure	NN	_	20	OPRD
27	of	of	IN	_	26	NMOD
28	a	a	DT	_	30	NMOD
29	tripeptide	tripeptide	NN	_	30	NMOD
30	analog	analog	NN	_	27	PMOD
31	bound	bind	VBN	_	30	NMOD
32	to	to	IN	_	31	ADV
33	sedolisin	sedolisin	NN	_	32	PMOD
34	.	.	.	_	10	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Sequence	sequence	NN	_	2	NMOD
2	alignment	alignment	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	bacterial	bacterial	JJ	_	7	NMOD
5	and	and	CC	_	4	COORD
6	mammalian	mammalian	JJ	_	5	CONJ
7	enzymes	enzyme	NNS	_	3	PMOD
8	.	.	.	_	2	P

1	Alignment	alignment	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	sequences	sequence	NNS	_	2	PMOD
5	of	of	IN	_	4	NMOD
6	sedolisin	sedolisin	NN	_	5	PMOD
7	,	,	,	_	6	P
8	kumamolisin	kumamolisin	NN	_	6	CONJ
9	,	,	,	_	8	P
10	and	and	CC	_	8	COORD
11	human	human	JJ	_	12	NMOD
12	CLN2	cln0	NN	_	10	CONJ
13	used	use	VBN	_	4	NMOD
14	in	in	IN	_	13	PRP
15	the	the	DT	_	16	NMOD
16	construction	construction	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	19	NMOD
19	model	model	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	the	the	DT	_	23	NMOD
22	latter	latter	JJ	_	23	NMOD
23	enzyme	enzyme	NN	_	20	PMOD
24	.	.	.	_	1	P

1	The	the	DT	_	3	NMOD
2	colors	color	NNS	_	3	NMOD
3	scheme	scheme	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	same	same	JJ	_	4	PRD
7	as	as	IN	_	6	NMOD
8	in	in	IN	_	7	PMOD
9	Figure	figure	NN	_	8	PMOD
10	2	0	CD	_	9	NMOD
11	.	.	.	_	4	P

1	The	the	DT	_	3	NMOD
2	r.m.s.	r.m.s.	NN	_	3	NMOD
3	deviation	deviation	NN	_	24	SBJ
4	between	between	IN	_	3	NMOD
5	the	the	DT	_	8	NMOD
6	corresponding	correspond	VBG	_	8	NMOD
7	Cα	cα	NN	_	8	NMOD
8	coordinates	coordinate	NNS	_	4	PMOD
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	11	NMOD
11	model	model	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	CLN2	cln0	NN	_	12	PMOD
14	(	(	-LRB-	_	15	P
15	Figure	figure	NN	_	11	PRN
16	5	0	CD	_	15	NMOD
17	)	)	-RRB-	_	15	P
18	and	and	CC	_	8	COORD
19	the	the	DT	_	21	NMOD
20	experimental	experimental	JJ	_	21	NMOD
21	structure	structure	NN	_	18	CONJ
22	of	of	IN	_	21	NMOD
23	sedolisin	sedolisin	NN	_	22	PMOD
24	is	be	VBZ	_	0	ROOT
25	about	about	RB	_	26	QMOD
26	1.75	0	CD	_	24	PRD
27	Å	å	SYM	_	26	P
28	,	,	,	_	26	P
29	not	not	RB	_	31	ADV
30	much	much	RB	_	31	AMOD
31	larger	large	JJR	_	26	NMOD
32	than	than	IN	_	31	AMOD
33	the	the	DT	_	35	NMOD
34	experimental	experimental	JJ	_	35	NMOD
35	difference	difference	NN	_	32	PMOD
36	between	between	IN	_	35	NMOD
37	sedolisin	sedolisin	NN	_	36	PMOD
38	and	and	CC	_	37	COORD
39	kumamolisin	kumamolisin	NN	_	38	CONJ
40	.	.	.	_	24	P

1	Interestingly	interestingly	RB	_	11	ADV
2	,	,	,	_	11	P
3	the	the	DT	_	7	NMOD
4	Cys327	cys0	NN	_	7	NMOD
5	and	and	CC	_	4	COORD
6	Cys342	cys0	NN	_	5	CONJ
7	residues	residue	NNS	_	11	SBJ
8	in	in	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	model	model	NN	_	8	PMOD
11	were	be	VBD	_	0	ROOT
12	found	find	VBN	_	11	VC
13	to	to	TO	_	12	OPRD
14	be	be	VB	_	13	IM
15	ideally	ideally	RB	_	14	ADV
16	positioned	position	VBN	_	14	VC
17	to	to	TO	_	16	PRP
18	form	form	VB	_	17	IM
19	a	a	DT	_	21	NMOD
20	disulfide	disulfide	NN	_	21	NMOD
21	bond	bond	NN	_	18	OBJ
22	even	even	RB	_	23	ADV
23	though	though	IN	_	16	ADV
24	this	this	DT	_	25	SBJ
25	was	be	VBD	_	23	SUB
26	not	not	RB	_	25	ADV
27	part	part	NN	_	25	PRD
28	of	of	IN	_	27	NMOD
29	the	the	DT	_	31	NMOD
30	design	design	NN	_	31	NMOD
31	strategy	strategy	NN	_	28	PMOD
32	.	.	.	_	11	P

1	That	that	IN	_	10	SBJ
2	this	this	DT	_	3	NMOD
3	bond	bond	NN	_	5	SBJ
4	likely	likely	RB	_	5	ADV
5	occurs	occur	VBZ	_	1	SUB
6	in	in	IN	_	5	LOC
7	the	the	DT	_	9	NMOD
8	real	real	JJ	_	9	NMOD
9	protein	protein	NN	_	6	PMOD
10	is	be	VBZ	_	0	ROOT
11	suggested	suggest	VBN	_	10	VC
12	by	by	IN	_	11	LGS
13	the	the	DT	_	14	NMOD
14	fact	fact	NN	_	12	PMOD
15	that	that	IN	_	14	NMOD
16	these	these	DT	_	18	NMOD
17	two	two	CD	_	18	NMOD
18	cysteines	cysteine	NNS	_	19	SBJ
19	are	be	VBP	_	15	SUB
20	strictly	strictly	RB	_	19	ADV
21	conserved	conserve	VBN	_	19	VC
22	in	in	IN	_	21	LOC
23	all	all	DT	_	26	NMOD
24	known	know	VBN	_	26	NMOD
25	animal	animal	NN	_	26	NMOD
26	species	specie	NNS	_	22	PMOD
27	of	of	IN	_	26	NMOD
28	CLN2	cln0	NN	_	27	PMOD
29	(	(	-LRB-	_	31	P
30	Figures	figure	NNS	_	31	NMOD
31	1	0	CD	_	21	PRN
32	and	and	CC	_	31	COORD
33	3	0	CD	_	32	CONJ
34	)	)	-RRB-	_	31	P
35	,	,	,	_	21	P
36	although	although	IN	_	21	ADV
37	they	they	PRP	_	38	SBJ
38	are	be	VBP	_	36	SUB
39	absent	absent	JJ	_	38	PRD
40	in	in	IN	_	38	LOC
41	all	all	DT	_	43	NMOD
42	known	know	VBN	_	43	NMOD
43	sequences	sequence	NNS	_	40	PMOD
44	of	of	IN	_	43	NMOD
45	bacterial	bacterial	JJ	_	46	NMOD
46	sedolisins	sedolisins	NNS	_	44	PMOD
47	.	.	.	_	10	P

1	Thus	thus	RB	_	14	ADV
2	,	,	,	_	14	P
3	if	if	IN	_	14	ADV
4	this	this	DT	_	5	NMOD
5	disulfide	disulfide	NN	_	6	SBJ
6	were	be	VBD	_	3	SUB
7	experimentally	experimentally	RB	_	6	ADV
8	found	find	VBN	_	6	VC
9	to	to	TO	_	8	OPRD
10	exist	exist	VB	_	9	IM
11	in	in	IN	_	10	LOC
12	CLN2	cln0	NN	_	11	PMOD
13	it	it	PRP	_	14	SBJ
14	would	would	MD	_	0	ROOT
15	provide	provide	VB	_	14	VC
16	support	support	NN	_	15	OBJ
17	for	for	IN	_	16	NMOD
18	the	the	DT	_	19	NMOD
19	correctness	correctness	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	the	the	DT	_	22	NMOD
22	model	model	NN	_	20	PMOD
23	.	.	.	_	14	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	A	a	DT	_	5	NMOD
2	homology	homology	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	derived	derive	VBN	_	5	NMOD
5	model	model	NN	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	human	human	JJ	_	8	NMOD
8	CLN2	cln0	NN	_	6	PMOD
9	.	.	.	_	5	P

1	Ribbon	ribbon	NN	_	2	NMOD
2	diagram	diagram	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	Cα	cα	NN	_	6	NMOD
6	trace	trace	NN	_	3	PMOD
7	of	of	IN	_	6	NMOD
8	CLN2	cln0	NN	_	7	PMOD
9	,	,	,	_	2	P
10	with	with	IN	_	2	ADV
11	the	the	DT	_	12	NMOD
12	segments	segment	NNS	_	33	SBJ
13	that	that	WDT	_	14	SBJ
14	were	be	VBD	_	12	NMOD
15	modeled	model	VBN	_	14	VC
16	based	base	VBN	_	15	ADV
17	on	on	IN	_	16	PMOD
18	the	the	DT	_	21	NMOD
19	highly	highly	RB	_	20	AMOD
20	conserved	conserve	VBN	_	21	NMOD
21	core	core	NN	_	17	PMOD
22	of	of	IN	_	21	NMOD
23	sedolisin	sedolisin	NN	_	22	PMOD
24	and	and	CC	_	23	COORD
25	kumamolisin	kumamolisin	NN	_	24	CONJ
26	(	(	-LRB-	_	28	P
27	r.m.s.	r.m.s.	NN	_	28	NMOD
28	deviation	deviation	NN	_	21	PRN
29	of	of	IN	_	28	NMOD
30	1	0	CD	_	31	NMOD
31	Å	å	NN	_	29	PMOD
32	)	)	-RRB-	_	28	P
33	colored	color	VBN	_	10	SUB
34	in	in	IN	_	33	ADV
35	red	red	NN	_	34	PMOD
36	.	.	.	_	2	P

1	Side	side	NN	_	2	NMOD
2	chains	chain	NNS	_	29	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	residues	residue	NNS	_	3	PMOD
6	that	that	WDT	_	7	SBJ
7	were	be	VBD	_	2	NMOD
8	found	find	VBN	_	7	VC
9	to	to	TO	_	8	OPRD
10	be	be	VB	_	9	IM
11	mutated	mutated	JJ	_	10	PRD
12	in	in	IN	_	10	LOC
13	the	the	DT	_	14	NMOD
14	genes	gene	NNS	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	families	family	NNS	_	15	PMOD
17	of	of	IN	_	16	NMOD
18	patients	patient	NNS	_	17	PMOD
19	with	with	IN	_	18	NMOD
20	late	late	JJ	_	22	AMOD
21	-	-	HYPH	_	20	P
22	infantile	infantile	JJ	_	25	NMOD
23	neuronal	neuronal	JJ	_	25	NMOD
24	ceroid	ceroid	NN	_	25	NMOD
25	lipofuscinosis	lipofuscinosis	NN	_	19	PMOD
26	[	[	-LRB-	_	27	P
27	17	0	CD	_	8	PRN
28	]	]	-RRB-	_	27	P
29	are	be	VBP	_	0	ROOT
30	marked	mark	VBN	_	29	VC
31	in	in	IN	_	30	ADV
32	ball	ball	NN	_	31	PMOD
33	-	-	HYPH	_	32	P
34	and	and	CC	_	32	COORD
35	-	-	HYPH	_	36	P
36	stick	stick	NN	_	34	CONJ
37	.	.	.	_	29	P

1	Comparisons	comparison	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	6	NMOD
4	substrate	substrate	NN	_	5	AMOD
5	binding	bind	VBG	_	6	NMOD
6	pockets	pocket	NNS	_	2	PMOD
7	of	of	IN	_	6	NMOD
8	CLN2	cln0	NN	_	7	PMOD
9	and	and	CC	_	8	COORD
10	sedolisin	sedolisin	NN	_	9	CONJ

1	Since	since	IN	_	15	PRP
2	the	the	DT	_	5	NMOD
3	principal	principal	JJ	_	5	NMOD
4	known	known	JJ	_	5	NMOD
5	activity	activity	NN	_	8	SBJ
6	of	of	IN	_	5	NMOD
7	CLN2	cln0	NN	_	6	PMOD
8	is	be	VBZ	_	1	SUB
9	that	that	DT	_	8	PRD
10	of	of	IN	_	9	NMOD
11	a	a	DT	_	12	NMOD
12	tripeptidase	tripeptidase	NN	_	10	PMOD
13	,	,	,	_	15	P
14	it	it	PRP	_	15	SBJ
15	is	be	VBZ	_	0	ROOT
16	expected	expect	VBN	_	15	VC
17	that	that	IN	_	16	OBJ
18	three	three	CD	_	22	NMOD
19	substrate	substrate	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	binding	bind	VBG	_	22	NMOD
22	pockets	pocket	NNS	_	40	SBJ
23	,	,	,	_	22	P
24	S1	s0	NN	_	22	APPO
25	through	through	IN	_	24	NMOD
26	S3	s0	NN	_	25	PMOD
27	(	(	-LRB-	_	28	P
28	using	use	VBG	_	24	PRN
29	the	the	DT	_	30	NMOD
30	nomenclature	nomenclature	NN	_	28	OBJ
31	of	of	IN	_	30	NMOD
32	Schechter	schechter	NNP	_	31	PMOD
33	and	and	CC	_	32	COORD
34	Berger	berger	NNP	_	33	CONJ
35	[	[	-LRB-	_	36	P
36	16	0	CD	_	28	PRN
37	]	]	-RRB-	_	36	P
38	)	)	-RRB-	_	28	P
39	,	,	,	_	40	P
40	should	should	MD	_	17	SUB
41	be	be	VB	_	40	VC
42	discernible	discernible	JJ	_	41	PRD
43	.	.	.	_	15	P

1	Residues	residue	NNS	_	2	NMOD
2	P1	p0	NN	_	13	SBJ
3	-	-	SYM	_	4	P
4	P3	p0	NN	_	2	NMOD
5	of	of	IN	_	2	NMOD
6	the	the	DT	_	7	NMOD
7	inhibitor	inhibitor	NN	_	5	PMOD
8	that	that	WDT	_	9	SBJ
9	should	should	MD	_	7	NMOD
10	occupy	occupy	VB	_	9	VC
11	these	these	DT	_	12	NMOD
12	pockets	pocket	NNS	_	10	OBJ
13	are	be	VBP	_	0	ROOT
14	shown	show	VBN	_	13	VC
15	in	in	IN	_	14	ADV
16	Figure	figure	NN	_	15	PMOD
17	6	0	CD	_	16	NMOD
18	.	.	.	_	13	P

1	All	all	PDT	_	4	NMOD
2	the	the	DT	_	4	NMOD
3	available	available	JJ	_	4	NMOD
4	structures	structure	NNS	_	15	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	complexes	complex	NNS	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	either	either	CC	_	10	COORD
10	sedolisin	sedolisin	NN	_	8	PMOD
11	or	or	CC	_	10	COORD
12	kumamolisin	kumamolisin	NN	_	11	CONJ
13	with	with	IN	_	7	NMOD
14	inhibitors	inhibitor	NNS	_	13	PMOD
15	contain	contain	VBP	_	0	ROOT
16	either	either	CC	_	18	COORD
17	a	a	DT	_	18	NMOD
18	tyrosine	tyrosine	NN	_	15	OBJ
19	or	or	CC	_	18	COORD
20	a	a	DT	_	21	NMOD
21	phenylalanine	phenylalanine	NN	_	19	CONJ
22	occupying	occupy	VBG	_	18	NMOD
23	the	the	DT	_	25	NMOD
24	S1	s0	NN	_	25	NMOD
25	pocket	pocket	NN	_	22	OBJ
26	.	.	.	_	15	P

1	Parts	part	NNS	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	this	this	DT	_	4	NMOD
4	pocket	pocket	NN	_	2	PMOD
5	are	be	VBP	_	0	ROOT
6	fully	fully	RB	_	5	ADV
7	conserved	conserve	VBN	_	5	VC
8	among	among	IN	_	7	ADV
9	different	different	JJ	_	10	NMOD
10	sedolisins	sedolisins	NNS	_	8	PMOD
11	,	,	,	_	7	P
12	whereas	whereas	IN	_	7	ADV
13	other	other	JJ	_	14	NMOD
14	parts	part	NNS	_	17	SBJ
15	of	of	IN	_	14	NMOD
16	it	it	PRP	_	15	PMOD
17	differ	differ	VBP	_	12	SUB
18	.	.	.	_	5	P

1	The	the	DT	_	5	NMOD
2	right	right	JJ	_	4	NMOD
3	-	-	HYPH	_	2	P
4	hand	hand	NN	_	5	NMOD
5	side	side	NN	_	18	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	pocket	pocket	NN	_	6	PMOD
9	(	(	-LRB-	_	5	P
10	in	in	IN	_	5	NMOD
11	the	the	DT	_	12	NMOD
12	view	view	NN	_	10	PMOD
13	used	use	VBN	_	12	NMOD
14	in	in	IN	_	13	ADV
15	Figure	figure	NN	_	14	PMOD
16	6	0	CD	_	15	NMOD
17	)	)	-RRB-	_	18	P
18	is	be	VBZ	_	0	ROOT
19	made	make	VBN	_	18	VC
20	of	of	IN	_	19	ADV
21	the	the	DT	_	23	NMOD
22	main	main	JJ	_	23	NMOD
23	chain	chain	NN	_	20	PMOD
24	including	include	VBG	_	23	NMOD
25	residues	residue	NNS	_	26	NMOD
26	164	0	CD	_	24	PMOD
27	–	–	SYM	_	28	P
28	165	0	CD	_	26	NMOD
29	(	(	-LRB-	_	36	P
30	unless	unless	IN	_	36	ADV
31	otherwise	otherwise	RB	_	32	ADV
32	indicated	indicate	VBN	_	30	SUB
33	,	,	,	_	36	P
34	the	the	DT	_	35	NMOD
35	numbering	numbering	NN	_	36	SBJ
36	refers	refer	VBZ	_	19	PRN
37	to	to	IN	_	36	ADV
38	the	the	DT	_	39	NMOD
39	sequence	sequence	NN	_	37	PMOD
40	of	of	IN	_	39	NMOD
41	the	the	DT	_	44	NMOD
42	mature	mature	JJ	_	44	NMOD
43	human	human	JJ	_	44	NMOD
44	CLN2	cln0	NN	_	40	PMOD
45	)	)	-RRB-	_	36	P
46	.	.	.	_	18	P

1	This	this	DT	_	2	NMOD
2	part	part	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	main	main	JJ	_	6	NMOD
6	chain	chain	NN	_	3	PMOD
7	is	be	VBZ	_	0	ROOT
8	held	hold	VBN	_	7	VC
9	in	in	IN	_	8	ADV
10	place	place	NN	_	9	PMOD
11	through	through	IN	_	8	MNR
12	a	a	DT	_	16	NMOD
13	hydrogen	hydrogen	NN	_	15	AMOD
14	-	-	HYPH	_	13	P
15	bonded	bond	VBN	_	16	NMOD
16	interaction	interaction	NN	_	11	PMOD
17	with	with	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	side	side	NN	_	20	NMOD
20	chain	chain	NN	_	30	SBJ
21	of	of	IN	_	20	NMOD
22	Thr279	thr0	NN	_	21	PMOD
23	,	,	,	_	22	P
24	part	part	NN	_	22	APPO
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	28	NMOD
27	signature	signature	NN	_	28	NMOD
28	sequence	sequence	NN	_	29	NMOD
29	SGTSAS	sgtsas	NN	_	25	PMOD
30	surrounding	surround	VBG	_	17	PMOD
31	the	the	DT	_	33	NMOD
32	catalytic	catalytic	JJ	_	33	NMOD
33	Ser280	ser0	NN	_	30	OBJ
34	and	and	CC	_	33	COORD
35	its	its	PRP$	_	36	NMOD
36	equivalents	equivalent	NNS	_	34	CONJ
37	in	in	IN	_	36	LOC
38	the	the	DT	_	40	NMOD
39	other	other	JJ	_	40	NMOD
40	enzymes	enzyme	NNS	_	37	PMOD
41	.	.	.	_	7	P

1	Asp165	asp0	NN	_	2	NMOD
2	itself	itself	PRP	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	also	also	RB	_	3	ADV
5	conserved	conserve	VBN	_	3	VC
6	since	since	IN	_	5	ADV
7	that	that	DT	_	8	NMOD
8	residue	residue	NN	_	9	SBJ
9	provides	provide	VBZ	_	6	SUB
10	the	the	DT	_	11	NMOD
11	lining	lining	NN	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	oxyanion	oxyanion	NN	_	15	NMOD
15	hole	hole	NN	_	12	PMOD
16	,	,	,	_	5	P
17	so	so	IN	_	5	PRP
18	it	it	PRP	_	19	SBJ
19	can	can	MD	_	17	SUB
20	be	be	VB	_	19	VC
21	safely	safely	RB	_	20	ADV
22	assumed	assume	VBN	_	20	VC
23	that	that	IN	_	22	OBJ
24	this	this	DT	_	25	NMOD
25	part	part	NN	_	30	SBJ
26	of	of	IN	_	25	NMOD
27	the	the	DT	_	29	NMOD
28	S1	s0	NN	_	29	NMOD
29	pocket	pocket	NN	_	26	PMOD
30	is	be	VBZ	_	23	SUB
31	virtually	virtually	RB	_	32	AMOD
32	identical	identical	JJ	_	30	PRD
33	.	.	.	_	3	P

1	No	no	DT	_	2	NMOD
2	side	side	NN	_	4	SBJ
3	chains	chain	VBZ	_	2	NMOD
4	point	point	VBP	_	0	ROOT
5	into	into	IN	_	4	DIR
6	the	the	DT	_	7	NMOD
7	pocket	pocket	NN	_	5	PMOD
8	from	from	IN	_	4	DIR
9	there	there	RB	_	8	PMOD
10	,	,	,	_	4	P
11	though	though	RB	_	4	ADV
12	,	,	,	_	4	P
13	so	so	IN	_	4	PRP
14	its	its	PRP$	_	15	NMOD
15	importance	importance	NN	_	16	SBJ
16	is	be	VBZ	_	13	SUB
17	limited	limit	VBN	_	16	VC
18	to	to	IN	_	17	ADV
19	providing	provide	VBG	_	18	PMOD
20	a	a	DT	_	22	NMOD
21	steric	steric	JJ	_	22	NMOD
22	barrier	barrier	NN	_	19	OBJ
23	and	and	CC	_	19	COORD
24	excluding	exclude	VBG	_	23	CONJ
25	solvent	solvent	NN	_	24	OBJ
26	.	.	.	_	4	P

1	Another	another	DT	_	2	NMOD
2	wall	wall	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	pocket	pocket	NN	_	3	PMOD
6	is	be	VBZ	_	0	ROOT
7	made	make	VBN	_	6	VC
8	up	up	RP	_	7	PRT
9	of	of	IN	_	7	ADV
10	the	the	DT	_	12	NMOD
11	main	main	JJ	_	12	NMOD
12	chain	chain	NN	_	9	PMOD
13	of	of	IN	_	12	NMOD
14	residues	residue	NNS	_	15	NMOD
15	130	0	CD	_	13	PMOD
16	–	–	SYM	_	17	P
17	132	0	CD	_	15	NMOD
18	that	that	WDT	_	19	SBJ
19	flank	flank	VBP	_	15	NMOD
20	the	the	DT	_	22	NMOD
21	conserved	conserve	VBN	_	22	NMOD
22	Gly131	gly0	NN	_	19	OBJ
23	.	.	.	_	6	P

1	Again	again	RB	_	8	ADV
2	,	,	,	_	8	P
3	this	this	DT	_	4	NMOD
4	part	part	NN	_	8	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	chain	chain	NN	_	5	PMOD
8	does	do	VBZ	_	0	ROOT
9	not	not	RB	_	8	ADV
10	provide	provide	VB	_	8	VC
11	any	any	DT	_	13	NMOD
12	specific	specific	JJ	_	13	NMOD
13	interactions	interaction	NNS	_	10	OBJ
14	with	with	IN	_	13	NMOD
15	the	the	DT	_	17	NMOD
16	P1	p0	NN	_	17	NMOD
17	residue	residue	NN	_	14	PMOD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	20	NMOD
20	substrate	substrate	NN	_	18	PMOD
21	.	.	.	_	8	P

1	Figure	figure	NN	_	0	ROOT
2	6	0	CD	_	1	NMOD

1	A	a	DT	_	2	NMOD
2	model	model	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	active	active	JJ	_	6	NMOD
6	site	site	NN	_	3	PMOD
7	of	of	IN	_	6	NMOD
8	human	human	JJ	_	9	NMOD
9	CLN2	cln0	NN	_	7	PMOD
10	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	enzyme	enzyme	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	shown	show	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	complex	complex	NN	_	5	PMOD
7	with	with	IN	_	4	ADV
8	pseudo-iodotyrostatin	pseudo-iodotyrostatin	NN	_	7	PMOD
9	,	,	,	_	8	P
10	a	a	DT	_	12	NMOD
11	good	good	JJ	_	12	NMOD
12	inhibitor	inhibitor	NN	_	8	APPO
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	16	NMOD
15	sedolisin	sedolisin	NN	_	16	NMOD
16	family	family	NN	_	13	PMOD
17	of	of	IN	_	16	NMOD
18	peptidases	peptidase	NNS	_	17	PMOD
19	.	.	.	_	3	P

1	Only	only	RB	_	3	NMOD
2	selected	select	VBN	_	3	NMOD
3	residues	residue	NNS	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	enzyme	enzyme	NN	_	4	PMOD
7	are	be	VBP	_	0	ROOT
8	explicitly	explicitly	RB	_	7	ADV
9	shown	show	VBN	_	7	VC
10	on	on	IN	_	9	ADV
11	the	the	DT	_	12	NMOD
12	background	background	NN	_	10	PMOD
13	consisting	consist	VBG	_	12	NMOD
14	of	of	IN	_	13	ADV
15	the	the	DT	_	17	NMOD
16	molecular	molecular	JJ	_	17	NMOD
17	surface	surface	NN	_	14	PMOD
18	.	.	.	_	7	P

1	The	the	DT	_	3	NMOD
2	stick	stick	NN	_	3	NMOD
3	model	model	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	inhibitor	inhibitor	NN	_	4	PMOD
7	is	be	VBZ	_	0	ROOT
8	colored	color	VBN	_	7	VC
9	gold	gold	JJ	_	8	OPRD
10	and	and	CC	_	7	COORD
11	the	the	DT	_	15	NMOD
12	P1	p0	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	P3	p0	NN	_	15	NMOD
15	residues	residue	NNS	_	16	SBJ
16	are	be	VBP	_	10	CONJ
17	labeled	label	VBN	_	16	VC
18	in	in	IN	_	17	MNR
19	black	black	NN	_	18	PMOD
20	.	.	.	_	7	P

1	Similar	similar	JJ	_	2	NMOD
2	views	view	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	been	be	VBN	_	3	VC
5	previously	previously	RB	_	4	TMP
6	published	publish	VBN	_	4	VC
7	for	for	IN	_	6	ADV
8	the	the	DT	_	12	NMOD
9	experimentally	experimentally	RB	_	11	AMOD
10	-	-	HYPH	_	9	P
11	determined	determine	VBN	_	12	NMOD
12	structures	structure	NNS	_	7	PMOD
13	of	of	IN	_	12	NMOD
14	sedolisin	sedolisin	NN	_	13	PMOD
15	and	and	CC	_	14	COORD
16	kumamolisin	kumamolisin	NN	_	15	CONJ
17	[	[	-LRB-	_	18	P
18	8	0	CD	_	6	PRN
19	]	]	-RRB-	_	18	P
20	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	figure	figure	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	prepared	prepare	VBN	_	3	VC
5	using	use	VBG	_	4	MNR
6	the	the	DT	_	7	NMOD
7	program	program	NN	_	8	NMOD
8	DINO	dino	NN	_	5	OBJ
9	.	.	.	_	3	P

1	Considerable	considerable	JJ	_	2	NMOD
2	differences	difference	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	seen	see	VBN	_	3	VC
5	,	,	,	_	4	P
6	however	however	RB	_	4	ADV
7	,	,	,	_	4	P
8	at	at	IN	_	4	LOC
9	the	the	DT	_	10	NMOD
10	bottom	bottom	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	13	NMOD
13	pocket	pocket	NN	_	11	PMOD
14	,	,	,	_	10	P
15	where	where	WRB	_	29	LOC
16	the	the	DT	_	18	NMOD
17	side	side	NN	_	18	NMOD
18	chains	chain	NNS	_	29	SBJ
19	of	of	IN	_	18	NMOD
20	Asp179	asp0	NN	_	19	PMOD
21	in	in	IN	_	18	NMOD
22	kumamolisin	kumamolisin	NN	_	21	PMOD
23	and	and	CC	_	18	COORD
24	the	the	DT	_	26	NMOD
25	equivalent	equivalent	JJ	_	26	NMOD
26	Ser190	ser0	NN	_	23	CONJ
27	in	in	IN	_	26	NMOD
28	sedolisin	sedolisin	NN	_	27	PMOD
29	make	make	VBP	_	10	NMOD
30	hydrogen	hydrogen	NN	_	31	NMOD
31	bonds	bond	NNS	_	29	OBJ
32	to	to	IN	_	31	NMOD
33	the	the	DT	_	35	NMOD
34	P1	p0	NN	_	35	NMOD
35	tyrosine	tyrosine	NN	_	32	PMOD
36	of	of	IN	_	35	NMOD
37	the	the	DT	_	38	NMOD
38	inhibitor	inhibitor	NN	_	36	PMOD
39	(	(	-LRB-	_	35	P
40	if	if	IN	_	35	ADV
41	present	present	JJ	_	40	SUB
42	)	)	-RRB-	_	3	P
43	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	equivalent	equivalent	JJ	_	3	NMOD
3	residue	residue	NN	_	6	SBJ
4	in	in	IN	_	3	LOC
5	CLN2	cln0	NN	_	4	PMOD
6	is	be	VBZ	_	0	ROOT
7	Thr182	thr0	NN	_	6	PRD
8	,	,	,	_	6	P
9	but	but	CC	_	6	COORD
10	it	it	PRP	_	11	SBJ
11	is	be	VBZ	_	9	CONJ
12	very	very	RB	_	13	AMOD
13	unlikely	unlikely	JJ	_	11	PRD
14	that	that	IN	_	11	OBJ
15	it	it	PRP	_	16	SBJ
16	can	can	MD	_	14	SUB
17	assume	assume	VB	_	16	VC
18	an	an	DT	_	19	NMOD
19	orientation	orientation	NN	_	17	OBJ
20	that	that	WDT	_	21	SBJ
21	would	would	MD	_	19	NMOD
22	allow	allow	VB	_	21	VC
23	it	it	PRP	_	24	SBJ
24	to	to	TO	_	22	OPRD
25	make	make	VB	_	24	IM
26	a	a	DT	_	28	NMOD
27	hydrogen	hydrogen	NN	_	28	NMOD
28	bond	bond	NN	_	25	OBJ
29	to	to	IN	_	28	NMOD
30	a	a	DT	_	32	NMOD
31	P1	p0	NN	_	32	NMOD
32	tyrosine	tyrosine	NN	_	29	PMOD
33	.	.	.	_	6	P

1	Other	other	JJ	_	3	NMOD
2	polar	polar	JJ	_	3	NMOD
3	residues	residue	NNS	_	7	SBJ
4	in	in	IN	_	3	LOC
5	the	the	DT	_	6	NMOD
6	vicinity	vicinity	NN	_	4	PMOD
7	are	be	VBP	_	0	ROOT
8	Glu175	glu0	NN	_	7	PRD
9	in	in	IN	_	8	LOC
10	sedolisin	sedolisin	NN	_	9	PMOD
11	and	and	CC	_	8	COORD
12	the	the	DT	_	14	NMOD
13	corresponding	corresponding	JJ	_	14	NMOD
14	Asp169	asp0	NN	_	11	CONJ
15	in	in	IN	_	14	LOC
16	kumamolisin	kumamolisin	NN	_	15	PMOD
17	.	.	.	_	7	P

1	However	however	RB	_	9	ADV
2	,	,	,	_	9	P
3	the	the	DT	_	4	NMOD
4	residue	residue	NN	_	9	SBJ
5	found	find	VBN	_	4	NMOD
6	here	here	RB	_	5	ADV
7	in	in	IN	_	5	LOC
8	CLN2	cln0	NN	_	7	PMOD
9	is	be	VBZ	_	0	ROOT
10	Cys170	cys0	NN	_	9	PRD
11	,	,	,	_	10	P
12	much	much	RB	_	14	AMOD
13	less	less	RBR	_	12	AMOD
14	polar	polar	JJ	_	10	NMOD
15	than	than	IN	_	14	AMOD
16	its	its	PRP$	_	17	NMOD
17	counterparts	counterpart	NNS	_	15	PMOD
18	.	.	.	_	9	P

1	There	there	EX	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	also	also	RB	_	2	ADV
4	no	no	RB	_	5	NMOD
5	equivalent	equivalent	JJ	_	2	PRD
6	to	to	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	polar	polar	JJ	_	9	NMOD
9	interaction	interaction	NN	_	6	PMOD
10	between	between	IN	_	9	NMOD
11	Glu175	glu0	NN	_	10	PMOD
12	and	and	CC	_	11	COORD
13	Glu171	glu0	NN	_	12	CONJ
14	in	in	IN	_	9	LOC
15	sedolisin	sedolisin	NN	_	14	PMOD
16	,	,	,	_	2	P
17	since	since	IN	_	2	PRP
18	the	the	DT	_	19	NMOD
19	equivalent	equivalent	NN	_	26	SBJ
20	of	of	IN	_	19	NMOD
21	the	the	DT	_	23	NMOD
22	latter	latter	JJ	_	23	NMOD
23	residue	residue	NN	_	20	PMOD
24	in	in	IN	_	19	LOC
25	CLN2	cln0	NN	_	24	PMOD
26	is	be	VBZ	_	17	SUB
27	Ser166	ser0	NN	_	26	PRD
28	,	,	,	_	27	P
29	much	much	RB	_	30	AMOD
30	smaller	small	JJR	_	27	NMOD
31	and	and	CC	_	30	COORD
32	pointing	point	VBG	_	31	CONJ
33	away	away	RB	_	32	ADV
34	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	side	side	NN	_	20	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	S1	s0	NN	_	6	NMOD
6	pocket	pocket	NN	_	3	PMOD
7	that	that	WDT	_	8	SBJ
8	is	be	VBZ	_	6	NMOD
9	created	create	VBN	_	8	VC
10	by	by	IN	_	9	LGS
11	the	the	DT	_	15	NMOD
12	very	very	RB	_	13	AMOD
13	flexible	flexible	JJ	_	15	NMOD
14	side	side	NN	_	15	NMOD
15	chain	chain	NN	_	10	PMOD
16	of	of	IN	_	15	NMOD
17	Arg179	arg0	NN	_	16	PMOD
18	in	in	IN	_	15	LOC
19	sedolisin	sedolisin	NN	_	18	PMOD
20	contains	contain	VBZ	_	0	ROOT
21	only	only	RB	_	25	NMOD
22	a	a	DT	_	25	NMOD
23	much	much	RB	_	24	AMOD
24	smaller	small	JJR	_	25	NMOD
25	Ser174	ser0	NN	_	20	OBJ
26	in	in	IN	_	20	LOC
27	CLN2	cln0	NN	_	26	PMOD
28	,	,	,	_	20	P
29	and	and	CC	_	20	COORD
30	thus	thus	RB	_	31	ADV
31	is	be	VBZ	_	29	CONJ
32	much	much	RB	_	34	AMOD
33	more	more	RBR	_	32	AMOD
34	open	open	JJ	_	31	PRD
35	in	in	IN	_	31	LOC
36	the	the	DT	_	38	NMOD
37	latter	latter	JJ	_	38	NMOD
38	protein	protein	NN	_	35	PMOD
39	.	.	.	_	20	P

1	This	this	DT	_	2	NMOD
2	part	part	NN	_	20	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	pocket	pocket	NN	_	3	PMOD
6	,	,	,	_	2	P
7	with	with	IN	_	2	NMOD
8	the	the	DT	_	10	NMOD
9	main	main	JJ	_	10	NMOD
10	chain	chain	NN	_	7	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	13	NMOD
13	protein	protein	NN	_	11	PMOD
14	quite	quite	RB	_	15	AMOD
15	distant	distant	JJ	_	10	NMOD
16	from	from	IN	_	15	AMOD
17	the	the	DT	_	18	NMOD
18	substrate	substrate	NN	_	16	PMOD
19	,	,	,	_	20	P
20	is	be	VBZ	_	0	ROOT
21	indeed	indeed	RB	_	20	ADV
22	not	not	RB	_	20	ADV
23	well	well	RB	_	24	AMOD
24	conserved	conserved	JJ	_	20	PRD
25	in	in	IN	_	20	LOC
26	these	these	DT	_	27	NMOD
27	proteins	protein	NNS	_	25	PMOD
28	,	,	,	_	20	P
29	with	with	IN	_	20	ADV
30	kumamolisin	kumamolisin	NN	_	31	SBJ
31	missing	miss	VBG	_	29	PMOD
32	it	it	PRP	_	31	OBJ
33	entirely	entirely	RB	_	31	ADV
34	due	due	IN	_	31	PRP
35	to	to	IN	_	34	PMOD
36	a	a	DT	_	37	NMOD
37	deletion	deletion	NN	_	34	PMOD
38	in	in	IN	_	37	LOC
39	the	the	DT	_	42	NMOD
40	corresponding	correspond	VBG	_	42	NMOD
41	sequence	sequence	NN	_	42	NMOD
42	position	position	NN	_	38	PMOD
43	.	.	.	_	20	P

1	In	in	IN	_	9	ADV
2	summary	summary	NN	_	1	PMOD
3	,	,	,	_	9	P
4	the	the	DT	_	6	NMOD
5	S1	s0	NN	_	6	NMOD
6	pocket	pocket	NN	_	9	SBJ
7	in	in	IN	_	6	LOC
8	CLN2	cln0	NN	_	7	PMOD
9	has	have	VBZ	_	0	ROOT
10	less	less	RBR	_	12	NMOD
11	polar	polar	JJ	_	12	NMOD
12	character	character	NN	_	9	OBJ
13	than	than	IN	_	12	NMOD
14	the	the	DT	_	16	NMOD
15	equivalent	equivalent	JJ	_	16	NMOD
16	pocket	pocket	NN	_	13	PMOD
17	in	in	IN	_	16	LOC
18	the	the	DT	_	20	NMOD
19	related	relate	VBN	_	20	NMOD
20	proteins	protein	NNS	_	17	PMOD
21	,	,	,	_	9	P
22	and	and	CC	_	9	COORD
23	is	be	VBZ	_	22	CONJ
24	lacking	lack	VBG	_	23	VC
25	direct	direct	JJ	_	27	NMOD
26	polar	polar	JJ	_	27	NMOD
27	anchors	anchor	NNS	_	24	OBJ
28	for	for	IN	_	24	ADV
29	any	any	DT	_	31	NMOD
30	side	side	NN	_	31	NMOD
31	chains	chain	NNS	_	28	PMOD
32	that	that	WDT	_	33	SBJ
33	might	might	MD	_	31	NMOD
34	be	be	VB	_	33	VC
35	present	present	JJ	_	34	PRD
36	in	in	IN	_	34	LOC
37	the	the	DT	_	38	NMOD
38	substrate	substrate	NN	_	36	PMOD
39	.	.	.	_	9	P

1	The	the	DT	_	3	NMOD
2	S2	s0	NN	_	3	NMOD
3	pocket	pocket	NN	_	6	SBJ
4	in	in	IN	_	3	NMOD
5	CLN2	cln0	NN	_	4	PMOD
6	is	be	VBZ	_	0	ROOT
7	also	also	RB	_	6	ADV
8	quite	quite	RB	_	9	AMOD
9	open	open	JJ	_	6	PRD
10	and	and	CC	_	9	COORD
11	accessible	accessible	JJ	_	10	CONJ
12	to	to	IN	_	9	AMOD
13	solvent	solvent	NN	_	12	PMOD
14	.	.	.	_	6	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	most	most	RBS	_	4	AMOD
4	likely	likely	RB	_	2	ADV
5	larger	large	JJR	_	2	PRD
6	than	than	IN	_	5	AMOD
7	the	the	DT	_	9	NMOD
8	equivalent	equivalent	JJ	_	9	NMOD
9	pockets	pocket	NNS	_	6	PMOD
10	in	in	IN	_	9	LOC
11	either	either	CC	_	12	COORD
12	sedolisin	sedolisin	NN	_	10	PMOD
13	or	or	CC	_	12	COORD
14	kumamolisin	kumamolisin	NN	_	13	CONJ
15	,	,	,	_	2	P
16	since	since	IN	_	2	PRP
17	these	these	DT	_	18	SBJ
18	are	be	VBP	_	16	SUB
19	limited	limit	VBN	_	18	VC
20	by	by	IN	_	19	LGS
21	Trp81	trp0	NN	_	20	PMOD
22	in	in	IN	_	21	LOC
23	the	the	DT	_	24	NMOD
24	former	former	JJ	_	22	PMOD
25	and	and	CC	_	21	COORD
26	Trp129	trp0	NN	_	25	CONJ
27	in	in	IN	_	26	LOC
28	the	the	DT	_	29	NMOD
29	latter	latter	JJ	_	27	PMOD
30	(	(	-LRB-	_	33	P
31	these	these	DT	_	32	NMOD
32	residues	residue	NNS	_	33	SBJ
33	originate	originate	VBP	_	19	PRN
34	from	from	IN	_	33	ADV
35	different	different	JJ	_	36	NMOD
36	parts	part	NNS	_	34	PMOD
37	of	of	IN	_	36	NMOD
38	the	the	DT	_	39	NMOD
39	backbone	backbone	NN	_	37	PMOD
40	in	in	IN	_	33	LOC
41	the	the	DT	_	43	NMOD
42	two	two	CD	_	43	NMOD
43	enzymes	enzyme	NNS	_	40	PMOD
44	and	and	CC	_	33	COORD
45	are	be	VBP	_	44	CONJ
46	not	not	RB	_	45	ADV
47	topologically	topologically	RB	_	45	ADV
48	related	relate	VBN	_	45	VC
49	)	)	-RRB-	_	33	P
50	.	.	.	_	2	P

1	Tyr130	tyr0	NN	_	12	SBJ
2	,	,	,	_	1	P
3	an	an	DT	_	4	NMOD
4	equivalent	equivalent	NN	_	1	APPO
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	latter	latter	JJ	_	8	NMOD
8	residue	residue	NN	_	5	PMOD
9	in	in	IN	_	4	LOC
10	CLN2	cln0	NN	_	9	PMOD
11	,	,	,	_	12	P
12	is	be	VBZ	_	0	ROOT
13	unlikely	unlikely	JJ	_	12	PRD
14	to	to	TO	_	13	AMOD
15	come	come	VB	_	14	IM
16	into	into	IN	_	15	ADV
17	direct	direct	JJ	_	18	NMOD
18	contact	contact	NN	_	16	PMOD
19	with	with	IN	_	18	NMOD
20	the	the	DT	_	22	NMOD
21	P2	p0	NN	_	22	NMOD
22	residue	residue	NN	_	19	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	25	NMOD
25	substrate	substrate	NN	_	23	PMOD
26	due	due	IN	_	12	PRP
27	to	to	IN	_	26	PMOD
28	its	its	PRP$	_	30	NMOD
29	greater	great	JJR	_	30	NMOD
30	distance	distance	NN	_	26	PMOD
31	(	(	-LRB-	_	33	P
32	almost	almost	RB	_	33	QMOD
33	4	0	CD	_	30	PRN
34	Å	å	SYM	_	33	P
35	for	for	IN	_	33	NMOD
36	the	the	DT	_	38	NMOD
37	closest	close	JJS	_	38	NMOD
38	atoms	atom	NNS	_	35	PMOD
39	)	)	-RRB-	_	33	P
40	.	.	.	_	12	P

1	An	an	DT	_	4	NMOD
2	important	important	JJ	_	4	NMOD
3	remaining	remaining	JJ	_	4	NMOD
4	puzzle	puzzle	NN	_	5	SBJ
5	is	be	VBZ	_	0	ROOT
6	that	that	IN	_	5	PRD
7	the	the	DT	_	9	NMOD
8	predicted	predict	VBN	_	9	NMOD
9	structure	structure	NN	_	12	SBJ
10	of	of	IN	_	9	NMOD
11	CLN2	cln0	NN	_	10	PMOD
12	does	do	VBZ	_	6	SUB
13	not	not	RB	_	12	ADV
14	show	show	VB	_	12	VC
15	any	any	DT	_	17	NMOD
16	clear	clear	JJ	_	17	NMOD
17	limitations	limitation	NNS	_	14	OBJ
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	S3	s0	NN	_	21	NMOD
21	pocket	pocket	NN	_	18	PMOD
22	that	that	WDT	_	23	SBJ
23	could	could	MD	_	17	NMOD
24	explain	explain	VB	_	23	VC
25	the	the	DT	_	27	NMOD
26	tripeptidase	tripeptidase	NN	_	27	NMOD
27	activity	activity	NN	_	24	OBJ
28	of	of	IN	_	27	NMOD
29	this	this	DT	_	30	NMOD
30	enzyme	enzyme	NN	_	28	PMOD
31	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	location	location	NN	_	11	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	7	NMOD
5	P3	p0	NN	_	7	NMOD
6	side	side	NN	_	7	NMOD
7	chain	chain	NN	_	3	PMOD
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	substrate	substrate	NN	_	8	PMOD
11	is	be	VBZ	_	0	ROOT
12	ambiguous	ambiguous	JJ	_	11	PRD
13	,	,	,	_	11	P
14	since	since	IN	_	11	PRP
15	it	it	PRP	_	16	SBJ
16	could	could	MD	_	14	SUB
17	point	point	VB	_	16	VC
18	in	in	IN	_	17	DIR
19	either	either	DT	_	20	NMOD
20	one	one	CD	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	two	two	CD	_	23	NMOD
23	directions	direction	NNS	_	21	PMOD
24	by	by	IN	_	17	PRP
25	exchange	exchange	NN	_	24	PMOD
26	with	with	IN	_	25	NMOD
27	the	the	DT	_	31	NMOD
28	N	n	NN	_	30	AMOD
29	-	-	HYPH	_	28	P
30	terminal	terminal	JJ	_	31	NMOD
31	amine	amine	NN	_	26	PMOD
32	.	.	.	_	11	P

1	The	the	DT	_	5	NMOD
2	only	only	RB	_	5	NMOD
3	negatively	negatively	RB	_	4	AMOD
4	charged	charged	JJ	_	5	NMOD
5	residue	residue	NN	_	14	SBJ
6	of	of	IN	_	5	NMOD
7	CLN2	cln0	NN	_	6	PMOD
8	that	that	WDT	_	9	SBJ
9	is	be	VBZ	_	5	NMOD
10	found	find	VBN	_	9	VC
11	in	in	IN	_	10	LOC
12	this	this	DT	_	13	NMOD
13	vicinity	vicinity	NN	_	11	PMOD
14	is	be	VBZ	_	0	ROOT
15	Asp132	asp0	NN	_	14	PRD
16	.	.	.	_	14	P

1	Although	although	IN	_	31	ADV
2	in	in	IN	_	23	ADV
3	the	the	DT	_	5	NMOD
4	current	current	JJ	_	5	NMOD
5	model	model	NN	_	2	PMOD
6	the	the	DT	_	7	NMOD
7	distance	distance	NN	_	23	SBJ
8	between	between	IN	_	7	NMOD
9	its	its	PRP$	_	10	NMOD
10	carboxylate	carboxylate	NN	_	8	PMOD
11	and	and	CC	_	10	COORD
12	the	the	DT	_	13	NMOD
13	nitrogen	nitrogen	NN	_	11	CONJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	18	NMOD
16	N	n	NN	_	18	NMOD
17	-	-	HYPH	_	16	P
18	terminus	terminus	NN	_	14	PMOD
19	of	of	IN	_	18	NMOD
20	the	the	DT	_	22	NMOD
21	modeled	model	VBN	_	22	NMOD
22	substrate	substrate	NN	_	19	PMOD
23	is	be	VBZ	_	1	SUB
24	about	about	RB	_	25	QMOD
25	6	0	CD	_	23	PRD
26	Å	å	SYM	_	25	P
27	,	,	,	_	31	P
28	these	these	DT	_	30	NMOD
29	two	two	CD	_	30	NMOD
30	groups	group	NNS	_	31	SBJ
31	could	could	MD	_	0	ROOT
32	be	be	VB	_	31	VC
33	brought	bring	VBN	_	32	VC
34	into	into	IN	_	33	ADV
35	hydrogen	hydrogen	NN	_	37	AMOD
36	-	-	HYPH	_	35	P
37	bonding	bond	VBG	_	38	NMOD
38	range	range	NN	_	34	PMOD
39	by	by	IN	_	33	LGS
40	some	some	DT	_	42	NMOD
41	allowed	allow	VBN	_	42	NMOD
42	changes	change	NNS	_	39	PMOD
43	in	in	IN	_	42	NMOD
44	the	the	DT	_	46	NMOD
45	torsion	torsion	NN	_	46	NMOD
46	angles	angle	NNS	_	43	PMOD
47	of	of	IN	_	46	NMOD
48	the	the	DT	_	49	NMOD
49	protein	protein	NN	_	47	PMOD
50	.	.	.	_	31	P

1	Such	such	PDT	_	4	NMOD
2	a	a	DT	_	4	NMOD
3	conformational	conformational	JJ	_	4	NMOD
4	change	change	NN	_	5	SBJ
5	would	would	MD	_	0	ROOT
6	involve	involve	VB	_	5	VC
7	breaking	breaking	NN	_	6	OBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	hydrogen	hydrogen	NN	_	11	NMOD
11	bond	bond	NN	_	8	PMOD
12	between	between	IN	_	11	LOC
13	Asp132	asp0	NN	_	12	PMOD
14	and	and	CC	_	13	COORD
15	Ser139	ser0	NN	_	14	CONJ
16	.	.	.	_	5	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	this	this	DT	_	5	NMOD
4	latter	latter	JJ	_	5	NMOD
5	interaction	interaction	NN	_	6	SBJ
6	is	be	VBZ	_	0	ROOT
7	not	not	RB	_	6	ADV
8	likely	likely	JJ	_	6	PRD
9	to	to	TO	_	8	AMOD
10	be	be	VB	_	9	IM
11	structurally	structurally	RB	_	12	AMOD
12	crucial	crucial	JJ	_	10	PRD
13	since	since	IN	_	6	PRP
14	the	the	DT	_	15	NMOD
15	serine	serine	NN	_	16	SBJ
16	is	be	VBZ	_	13	SUB
17	not	not	RB	_	16	ADV
18	absolutely	absolutely	RB	_	16	ADV
19	conserved	conserve	VBN	_	16	VC
20	in	in	IN	_	19	LOC
21	all	all	DT	_	25	NMOD
22	CLN2	cln0	NN	_	24	AMOD
23	-	-	HYPH	_	22	P
24	like	like	JJ	_	25	NMOD
25	enzymes	enzyme	NNS	_	20	PMOD
26	.	.	.	_	6	P

1	Location	location	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	mutations	mutation	NNS	_	2	PMOD
4	implicated	implicate	VBN	_	3	NMOD
5	in	in	IN	_	4	ADV
6	disease	disease	NN	_	5	PMOD

1	Location	location	NN	_	20	SBJ
2	of	of	IN	_	1	NMOD
3	mutations	mutation	NNS	_	2	PMOD
4	found	find	VBN	_	3	NMOD
5	through	through	IN	_	4	MNR
6	a	a	DT	_	8	NMOD
7	genetic	genetic	JJ	_	8	NMOD
8	survey	survey	NN	_	5	PMOD
9	of	of	IN	_	8	NMOD
10	families	family	NNS	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	classic	classic	JJ	_	19	NMOD
13	late	late	JJ	_	15	AMOD
14	-	-	HYPH	_	13	P
15	infantile	infantile	JJ	_	19	NMOD
16	neuronal	neuronal	JJ	_	19	NMOD
17	ceroid	ceroid	JJ	_	19	NMOD
18	lipofuscinosis	lipofuscinosis	NN	_	19	NMOD
19	patients	patient	NNS	_	11	PMOD
20	has	have	VBZ	_	0	ROOT
21	been	be	VBN	_	20	VC
22	described	describe	VBN	_	21	VC
23	previously	previously	RB	_	22	TMP
24	[	[	-LRB-	_	25	P
25	17	0	CD	_	22	PRN
26	]	]	-RRB-	_	25	P
27	.	.	.	_	20	P

1	Most	most	JJS	_	3	NMOD
2	such	such	JJ	_	3	NMOD
3	mutations	mutation	NNS	_	4	SBJ
4	result	result	VBP	_	0	ROOT
5	in	in	IN	_	4	ADV
6	expression	expression	NN	_	5	PMOD
7	of	of	IN	_	6	NMOD
8	either	either	CC	_	10	COORD
9	truncated	truncate	VBN	_	10	NMOD
10	enzyme	enzyme	NN	_	7	PMOD
11	or	or	CC	_	5	COORD
12	in	in	IN	_	11	CONJ
13	incorrect	incorrect	JJ	_	17	NMOD
14	intron	intron	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	exon	exon	NN	_	17	NMOD
17	splices	splice	NNS	_	12	PMOD
18	.	.	.	_	4	P

1	However	however	RB	_	7	ADV
2	,	,	,	_	7	P
3	some	some	DT	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	mutations	mutation	NNS	_	4	PMOD
7	lead	lead	VBP	_	0	ROOT
8	to	to	IN	_	7	ADV
9	single	single	JJ	_	12	NMOD
10	amino	amino	NN	_	11	NMOD
11	acid	acid	NN	_	12	NMOD
12	substitutions	substitution	NNS	_	8	PMOD
13	in	in	IN	_	7	LOC
14	the	the	DT	_	16	NMOD
15	mature	mature	JJ	_	16	NMOD
16	enzyme	enzyme	NN	_	13	PMOD
17	.	.	.	_	7	P

1	Such	such	JJ	_	2	NMOD
2	mutations	mutation	NNS	_	3	SBJ
3	include	include	VBP	_	0	ROOT
4	I92N	i0n	NN	_	3	OBJ
5	,	,	,	_	4	P
6	E148K	e0k	NN	_	4	CONJ
7	,	,	,	_	6	P
8	C170R	c0r	NN	_	6	CONJ
9	and	and	CC	_	8	COORD
10	C170Y	c0y	NN	_	9	CONJ
11	,	,	,	_	8	P
12	V190D	v0d	NN	_	8	CONJ
13	,	,	,	_	12	P
14	G194E	g0e	NN	_	12	CONJ
15	,	,	,	_	14	P
16	Q227H	q0h	NN	_	14	CONJ
17	,	,	,	_	16	P
18	R252H	r0h	NN	_	16	CONJ
19	,	,	,	_	18	P
20	A259E	a0e	NN	_	18	CONJ
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	S280L	s0l	NN	_	22	CONJ
24	(	(	-LRB-	_	25	P
25	Figure	figure	NN	_	3	PRN
26	5	0	CD	_	25	NMOD
27	)	)	-RRB-	_	25	P
28	.	.	.	_	3	P

1	Only	only	RB	_	3	NMOD
2	the	the	DT	_	3	NMOD
3	role	role	NN	_	8	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	7	NMOD
6	latter	latter	JJ	_	7	NMOD
7	mutation	mutation	NN	_	4	PMOD
8	is	be	VBZ	_	0	ROOT
9	completely	completely	RB	_	10	AMOD
10	clear	clear	JJ	_	8	PRD
11	,	,	,	_	8	P
12	since	since	IN	_	8	PRP
13	it	it	PRP	_	14	SBJ
14	replaces	replace	VBZ	_	12	SUB
15	the	the	DT	_	17	NMOD
16	catalytic	catalytic	JJ	_	17	NMOD
17	serine	serine	NN	_	14	OBJ
18	of	of	IN	_	17	NMOD
19	CLN2	cln0	NN	_	18	PMOD
20	with	with	IN	_	14	ADV
21	a	a	DT	_	23	NMOD
22	side	side	NN	_	23	NMOD
23	chain	chain	NN	_	20	PMOD
24	that	that	WDT	_	25	SBJ
25	can	can	MD	_	23	NMOD
26	not	not	RB	_	25	ADV
27	support	support	VB	_	25	VC
28	its	its	PRP$	_	30	NMOD
29	enzymatic	enzymatic	JJ	_	30	NMOD
30	activity	activity	NN	_	27	OBJ
31	.	.	.	_	8	P

1	No	no	DT	_	3	NMOD
2	other	other	JJ	_	3	NMOD
3	residues	residue	NNS	_	4	SBJ
4	appear	appear	VBP	_	0	ROOT
5	to	to	TO	_	4	OPRD
6	be	be	VB	_	5	IM
7	located	locate	VBN	_	6	VC
8	in	in	IN	_	7	LOC
9	the	the	DT	_	11	NMOD
10	immediate	immediate	JJ	_	11	NMOD
11	vicinity	vicinity	NN	_	8	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	14	NMOD
14	substrate	substrate	NN	_	12	PMOD
15	.	.	.	_	4	P

1	Residues	residue	NNS	_	2	NMOD
2	Val190	val0	NN	_	8	SBJ
3	,	,	,	_	2	P
4	Gly194	gly0	NN	_	2	CONJ
5	,	,	,	_	4	P
6	and	and	CC	_	4	COORD
7	Arg252	arg0	NN	_	6	CONJ
8	are	be	VBP	_	0	ROOT
9	very	very	RB	_	10	AMOD
10	highly	highly	RB	_	11	AMOD
11	conserved	conserved	JJ	_	8	PRD
12	not	not	RB	_	14	COORD
13	only	only	RB	_	12	ADV
14	in	in	IN	_	8	LOC
15	CLN2	cln0	NN	_	14	PMOD
16	but	but	CC	_	14	COORD
17	also	also	RB	_	16	ADV
18	in	in	IN	_	16	CONJ
19	other	other	JJ	_	20	NMOD
20	sedolisins	sedolisins	NNS	_	18	PMOD
21	and	and	CC	_	8	COORD
22	must	must	MD	_	21	CONJ
23	play	play	VB	_	22	VC
24	an	an	DT	_	27	NMOD
25	important	important	JJ	_	27	NMOD
26	structural	structural	JJ	_	27	NMOD
27	role	role	NN	_	23	OBJ
28	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	reasons	reason	NNS	_	15	SBJ
3	why	why	WRB	_	8	PRP
4	the	the	DT	_	6	NMOD
5	remaining	remain	VBG	_	6	NMOD
6	mutations	mutation	NNS	_	7	SBJ
7	would	would	MD	_	2	NMOD
8	lead	lead	VB	_	7	VC
9	to	to	IN	_	8	ADV
10	the	the	DT	_	11	NMOD
11	loss	loss	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	enzymatic	enzymatic	JJ	_	14	NMOD
14	activity	activity	NN	_	12	PMOD
15	are	be	VBP	_	0	ROOT
16	much	much	RB	_	18	AMOD
17	less	less	RBR	_	16	AMOD
18	clear	clear	JJ	_	15	PRD
19	,	,	,	_	15	P
20	but	but	CC	_	15	COORD
21	the	the	DT	_	23	NMOD
22	wide	wide	JJ	_	23	NMOD
23	distribution	distribution	NN	_	30	SBJ
24	of	of	IN	_	23	NMOD
25	these	these	DT	_	26	NMOD
26	mutations	mutation	NNS	_	24	PMOD
27	in	in	IN	_	23	LOC
28	the	the	DT	_	29	NMOD
29	structure	structure	NN	_	27	PMOD
30	supports	support	VBZ	_	20	CONJ
31	the	the	DT	_	32	NMOD
32	conclusion	conclusion	NN	_	30	OBJ
33	that	that	IN	_	32	NMOD
34	any	any	DT	_	35	NMOD
35	modifications	modification	NNS	_	45	SBJ
36	to	to	IN	_	35	NMOD
37	CLN2	cln0	NN	_	36	PMOD
38	that	that	WDT	_	39	SBJ
39	would	would	MD	_	35	NMOD
40	abolish	abolish	VB	_	39	VC
41	or	or	CC	_	40	COORD
42	impair	impair	VB	_	41	CONJ
43	its	its	PRP$	_	44	NMOD
44	function	function	NN	_	40	OBJ
45	could	could	MD	_	33	SUB
46	lead	lead	VB	_	45	VC
47	to	to	IN	_	46	ADV
48	the	the	DT	_	49	NMOD
49	development	development	NN	_	47	PMOD
50	of	of	IN	_	49	NMOD
51	the	the	DT	_	52	NMOD
52	disease	disease	NN	_	50	PMOD
53	.	.	.	_	15	P

1	Substrates	substrate	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	inhibitors	inhibitor	NNS	_	2	CONJ
4	of	of	IN	_	1	NMOD
5	CLN2	cln0	NN	_	4	PMOD

1	Little	little	JJ	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	known	know	VBN	_	2	VC
4	at	at	IN	_	3	TMP
5	this	this	DT	_	6	NMOD
6	time	time	NN	_	4	PMOD
7	about	about	IN	_	3	ADV
8	biologically	biologically	RB	_	10	AMOD
9	-	-	HYPH	_	8	P
10	relevant	relevant	JJ	_	11	NMOD
11	substrates	substrate	NNS	_	7	PMOD
12	of	of	IN	_	11	NMOD
13	CLN2	cln0	NN	_	12	PMOD
14	.	.	.	_	2	P

1	Various	various	JJ	_	2	NMOD
2	defects	defect	NNS	_	13	SBJ
3	that	that	WDT	_	4	SBJ
4	include	include	VBP	_	2	NMOD
5	truncations	truncation	NNS	_	4	OBJ
6	and	and	CC	_	5	COORD
7	single	single	JJ	_	9	NMOD
8	-	-	HYPH	_	7	P
9	site	site	NN	_	10	NMOD
10	mutations	mutation	NNS	_	6	CONJ
11	in	in	IN	_	5	LOC
12	CLN2	cln0	NN	_	11	PMOD
13	have	have	VBP	_	0	ROOT
14	been	be	VBN	_	13	VC
15	found	find	VBN	_	14	VC
16	in	in	IN	_	15	LOC
17	the	the	DT	_	18	NMOD
18	genes	gene	NNS	_	16	PMOD
19	of	of	IN	_	18	NMOD
20	patients	patient	NNS	_	19	PMOD
21	that	that	WDT	_	22	SBJ
22	display	display	VBP	_	20	NMOD
23	symptoms	symptom	NNS	_	22	OBJ
24	of	of	IN	_	23	NMOD
25	late	late	JJ	_	27	AMOD
26	-	-	HYPH	_	25	P
27	infantile	infantile	JJ	_	30	NMOD
28	neuronal	neuronal	JJ	_	30	NMOD
29	ceroid	ceroid	NN	_	30	NMOD
30	lipofuscinosis	lipofuscinosis	NN	_	24	PMOD
31	[	[	-LRB-	_	32	P
32	17	0	CD	_	15	PRN
33	]	]	-RRB-	_	32	P
34	.	.	.	_	13	P

1	One	one	CD	_	8	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	symptoms	symptom	NNS	_	2	PMOD
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	disease	disease	NN	_	5	PMOD
8	is	be	VBZ	_	0	ROOT
9	the	the	DT	_	10	NMOD
10	accumulation	accumulation	NN	_	8	PRD
11	of	of	IN	_	10	NMOD
12	an	an	DT	_	14	NMOD
13	autofluorescent	autofluorescent	JJ	_	14	NMOD
14	material	material	NN	_	11	PMOD
15	,	,	,	_	14	P
16	ceroid	ceroid	NN	_	18	NMOD
17	-	-	HYPH	_	16	P
18	lipofuscin	lipofuscin	NN	_	14	APPO
19	,	,	,	_	8	P
20	in	in	IN	_	8	LOC
21	lysosomal	lysosomal	JJ	_	23	NMOD
22	storage	storage	NN	_	23	NMOD
23	bodies	body	NNS	_	20	PMOD
24	in	in	IN	_	23	LOC
25	various	various	JJ	_	27	NMOD
26	cell	cell	NN	_	27	NMOD
27	types	type	NNS	_	24	PMOD
28	,	,	,	_	27	P
29	primarily	primarily	RB	_	30	PMOD
30	in	in	IN	_	27	LOC
31	the	the	DT	_	33	NMOD
32	nervous	nervous	JJ	_	33	NMOD
33	system	system	NN	_	30	PMOD
34	.	.	.	_	8	P

1	Since	since	IN	_	21	PRP
2	a	a	DT	_	4	NMOD
3	major	major	JJ	_	4	NMOD
4	component	component	NN	_	8	SBJ
5	of	of	IN	_	4	NMOD
6	such	such	JJ	_	7	NMOD
7	bodies	body	NNS	_	5	PMOD
8	appears	appear	VBZ	_	1	SUB
9	to	to	TO	_	8	OPRD
10	be	be	VB	_	9	IM
11	intact	intact	JJ	_	13	NMOD
12	subunit	subunit	NN	_	13	NMOD
13	c	c	NN	_	10	PRD
14	of	of	IN	_	13	NMOD
15	mitochondrial	mitochondrial	JJ	_	17	NMOD
16	ATP	atp	NN	_	17	NMOD
17	synthase	synthase	NN	_	14	PMOD
18	,	,	,	_	21	P
19	this	this	DT	_	20	NMOD
20	protein	protein	NN	_	21	SBJ
21	has	have	VBZ	_	0	ROOT
22	been	be	VBN	_	21	VC
23	implicated	implicate	VBN	_	22	VC
24	as	as	IN	_	23	ADV
25	a	a	DT	_	28	NMOD
26	potential	potential	JJ	_	28	NMOD
27	biological	biological	JJ	_	28	NMOD
28	target	target	NN	_	24	PMOD
29	of	of	IN	_	28	NMOD
30	the	the	DT	_	31	NMOD
31	protease	protease	NN	_	29	PMOD
32	.	.	.	_	21	P

1	It	it	PRP	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	been	be	VBN	_	2	VC
4	shown	show	VBN	_	3	VC
5	recently	recently	RB	_	4	TMP
6	that	that	IN	_	4	OBJ
7	CLN2	cln0	NN	_	8	SBJ
8	can	can	MD	_	6	SUB
9	indeed	indeed	RB	_	8	ADV
10	degrade	degrade	VB	_	8	VC
11	this	this	DT	_	12	NMOD
12	subunit	subunit	NN	_	10	OBJ
13	on	on	IN	_	10	LOC
14	its	its	PRP$	_	16	NMOD
15	N	n	NN	_	16	NMOD
16	terminus	terminus	NN	_	13	PMOD
17	[	[	-LRB-	_	18	P
18	18	0	CD	_	4	PRN
19	]	]	-RRB-	_	18	P
20	,	,	,	_	2	P
21	but	but	CC	_	2	COORD
22	the	the	DT	_	24	NMOD
23	unambiguous	unambiguous	JJ	_	24	NMOD
24	proof	proof	NN	_	33	SBJ
25	that	that	IN	_	24	NMOD
26	this	this	DT	_	27	SBJ
27	is	be	VBZ	_	25	SUB
28	indeed	indeed	RB	_	27	ADV
29	the	the	DT	_	32	NMOD
30	most	most	RBS	_	31	AMOD
31	important	important	JJ	_	32	NMOD
32	target	target	NN	_	27	PRD
33	is	be	VBZ	_	21	CONJ
34	still	still	RB	_	33	TMP
35	lacking	lacking	JJ	_	33	PRD
36	.	.	.	_	2	P

1	CLN2	cln0	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	capable	capable	JJ	_	2	PRD
4	of	of	IN	_	3	AMOD
5	processing	process	VBG	_	4	PMOD
6	a	a	DT	_	7	NMOD
7	number	number	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	different	different	JJ	_	13	NMOD
10	angiotensin	angiotensin	NN	_	12	AMOD
11	-	-	HYPH	_	10	P
12	derived	derive	VBN	_	13	NMOD
13	peptides	peptide	NNS	_	8	PMOD
14	[	[	-LRB-	_	15	P
15	19	0	CD	_	2	PRN
16	]	]	-RRB-	_	15	P
17	,	,	,	_	2	P
18	with	with	IN	_	2	ADV
19	the	the	DT	_	20	NMOD
20	efficiency	efficiency	NN	_	18	SUB
21	of	of	IN	_	20	NMOD
22	cleavage	cleavage	NN	_	21	PMOD
23	dependent	dependent	JJ	_	20	OPRD
24	on	on	IN	_	23	AMOD
25	the	the	DT	_	26	NMOD
26	length	length	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	such	such	JJ	_	29	NMOD
29	peptides	peptide	NNS	_	27	PMOD
30	.	.	.	_	2	P

1	The	the	DT	_	5	NMOD
2	most	most	RBS	_	3	AMOD
3	efficiently	efficiently	RB	_	4	AMOD
4	processed	process	VBN	_	5	NMOD
5	peptide	peptide	NN	_	6	SBJ
6	consisted	consist	VBD	_	0	ROOT
7	of	of	IN	_	6	ADV
8	14	0	CD	_	10	NMOD
9	amino	amino	NN	_	10	NMOD
10	acids	acid	NNS	_	7	PMOD
11	,	,	,	_	6	P
12	with	with	IN	_	6	ADV
13	the	the	DT	_	14	NMOD
14	tripeptide	tripeptide	NN	_	19	NMOD
15	Asp	asp	NN	_	19	NMOD
16	-	-	HYPH	_	15	P
17	Arg	arg	NN	_	19	NMOD
18	-	-	HYPH	_	17	P
19	Val	val	NN	_	20	SBJ
20	removed	remove	VBN	_	12	SUB
21	from	from	IN	_	20	ADV
22	its	its	PRP$	_	24	NMOD
23	N	n	NN	_	24	NMOD
24	terminus	terminus	NN	_	21	PMOD
25	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	model	model	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	CLN2	cln0	NN	_	3	PMOD
5	presented	present	VBN	_	2	NMOD
6	here	here	RB	_	5	ADV
7	can	can	MD	_	0	ROOT
8	easily	easily	RB	_	7	ADV
9	accommodate	accommodate	VB	_	7	VC
10	this	this	DT	_	11	NMOD
11	peptide	peptide	NN	_	9	OBJ
12	on	on	IN	_	9	LOC
13	the	the	DT	_	15	NMOD
14	P	p	NN	_	15	NMOD
15	side	side	NN	_	12	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	21	NMOD
18	substrate	substrate	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	binding	bind	VBG	_	21	NMOD
21	site	site	NN	_	16	PMOD
22	,	,	,	_	9	P
23	although	although	IN	_	9	ADV
24	the	the	DT	_	26	NMOD
25	exact	exact	JJ	_	26	NMOD
26	mode	mode	NN	_	38	SBJ
27	of	of	IN	_	26	NMOD
28	binding	binding	NN	_	27	PMOD
29	of	of	IN	_	28	NMOD
30	the	the	DT	_	34	NMOD
31	long	long	JJ	_	34	NMOD
32	P	p	NN	_	34	NMOD
33	'	'	SYM	_	32	P
34	portion	portion	NN	_	29	PMOD
35	of	of	IN	_	34	NMOD
36	the	the	DT	_	37	NMOD
37	substrate	substrate	NN	_	35	PMOD
38	remains	remain	VBZ	_	23	SUB
39	obscure	obscure	JJ	_	38	PRD
40	.	.	.	_	7	P

1	The	the	DT	_	2	NMOD
2	observation	observation	NN	_	16	SBJ
3	that	that	IN	_	2	NMOD
4	an	an	DT	_	6	NMOD
5	analogous	analogous	JJ	_	6	NMOD
6	peptide	peptide	NN	_	12	SBJ
7	acetylated	acetylate	VBN	_	6	NMOD
8	on	on	IN	_	7	LOC
9	its	its	PRP$	_	11	NMOD
10	N	n	NN	_	11	NMOD
11	terminus	terminus	NN	_	8	PMOD
12	can	can	MD	_	3	SUB
13	not	not	RB	_	12	ADV
14	be	be	VB	_	12	VC
15	processed	process	VBN	_	14	VC
16	supports	support	VBZ	_	0	ROOT
17	the	the	DT	_	18	NMOD
18	postulate	postulate	NN	_	16	OBJ
19	that	that	IN	_	18	NMOD
20	the	the	DT	_	21	NMOD
21	interactions	interaction	NNS	_	35	SBJ
22	of	of	IN	_	21	NMOD
23	the	the	DT	_	28	NMOD
24	N	n	NN	_	26	AMOD
25	-	-	HYPH	_	24	P
26	terminal	terminal	JJ	_	28	NMOD
27	amino	amino	NN	_	28	NMOD
28	group	group	NN	_	22	PMOD
29	with	with	IN	_	21	NMOD
30	the	the	DT	_	32	NMOD
31	side	side	NN	_	32	NMOD
32	chain	chain	NN	_	29	PMOD
33	of	of	IN	_	32	NMOD
34	Asp132	asp0	NN	_	33	PMOD
35	may	may	MD	_	19	SUB
36	be	be	VB	_	35	VC
37	the	the	DT	_	40	NMOD
38	most	most	RBS	_	39	AMOD
39	important	important	JJ	_	40	NMOD
40	feature	feature	NN	_	36	PRD
41	defining	define	VBG	_	40	NMOD
42	the	the	DT	_	44	NMOD
43	tripeptidase	tripeptidase	NN	_	44	NMOD
44	specificity	specificity	NN	_	41	OBJ
45	of	of	IN	_	44	NMOD
46	CLN2	cln0	NN	_	45	PMOD
47	.	.	.	_	16	P

1	A	a	DT	_	2	NMOD
2	number	number	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	different	different	JJ	_	5	NMOD
5	tripeptides	tripeptides	NNS	_	3	PMOD
6	can	can	MD	_	0	ROOT
7	be	be	VB	_	6	VC
8	serially	serially	RB	_	7	ADV
9	processed	process	VBN	_	7	VC
10	from	from	IN	_	9	ADV
11	glucagon	glucagon	NN	_	10	PMOD
12	,	,	,	_	9	P
13	with	with	IN	_	9	ADV
14	their	their	PRP$	_	15	NMOD
15	sequences	sequence	NNS	_	16	SBJ
16	varying	vary	VBG	_	13	PMOD
17	widely	widely	RB	_	16	ADV
18	[	[	-LRB-	_	19	P
19	20	0	CD	_	9	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	6	P

1	Again	again	RB	_	9	ADV
2	,	,	,	_	9	P
3	however	however	RB	_	9	ADV
4	,	,	,	_	9	P
5	all	all	DT	_	9	SBJ
6	of	of	IN	_	5	NMOD
7	these	these	DT	_	8	NMOD
8	tripeptides	tripeptides	NNS	_	6	PMOD
9	can	can	MD	_	0	ROOT
10	be	be	VB	_	9	VC
11	easily	easily	RB	_	10	ADV
12	accommodated	accommodate	VBN	_	10	VC
13	in	in	IN	_	12	LOC
14	the	the	DT	_	18	NMOD
15	substrate	substrate	NN	_	17	AMOD
16	-	-	HYPH	_	15	P
17	binding	bind	VBG	_	18	NMOD
18	site	site	NN	_	13	PMOD
19	of	of	IN	_	18	NMOD
20	the	the	DT	_	22	NMOD
21	CLN2	cln0	NN	_	22	NMOD
22	model	model	NN	_	19	PMOD
23	.	.	.	_	9	P

1	Other	other	JJ	_	5	NMOD
2	potentially	potentially	RB	_	4	AMOD
3	biologically	biologically	RB	_	4	AMOD
4	relevant	relevant	JJ	_	5	NMOD
5	substrates	substrate	NNS	_	6	SBJ
6	include	include	VBP	_	0	ROOT
7	cholecystokinin	cholecystokinin	NN	_	6	OBJ
8	and	and	CC	_	7	COORD
9	possibly	possibly	RB	_	11	NMOD
10	other	other	JJ	_	11	NMOD
11	neuropeptides	neuropeptides	NNS	_	8	CONJ
12	[	[	-LRB-	_	13	P
13	21	0	CD	_	6	PRN
14	]	]	-RRB-	_	13	P
15	.	.	.	_	6	P

1	An	an	DT	_	3	NMOD
2	intriguing	intriguing	JJ	_	3	NMOD
3	property	property	NN	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	CLN2	cln0	NN	_	4	PMOD
6	is	be	VBZ	_	0	ROOT
7	its	its	PRP$	_	9	NMOD
8	reported	report	VBN	_	9	NMOD
9	ability	ability	NN	_	6	PRD
10	to	to	TO	_	9	NMOD
11	cleave	cleave	VB	_	10	IM
12	collagen	collagen	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	related	relate	VBN	_	15	NMOD
15	peptides	peptide	NNS	_	11	OBJ
16	[	[	-LRB-	_	17	P
17	22	0	CD	_	6	PRN
18	]	]	-RRB-	_	17	P
19	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	tripeptides	tripeptides	NNS	_	7	SBJ
3	resulting	result	VBG	_	2	NMOD
4	from	from	IN	_	3	ADV
5	such	such	JJ	_	6	NMOD
6	processing	processing	NN	_	4	PMOD
7	include	include	VBP	_	0	ROOT
8	Gly	gly	NN	_	12	NMOD
9	-	-	HYPH	_	8	P
10	Pro	pro	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	Met	met	NN	_	7	OBJ
13	,	,	,	_	12	P
14	Gly	gly	NN	_	18	NMOD
15	-	-	HYPH	_	14	P
16	Pro	pro	NN	_	18	NMOD
17	-	-	HYPH	_	16	P
18	Arg	arg	NN	_	12	CONJ
19	,	,	,	_	18	P
20	and	and	CC	_	18	COORD
21	Gly	gly	NN	_	25	NMOD
22	-	-	HYPH	_	21	P
23	Pro	pro	NN	_	25	NMOD
24	-	-	HYPH	_	23	P
25	Ala	ala	NN	_	20	CONJ
26	.	.	.	_	7	P

1	It	it	PRP	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	been	be	VBN	_	2	VC
4	recently	recently	RB	_	3	TMP
5	reported	report	VBN	_	3	VC
6	that	that	IN	_	5	OBJ
7	kumamolisin	kumamolisin	NN	_	23	SBJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	particularly	particularly	RB	_	21	NMOD
11	a	a	DT	_	14	NMOD
12	closely	closely	RB	_	13	AMOD
13	related	related	JJ	_	14	NMOD
14	protein	protein	NN	_	21	NMOD
15	from	from	IN	_	14	NMOD
16	Alicyclobacillus	alicyclobacillus	NNP	_	17	NMOD
17	sendaiensis	sendaiensis	NNP	_	15	PMOD
18	(	(	-LRB-	_	21	P
19	kumamolisin	kumamolisin	NNS	_	21	NMOD
20	-	-	HYPH	_	19	P
21	As	a	NNS	_	9	CONJ
22	)	)	-RRB-	_	23	P
23	can	can	MD	_	6	SUB
24	efficiently	efficiently	RB	_	23	ADV
25	cleave	cleave	VB	_	23	VC
26	not	not	RB	_	31	COORD
27	only	only	RB	_	26	ADV
28	collagen	collagen	NN	_	30	AMOD
29	-	-	HYPH	_	28	P
30	related	relate	VBN	_	31	NMOD
31	peptides	peptide	NNS	_	25	OBJ
32	,	,	,	_	31	P
33	but	but	CC	_	31	COORD
34	also	also	RB	_	33	ADV
35	native	native	JJ	_	38	NMOD
36	type	type	NN	_	38	NMOD
37	I	i	CD	_	36	NMOD
38	collagen	collagen	NN	_	33	CONJ
39	[	[	-LRB-	_	40	P
40	23	0	CD	_	5	PRN
41	]	]	-RRB-	_	40	P
42	.	.	.	_	2	P

1	With	with	IN	_	38	ADV
2	the	the	DT	_	6	NMOD
3	substrate	substrate	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	binding	bind	VBG	_	6	NMOD
6	site	site	NN	_	9	SBJ
7	of	of	IN	_	6	NMOD
8	CLN2	cln0	NN	_	7	PMOD
9	resembling	resemble	VBG	_	1	PMOD
10	that	that	DT	_	9	OBJ
11	of	of	IN	_	10	NMOD
12	kumamolisin	kumamolisin	NN	_	11	PMOD
13	more	more	RBR	_	9	ADV
14	than	than	IN	_	13	AMOD
15	sedolisin	sedolisin	NN	_	14	PMOD
16	(	(	-LRB-	_	20	P
17	the	the	DT	_	19	NMOD
18	latter	latter	JJ	_	19	NMOD
19	enzyme	enzyme	NN	_	20	SBJ
20	has	have	VBZ	_	9	PRN
21	low	low	JJ	_	27	NMOD
22	,	,	,	_	23	P
23	if	if	IN	_	27	PRN
24	any	any	DT	_	23	SUB
25	,	,	,	_	23	P
26	collagenase	collagenase	NN	_	27	NMOD
27	activity	activity	NN	_	20	OBJ
28	)	)	-RRB-	_	20	P
29	,	,	,	_	38	P
30	the	the	DT	_	35	NMOD
31	potential	potential	JJ	_	35	NMOD
32	collagen	collagen	NN	_	34	AMOD
33	-	-	HYPH	_	32	P
34	processing	process	VBG	_	35	NMOD
35	role	role	NN	_	38	SBJ
36	of	of	IN	_	35	NMOD
37	CLN2	cln0	NN	_	36	PMOD
38	might	might	MD	_	0	ROOT
39	warrant	warrant	VB	_	38	VC
40	further	further	JJ	_	41	NMOD
41	investigation	investigation	NN	_	39	OBJ
42	.	.	.	_	38	P

1	Conclusions	conclusion	NNS	_	0	ROOT

1	Since	since	IN	_	34	PRP
2	the	the	DT	_	4	NMOD
3	catalytic	catalytic	JJ	_	4	NMOD
4	machinery	machinery	NN	_	7	SBJ
5	of	of	IN	_	4	NMOD
6	CLN2	cln0	NN	_	5	PMOD
7	matches	match	VBZ	_	1	SUB
8	closely	closely	RB	_	7	ADV
9	that	that	DT	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	sedolisin	sedolisin	NN	_	10	PMOD
12	,	,	,	_	11	P
13	kumamolisin	kumamolisin	NN	_	11	CONJ
14	,	,	,	_	13	P
15	and	and	CC	_	13	COORD
16	other	other	JJ	_	17	NMOD
17	members	member	NNS	_	15	CONJ
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	20	NMOD
20	family	family	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	serine	serine	NN	_	24	NMOD
23	-	-	HYPH	_	22	P
24	carboxyl	carboxyl	NN	_	25	NMOD
25	peptidases	peptidase	NNS	_	21	PMOD
26	,	,	,	_	34	P
27	the	the	DT	_	29	NMOD
28	enzymatic	enzymatic	JJ	_	29	NMOD
29	mechanism	mechanism	NN	_	34	SBJ
30	of	of	IN	_	29	NMOD
31	all	all	PDT	_	33	NMOD
32	these	these	DT	_	33	NMOD
33	enzymes	enzyme	NNS	_	30	PMOD
34	is	be	VBZ	_	0	ROOT
35	most	most	RBS	_	36	AMOD
36	likely	likely	RB	_	34	ADV
37	the	the	DT	_	38	NMOD
38	same	same	JJ	_	34	PRD
39	.	.	.	_	34	P

1	Design	design	NN	_	7	SBJ
2	of	of	IN	_	1	NMOD
3	inhibitors	inhibitor	NNS	_	2	PMOD
4	specific	specific	JJ	_	3	NMOD
5	for	for	IN	_	3	NMOD
6	CLN2	cln0	NN	_	5	PMOD
7	should	should	MD	_	0	ROOT
8	incorporate	incorporate	VB	_	7	VC
9	the	the	DT	_	10	NMOD
10	features	feature	NNS	_	8	OBJ
11	that	that	WDT	_	12	SBJ
12	have	have	VBP	_	10	NMOD
13	been	be	VBN	_	12	VC
14	proven	prove	VBN	_	13	VC
15	to	to	TO	_	14	OPRD
16	be	be	VB	_	15	IM
17	important	important	JJ	_	16	PRD
18	for	for	IN	_	16	ADV
19	the	the	DT	_	21	NMOD
20	related	relate	VBN	_	21	NMOD
21	enzymes	enzyme	NNS	_	18	PMOD
22	,	,	,	_	21	P
23	such	such	JJ	_	24	PMOD
24	as	as	IN	_	21	NMOD
25	the	the	DT	_	26	NMOD
26	placement	placement	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	an	an	DT	_	30	NMOD
29	aldehyde	aldehyde	NN	_	30	NMOD
30	functionality	functionality	NN	_	27	PMOD
31	capable	capable	JJ	_	30	NMOD
32	of	of	IN	_	31	AMOD
33	making	make	VBG	_	32	PMOD
34	covalent	covalent	JJ	_	35	NMOD
35	interactions	interaction	NNS	_	33	OBJ
36	with	with	IN	_	35	NMOD
37	the	the	DT	_	39	NMOD
38	catalytic	catalytic	JJ	_	39	NMOD
39	serine	serine	NN	_	36	PMOD
40	,	,	,	_	26	P
41	or	or	CC	_	26	COORD
42	the	the	DT	_	43	NMOD
43	utilization	utilization	NN	_	41	CONJ
44	of	of	IN	_	43	NMOD
45	chloromethyl	chloromethyl	NN	_	46	NMOD
46	ketone	ketone	NN	_	44	PMOD
47	for	for	IN	_	43	NMOD
48	the	the	DT	_	50	NMOD
49	same	same	JJ	_	50	NMOD
50	purpose	purpose	NN	_	47	PMOD
51	.	.	.	_	7	P

1	Since	since	IN	_	38	PRP
2	the	the	DT	_	4	NMOD
3	few	few	JJ	_	4	NMOD
4	inhibitors	inhibitor	NNS	_	15	SBJ
5	that	that	WDT	_	6	SBJ
6	have	have	VBP	_	4	NMOD
7	been	be	VBN	_	6	VC
8	successfully	successfully	RB	_	7	ADV
9	used	use	VBN	_	7	VC
10	in	in	IN	_	9	ADV
11	the	the	DT	_	12	NMOD
12	studies	study	NNS	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	sedolisins	sedolisins	NNS	_	13	PMOD
15	are	be	VBP	_	1	SUB
16	either	either	RB	_	15	PRD
17	longer	long	JJR	_	16	DEP
18	than	than	IN	_	17	AMOD
19	tripeptides	tripeptides	NNS	_	18	PMOD
20	or	or	CC	_	17	COORD
21	contain	contain	VB	_	20	CONJ
22	blocking	block	VBG	_	23	NMOD
23	groups	group	NNS	_	21	OBJ
24	on	on	IN	_	21	LOC
25	their	their	PRP$	_	27	NMOD
26	N	n	NN	_	27	NMOD
27	termini	terminus	NNS	_	24	PMOD
28	,	,	,	_	38	P
29	new	new	JJ	_	33	NMOD
30	tripeptide	tripeptide	NN	_	32	AMOD
31	-	-	HYPH	_	30	P
32	based	base	VBN	_	33	NMOD
33	inhibitors	inhibitor	NNS	_	38	SBJ
34	with	with	IN	_	33	NMOD
35	free	free	JJ	_	37	NMOD
36	N	n	NN	_	37	NMOD
37	termini	terminus	NNS	_	34	PMOD
38	are	be	VBP	_	0	ROOT
39	now	now	RB	_	38	TMP
40	being	be	VBG	_	38	VC
41	synthesized	synthesize	VBN	_	40	VC
42	(	(	-LRB-	_	43	P
43	Oda	oda	NNP	_	41	CIT
44	,	,	,	_	43	P
45	unpublished	unpublished	JJ	_	43	DEP
46	)	)	-RRB-	_	43	P
47	.	.	.	_	38	P

1	It	it	PRP	_	2	SBJ
2	will	will	MD	_	0	ROOT
3	be	be	VB	_	2	VC
4	necessary	necessary	JJ	_	3	PRD
5	to	to	TO	_	3	OPRD
6	test	test	VB	_	5	IM
7	the	the	DT	_	9	NMOD
8	binding	binding	NN	_	9	NMOD
9	properties	property	NNS	_	6	OBJ
10	of	of	IN	_	9	NMOD
11	different	different	JJ	_	12	NMOD
12	substrates	substrate	NNS	_	10	PMOD
13	in	in	IN	_	6	ADV
14	order	order	NN	_	13	PMOD
15	to	to	TO	_	14	NMOD
16	determine	determine	VB	_	15	IM
17	the	the	DT	_	21	NMOD
18	most	most	RBS	_	19	AMOD
19	promising	promising	JJ	_	21	NMOD
20	peptide	peptide	NN	_	21	NMOD
21	sequences	sequence	NNS	_	16	OBJ
22	.	.	.	_	2	P

1	Analysis	analysis	NN	_	7	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	model	model	NN	_	2	PMOD
5	of	of	IN	_	4	NMOD
6	CLN2	cln0	NN	_	5	PMOD
7	suggests	suggest	VBZ	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	the	the	DT	_	10	NMOD
10	size	size	NN	_	15	SBJ
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	S1	s0	NN	_	14	NMOD
14	subsite	subsite	NN	_	11	PMOD
15	is	be	VBZ	_	8	SUB
16	much	much	RB	_	17	AMOD
17	larger	large	JJR	_	15	PRD
18	than	than	IN	_	17	AMOD
19	in	in	IN	_	18	LOC
20	either	either	CC	_	21	COORD
21	sedolisin	sedolisin	NN	_	19	PMOD
22	or	or	CC	_	21	COORD
23	kumamolisin	kumamolisin	NN	_	22	CONJ
24	,	,	,	_	15	P
25	and	and	CC	_	15	COORD
26	thus	thus	RB	_	34	ADV
27	the	the	DT	_	28	NMOD
28	use	use	NN	_	34	SBJ
29	of	of	IN	_	28	NMOD
30	a	a	DT	_	33	NMOD
31	large	large	JJ	_	33	NMOD
32	P1	p0	NN	_	33	NMOD
33	group	group	NN	_	29	PMOD
34	might	might	MD	_	25	CONJ
35	be	be	VB	_	34	VC
36	indicated	indicate	VBN	_	35	VC
37	.	.	.	_	7	P

1	Of	of	RB	_	2	AMOD
2	course	course	RB	_	11	ADV
3	,	,	,	_	11	P
4	the	the	DT	_	5	NMOD
5	availability	availability	NN	_	11	SBJ
6	of	of	IN	_	5	NMOD
7	an	an	DT	_	10	NMOD
8	experimental	experimental	JJ	_	10	NMOD
9	crystal	crystal	JJ	_	10	NMOD
10	structure	structure	NN	_	6	PMOD
11	will	will	MD	_	0	ROOT
12	make	make	VB	_	11	VC
13	the	the	DT	_	14	NMOD
14	design	design	NN	_	12	OBJ
15	of	of	IN	_	14	NMOD
16	inhibitors	inhibitor	NNS	_	15	PMOD
17	easier	easy	JJR	_	14	OPRD
18	and	and	CC	_	11	COORD
19	we	we	PRP	_	20	SBJ
20	are	be	VBP	_	18	CONJ
21	continuing	continue	VBG	_	20	VC
22	our	our	PRP$	_	23	NMOD
23	efforts	effort	NNS	_	21	OBJ
24	to	to	TO	_	23	NMOD
25	crystallize	crystallize	VB	_	24	IM
26	CLN2	cln0	NN	_	25	OBJ
27	from	from	IN	_	25	ADV
28	different	different	JJ	_	29	NMOD
29	sources	source	NNS	_	27	PMOD
30	.	.	.	_	11	P

1	Methods	method	NNS	_	0	ROOT

1	Homology	homology	NN	_	2	NMOD
2	modeling	modeling	NN	_	0	ROOT

1	Three	three	CD	_	3	AMOD
2	-	-	HYPH	_	1	P
3	dimensional	dimensional	JJ	_	8	NMOD
4	,	,	,	_	8	P
5	atomic	atomic	JJ	_	7	NMOD
6	-	-	HYPH	_	5	P
7	scale	scale	NN	_	8	NMOD
8	models	model	NNS	_	11	SBJ
9	of	of	IN	_	8	NMOD
10	CLN2	cln0	NN	_	9	PMOD
11	were	be	VBD	_	0	ROOT
12	developed	develop	VBN	_	11	VC
13	by	by	IN	_	12	MNR
14	exploiting	exploit	VBG	_	13	PMOD
15	the	the	DT	_	17	NMOD
16	sequence	sequence	NN	_	17	NMOD
17	similarity	similarity	NN	_	14	OBJ
18	to	to	IN	_	17	NMOD
19	the	the	DT	_	23	NMOD
20	sedolisin	sedolisin	NN	_	23	NMOD
21	and	and	CC	_	20	COORD
22	kumamolisin	kumamolisin	NN	_	21	CONJ
23	proteins	protein	NNS	_	18	PMOD
24	(	(	-LRB-	_	26	P
25	r.m.s.	r.m.s.	NN	_	26	NMOD
26	deviation	deviation	NN	_	17	PRN
27	of	of	IN	_	26	NMOD
28	1.0	0	CD	_	27	PMOD
29	Å	å	SYM	_	28	P
30	for	for	IN	_	26	NMOD
31	273	0	CD	_	32	NMOD
32	pairs	pair	NNS	_	30	PMOD
33	of	of	IN	_	32	NMOD
34	Cα	cα	NN	_	35	NMOD
35	atoms	atom	NNS	_	33	PMOD
36	in	in	IN	_	26	LOC
37	the	the	DT	_	38	NMOD
38	core	core	NN	_	36	PMOD
39	of	of	IN	_	38	NMOD
40	the	the	DT	_	41	NMOD
41	enzymes	enzyme	NNS	_	39	PMOD
42	)	)	-RRB-	_	26	P
43	.	.	.	_	11	P

1	Presently	presently	RB	_	6	TMP
2	,	,	,	_	6	P
3	these	these	DT	_	5	NMOD
4	two	two	CD	_	5	NMOD
5	enzymes	enzyme	NNS	_	6	SBJ
6	are	be	VBP	_	0	ROOT
7	the	the	DT	_	9	NMOD
8	only	only	JJ	_	9	NMOD
9	members	member	NNS	_	6	PRD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	21	NMOD
12	newly	newly	RB	_	14	AMOD
13	-	-	HYPH	_	12	P
14	defined	define	VBN	_	21	NMOD
15	sedolisin	sedolisin	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	serine	serine	NN	_	19	NMOD
18	-	-	HYPH	_	17	P
19	carboxyl	carboxyl	NN	_	20	NMOD
20	peptidase	peptidase	NN	_	21	NMOD
21	family	family	NN	_	10	PMOD
22	[	[	-LRB-	_	23	P
23	8	0	CD	_	9	PRN
24	]	]	-RRB-	_	23	P
25	for	for	IN	_	32	ADV
26	which	which	WDT	_	25	PMOD
27	the	the	DT	_	29	NMOD
28	crystal	crystal	JJ	_	29	NMOD
29	structures	structure	NNS	_	30	SBJ
30	have	have	VBP	_	9	NMOD
31	been	be	VBN	_	30	VC
32	published	publish	VBN	_	31	VC
33	[	[	-LRB-	_	34	P
34	5	0	CD	_	32	PRN
35	-	-	SYM	_	36	P
36	7	0	CD	_	34	NMOD
37	]	]	-RRB-	_	34	P
38	.	.	.	_	6	P

1	The	the	DT	_	11	NMOD
2	actual	actual	JJ	_	11	NMOD
3	Protein	protein	NNP	_	5	NMOD
4	Data	datum	NNP	_	5	NMOD
5	Bank	bank	NNP	_	11	NMOD
6	[	[	-LRB-	_	7	P
7	24	0	CD	_	5	PRN
8	]	]	-RRB-	_	7	P
9	:	:	:	_	7	P
10	)	)	-RRB-	_	7	P
11	entries	entry	NNS	_	16	SBJ
12	used	use	VBN	_	11	NMOD
13	in	in	IN	_	12	ADV
14	the	the	DT	_	15	NMOD
15	modeling	modeling	NN	_	13	PMOD
16	were	be	VBD	_	0	ROOT
17	1GA4.pdb	0ga0.pdb	NN	_	16	PRD
18	and	and	CC	_	17	COORD
19	1GT9.pdb	0gt0.pdb	NN	_	18	CONJ
20	for	for	IN	_	17	NMOD
21	sedolisin	sedolisin	NN	_	20	PMOD
22	and	and	CC	_	21	COORD
23	kumamolisin	kumamolisin	NN	_	22	CONJ
24	,	,	,	_	16	P
25	respectively	respectively	RB	_	16	ADV
26	.	.	.	_	16	P

1	The	the	DT	_	3	NMOD
2	first	$#ORD#$	JJ	_	3	NMOD
3	step	step	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	to	to	TO	_	4	PRD
6	form	form	VB	_	5	IM
7	a	a	DT	_	12	NMOD
8	global	global	JJ	_	12	NMOD
9	,	,	,	_	12	P
10	multiple	multiple	JJ	_	11	NMOD
11	sequence	sequence	NN	_	12	NMOD
12	alignment	alignment	NN	_	6	OBJ
13	between	between	IN	_	6	ADV
14	all	all	DT	_	16	NMOD
15	known	know	VBN	_	16	NMOD
16	members	member	NNS	_	13	PMOD
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	sedolisin	sedolisin	NN	_	20	NMOD
20	family	family	NN	_	17	PMOD
21	.	.	.	_	4	P

1	Studies	study	NNS	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	shown	show	VBN	_	2	VC
4	that	that	IN	_	3	OBJ
5	incorporating	incorporate	VBG	_	24	SBJ
6	the	the	DT	_	8	NMOD
7	specific	specific	JJ	_	8	NMOD
8	patterns	pattern	NNS	_	5	OBJ
9	of	of	IN	_	8	NMOD
10	amino	amino	NN	_	11	NMOD
11	acid	acid	NN	_	15	NMOD
12	residue	residue	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	type	type	NN	_	15	NMOD
15	variation	variation	NN	_	9	PMOD
16	and	and	CC	_	15	COORD
17	conservation	conservation	NN	_	16	CONJ
18	among	among	IN	_	8	NMOD
19	a	a	DT	_	20	NMOD
20	family	family	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	homologous	homologous	JJ	_	23	NMOD
23	proteins	protein	NNS	_	21	PMOD
24	provides	provide	VBZ	_	4	SUB
25	superior	superior	JJ	_	26	NMOD
26	results	result	NNS	_	24	OBJ
27	over	over	IN	_	24	ADV
28	simple	simple	JJ	_	32	NMOD
29	,	,	,	_	32	P
30	pair-wise	pair-wise	JJ	_	32	NMOD
31	sequence	sequence	NN	_	32	NMOD
32	alignment	alignment	NN	_	27	PMOD
33	[	[	-LRB-	_	34	P
34	25	0	CD	_	3	PRN
35	]	]	-RRB-	_	34	P
36	.	.	.	_	2	P

1	Sequence	sequence	NN	_	2	NMOD
2	files	file	NNS	_	7	SBJ
3	representing	represent	VBG	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	different	different	JJ	_	6	NMOD
6	subfamilies	subfamily	NNS	_	3	OBJ
7	were	be	VBD	_	0	ROOT
8	extracted	extract	VBN	_	7	VC
9	from	from	IN	_	8	ADV
10	the	the	DT	_	13	NMOD
11	non-redundant	non-redundant	JJ	_	13	NMOD
12	GenBank	genbank	NNP	_	13	NMOD
13	database	database	NN	_	9	PMOD
14	[	[	-LRB-	_	15	P
15	26	0	CD	_	13	PRN
16	]	]	-RRB-	_	15	P
17	using	use	VBG	_	8	MNR
18	sedolisin	sedolisin	NN	_	17	OBJ
19	,	,	,	_	18	P
20	kumamolisin	kumamolisin	NN	_	18	CONJ
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	the	the	DT	_	26	NMOD
24	human	human	JJ	_	25	NMOD
25	CLN2	cln0	NN	_	26	NMOD
26	sequences	sequence	NNS	_	22	CONJ
27	as	as	IN	_	17	ADV
28	queries	query	NNS	_	27	PMOD
29	to	to	IN	_	28	NMOD
30	the	the	DT	_	34	NMOD
31	web	web	NN	_	33	AMOD
32	-	-	HYPH	_	31	P
33	based	base	VBN	_	34	NMOD
34	version	version	NN	_	29	PMOD
35	of	of	IN	_	34	NMOD
36	the	the	DT	_	38	NMOD
37	BLAST	blast	NN	_	38	NMOD
38	program	program	NN	_	35	PMOD
39	[	[	-LRB-	_	40	P
40	27	0	CD	_	8	PRN
41	]	]	-RRB-	_	40	P
42	:	:	:	_	7	P
43	.	.	.	_	7	P

1	Initial	initial	JJ	_	4	NMOD
2	multiple	multiple	JJ	_	3	NMOD
3	sequence	sequence	NN	_	4	NMOD
4	alignments	alignment	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	formed	form	VBN	_	5	VC
7	with	with	IN	_	6	MNR
8	the	the	DT	_	11	NMOD
9	ClustalX	clustalx	NN	_	11	NMOD
10	computer	computer	NN	_	11	NMOD
11	program	program	NN	_	7	PMOD
12	[	[	-LRB-	_	13	P
13	28	0	CD	_	6	PRN
14	]	]	-RRB-	_	13	P
15	.	.	.	_	5	P

1	As	as	IN	_	14	ADV
2	is	be	VBZ	_	1	SUB
3	expected	expect	VBN	_	2	VC
4	for	for	IN	_	3	ADV
5	a	a	DT	_	6	NMOD
6	family	family	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	proteins	protein	NNS	_	7	PMOD
9	,	,	,	_	14	P
10	highly	highly	RB	_	12	AMOD
11	-	-	HYPH	_	10	P
12	conserved	conserve	VBN	_	13	NMOD
13	segments	segment	NNS	_	14	SBJ
14	were	be	VBD	_	0	ROOT
15	found	find	VBN	_	14	VC
16	aligned	align	VBN	_	15	OPRD
17	to	to	IN	_	16	ADV
18	the	the	DT	_	24	NMOD
19	crystal	crystal	JJ	_	24	NMOD
20	structure	structure	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	identified	identify	VBN	_	24	NMOD
23	core	core	NN	_	24	NMOD
24	regions	region	NNS	_	17	PMOD
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	30	NMOD
27	sedolisin	sedolisin	NN	_	30	NMOD
28	and	and	CC	_	27	COORD
29	kumamolisin	kumamolisin	NN	_	28	CONJ
30	sequences	sequence	NNS	_	25	PMOD
31	.	.	.	_	14	P

1	Subsequently	subsequently	RB	_	5	TMP
2	,	,	,	_	5	P
3	the	the	DT	_	4	NMOD
4	sequences	sequence	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	divided	divide	VBN	_	5	VC
7	into	into	IN	_	6	ADV
8	two	two	CD	_	9	NMOD
9	groups	group	NNS	_	11	NMOD
10	:	:	:	_	11	P
11	those	those	DT	_	7	PMOD
12	closer	closer	RBR	_	13	AMOD
13	to	to	IN	_	11	NMOD
14	sedolisin	sedolisin	NN	_	13	PMOD
15	than	than	IN	_	13	AMOD
16	kumamolisin	kumamolisin	NN	_	15	PMOD
17	and	and	CC	_	11	COORD
18	vise	vise	FW	_	22	NMOD
19	-	-	HYPH	_	18	P
20	a	a	FW	_	22	NMOD
21	-	-	HYPH	_	20	P
22	versa	versa	FW	_	17	CONJ
23	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	alignment	alignment	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	these	these	DT	_	6	NMOD
5	two	two	CD	_	6	NMOD
6	groups	group	NNS	_	3	PMOD
7	was	be	VBD	_	0	ROOT
8	then	then	RB	_	7	TMP
9	manually	manually	RB	_	7	MNR
10	set	set	VBN	_	7	VC
11	by	by	IN	_	10	MNR
12	the	the	DT	_	15	NMOD
13	observed	observe	VBN	_	15	NMOD
14	structural	structural	JJ	_	15	NMOD
15	alignment	alignment	NN	_	11	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	21	NMOD
18	sedolisin	sedolisin	NN	_	21	NMOD
19	and	and	CC	_	18	COORD
20	kumamolisin	kumamolisin	NN	_	19	CONJ
21	proteins	protein	NNS	_	16	PMOD
22	.	.	.	_	7	P

1	Finally	finally	RB	_	6	ADV
2	,	,	,	_	6	P
3	some	some	DT	_	5	NMOD
4	additional	additional	JJ	_	5	NMOD
5	adjustment	adjustment	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	required	require	VBN	_	6	VC
8	to	to	TO	_	7	PRP
9	correct	correct	VB	_	8	IM
10	the	the	DT	_	12	NMOD
11	few	few	JJ	_	12	NMOD
12	places	place	NNS	_	9	OBJ
13	where	where	WRB	_	21	LOC
14	highly	highly	RB	_	15	AMOD
15	conserved	conserve	VBN	_	16	NMOD
16	residues	residue	NNS	_	21	SBJ
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	core	core	NN	_	20	NMOD
20	regions	region	NNS	_	17	PMOD
21	were	be	VBD	_	12	NMOD
22	slightly	slightly	RB	_	23	PMOD
23	out	out	IN	_	21	PRD
24	of	of	IN	_	23	PMOD
25	alignment	alignment	NN	_	24	PMOD
26	among	among	IN	_	21	ADV
27	different	different	JJ	_	28	NMOD
28	subfamilies	subfamily	NNS	_	26	PMOD
29	of	of	IN	_	28	NMOD
30	sequences	sequence	NNS	_	29	PMOD
31	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	model	model	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	human	human	JJ	_	5	NMOD
5	CLN2	cln0	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	built	build	VBN	_	6	VC
8	using	use	VBG	_	7	MNR
9	the	the	DT	_	10	NMOD
10	structure	structure	NN	_	8	OBJ
11	of	of	IN	_	10	NMOD
12	sedolisin	sedolisin	NN	_	11	PMOD
13	complexed	complexed	VBN	_	12	NMOD
14	with	with	IN	_	13	ADV
15	the	the	DT	_	16	NMOD
16	inhibitor	inhibitor	NN	_	17	NMOD
17	pseudo-tyrostatin	pseudo-tyrostatin	NN	_	14	PMOD
18	[	[	-LRB-	_	21	P
19	5	0	CD	_	21	NMOD
20	,	,	,	_	21	P
21	6	0	CD	_	10	PRN
22	]	]	-RRB-	_	21	P
23	as	as	IN	_	8	ADV
24	a	a	DT	_	25	NMOD
25	template	template	NN	_	23	PMOD
26	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	reason	reason	NN	_	6	SBJ
3	for	for	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	choice	choice	NN	_	3	PMOD
6	is	be	VBZ	_	0	ROOT
7	that	that	IN	_	6	PRD
8	while	while	IN	_	19	ADV
9	different	different	JJ	_	11	NMOD
10	protein	protein	NN	_	11	NMOD
11	models	model	NNS	_	12	SBJ
12	were	be	VBD	_	8	SUB
13	generally	generally	RB	_	14	AMOD
14	comparable	comparable	JJ	_	12	PRD
15	,	,	,	_	19	P
16	the	the	DT	_	18	NMOD
17	chosen	choose	VBN	_	18	NMOD
18	inhibitor	inhibitor	NN	_	19	SBJ
19	was	be	VBD	_	7	SUB
20	most	most	RBS	_	21	AMOD
21	compatible	compatible	JJ	_	19	PRD
22	with	with	IN	_	21	AMOD
23	the	the	DT	_	25	NMOD
24	tripeptidase	tripeptidase	NN	_	25	NMOD
25	character	character	NN	_	22	PMOD
26	of	of	IN	_	25	NMOD
27	CLN2	cln0	NN	_	26	PMOD
28	.	.	.	_	6	P

1	With	with	IN	_	13	ADV
2	the	the	DT	_	3	NMOD
3	correspondence	correspondence	NN	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	residues	residue	NNS	_	4	PMOD
6	specified	specify	VBN	_	1	SUB
7	in	in	IN	_	6	ADV
8	the	the	DT	_	9	NMOD
9	alignments	alignment	NNS	_	7	PMOD
10	,	,	,	_	13	P
11	atomic	atomic	JJ	_	12	NMOD
12	coordinates	coordinate	NNS	_	13	SBJ
13	were	be	VBD	_	0	ROOT
14	transferred	transfer	VBN	_	13	VC
15	to	to	IN	_	14	DIR
16	the	the	DT	_	18	NMOD
17	target	target	NN	_	18	NMOD
18	sequence	sequence	NN	_	15	PMOD
19	by	by	IN	_	14	MNR
20	a	a	DT	_	21	NMOD
21	variety	variety	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	methods	method	NNS	_	22	PMOD
24	,	,	,	_	21	P
25	including	include	VBG	_	21	NMOD
26	the	the	DT	_	29	NMOD
27	homology	homology	NN	_	28	AMOD
28	modeling	model	VBG	_	29	NMOD
29	modules	module	NNS	_	25	PMOD
30	of	of	IN	_	29	NMOD
31	the	the	DT	_	45	NMOD
32	Look	look	NN	_	34	NMOD
33	/	/	HYPH	_	32	P
34	GeneMine	genemine	NN	_	45	NMOD
35	[	[	-LRB-	_	36	P
36	29	0	CD	_	34	PRN
37	]	]	-RRB-	_	36	P
38	and	and	CC	_	34	COORD
39	DeepView	deepview	NN	_	38	CONJ
40	[	[	-LRB-	_	41	P
41	30	0	CD	_	39	PRN
42	]	]	-RRB-	_	41	P
43	computer	computer	NN	_	44	NMOD
44	program	program	NN	_	45	NMOD
45	packages	package	NNS	_	30	PMOD
46	.	.	.	_	13	P

1	For	for	IN	_	15	ADV
2	the	the	DT	_	3	NMOD
3	core	core	NN	_	1	PMOD
4	and	and	CC	_	3	COORD
5	active	active	JJ	_	6	NMOD
6	site	site	NN	_	4	CONJ
7	of	of	IN	_	3	NMOD
8	the	the	DT	_	9	NMOD
9	protein	protein	NN	_	7	PMOD
10	,	,	,	_	15	P
11	coordinates	coordinate	VBZ	_	15	SBJ
12	for	for	IN	_	11	NMOD
13	identical	identical	JJ	_	14	NMOD
14	residues	residue	NNS	_	12	PMOD
15	were	be	VBD	_	0	ROOT
16	simply	simply	RB	_	15	ADV
17	transferred	transfer	VBN	_	15	VC
18	unchanged	unchanged	JJ	_	17	ADV
19	;	;	:	_	17	P
20	whereas	whereas	IN	_	17	ADV
21	,	,	,	_	20	P
22	special	special	JJ	_	23	NMOD
23	care	care	NN	_	24	SBJ
24	was	be	VBD	_	20	SUB
25	required	require	VBN	_	24	VC
26	to	to	TO	_	25	PRP
27	position	position	VB	_	26	IM
28	the	the	DT	_	30	NMOD
29	side	side	NN	_	30	NMOD
30	chains	chain	NNS	_	27	OBJ
31	of	of	IN	_	30	NMOD
32	residues	residue	NNS	_	31	PMOD
33	differing	differ	VBG	_	32	NMOD
34	from	from	IN	_	33	ADV
35	the	the	DT	_	36	NMOD
36	template	template	NN	_	34	PMOD
37	.	.	.	_	15	P

1	This	this	DT	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	first	$#ORD#$	RB	_	4	TMP
4	accomplished	accomplish	VBN	_	2	VC
5	automatically	automatically	RB	_	4	MNR
6	by	by	IN	_	4	MNR
7	the	the	DT	_	10	NMOD
8	two	two	CD	_	10	NMOD
9	computer	computer	NN	_	10	NMOD
10	packages	package	NNS	_	6	PMOD
11	,	,	,	_	4	P
12	then	then	RB	_	14	TMP
13	manually	manually	RB	_	14	MNR
14	adjusted	adjust	VBN	_	4	VC
15	in	in	IN	_	14	ADV
16	the	the	DT	_	20	NMOD
17	Quanta	quantum	NNP	_	20	NMOD
18	molecular	molecular	JJ	_	19	NMOD
19	modeling	modeling	NN	_	20	NMOD
20	package	package	NN	_	15	PMOD
21	(	(	-LRB-	_	24	P
22	Accelrys	accelrys	NNP	_	24	NMOD
23	,	,	,	_	24	P
24	Inc.	inc.	NNP	_	20	PRN
25	)	)	-RRB-	_	24	P
26	to	to	TO	_	14	PRP
27	better	well	RBR	_	26	ADV
28	mimic	mimic	VB	_	26	IM
29	the	the	DT	_	30	NMOD
30	templates	template	NNS	_	28	OBJ
31	and	and	CC	_	28	COORD
32	optimize	optimize	VB	_	31	CONJ
33	the	the	DT	_	34	NMOD
34	interactions	interaction	NNS	_	32	OBJ
35	with	with	IN	_	34	NMOD
36	surrounding	surround	VBG	_	37	NMOD
37	residues	residue	NNS	_	35	PMOD
38	.	.	.	_	2	P

1	A	a	DT	_	6	NMOD
2	similar	similar	JJ	_	6	NMOD
3	two	two	CD	_	5	NMOD
4	-	-	HYPH	_	3	P
5	step	step	NN	_	6	NMOD
6	approach	approach	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	used	use	VBN	_	7	VC
9	to	to	TO	_	8	PRP
10	manifest	manifest	VB	_	9	IM
11	the	the	DT	_	12	NMOD
12	insertions	insertion	NNS	_	10	OBJ
13	and	and	CC	_	12	COORD
14	deletions	deletion	NNS	_	13	CONJ
15	in	in	IN	_	12	LOC
16	the	the	DT	_	20	NMOD
17	variable	variable	JJ	_	20	NMOD
18	,	,	,	_	20	P
19	loop	loop	NN	_	20	NMOD
20	regions	region	NNS	_	15	PMOD
21	of	of	IN	_	20	NMOD
22	the	the	DT	_	23	NMOD
23	protein	protein	NN	_	21	PMOD
24	,	,	,	_	23	P
25	where	where	WRB	_	27	LOC
26	it	it	PRP	_	27	SBJ
27	was	be	VBD	_	23	NMOD
28	necessary	necessary	JJ	_	27	PRD
29	to	to	TO	_	27	OPRD
30	create	create	VB	_	29	IM
31	new	new	JJ	_	32	NMOD
32	backbone	backbone	NN	_	30	OBJ
33	as	as	RB	_	35	ADV
34	well	well	RB	_	35	ADV
35	as	as	IN	_	32	COORD
36	side	side	NN	_	37	NMOD
37	chain	chain	NN	_	35	CONJ
38	coordinates	coordinate	VBZ	_	37	NMOD
39	for	for	IN	_	30	ADV
40	the	the	DT	_	41	NMOD
41	models	model	NNS	_	39	PMOD
42	.	.	.	_	7	P

1	It	it	PRP	_	2	SBJ
2	should	should	MD	_	0	ROOT
3	be	be	VB	_	2	VC
4	noted	note	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	,	,	,	_	5	P
7	for	for	IN	_	18	ADV
8	obvious	obvious	JJ	_	9	NMOD
9	reasons	reason	NNS	_	7	PMOD
10	,	,	,	_	18	P
11	the	the	DT	_	12	NMOD
12	conformation	conformation	NN	_	18	SBJ
13	of	of	IN	_	12	NMOD
14	poorly	poorly	RB	_	15	AMOD
15	conserved	conserve	VBN	_	17	NMOD
16	loop	loop	NN	_	17	NMOD
17	regions	region	NNS	_	13	PMOD
18	is	be	VBZ	_	5	SUB
19	generally	generally	RB	_	18	ADV
20	the	the	DT	_	23	NMOD
21	least	least	JJS	_	22	AMOD
22	accurate	accurate	JJ	_	23	NMOD
23	aspect	aspect	NN	_	18	PRD
24	of	of	IN	_	23	NMOD
25	a	a	DT	_	27	NMOD
26	homology	homology	NN	_	27	NMOD
27	model	model	NN	_	24	PMOD
28	.	.	.	_	2	P

1	Fortunately	fortunately	RB	_	6	ADV
2	,	,	,	_	6	P
3	these	these	DT	_	5	NMOD
4	problematic	problematic	JJ	_	5	NMOD
5	loops	loop	NNS	_	6	SBJ
6	will	will	MD	_	0	ROOT
7	not	not	RB	_	6	ADV
8	significantly	significantly	RB	_	6	ADV
9	affect	affect	VB	_	6	VC
10	the	the	DT	_	12	NMOD
11	active	active	JJ	_	12	NMOD
12	site	site	NN	_	9	OBJ
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	model	model	NN	_	13	PMOD
16	,	,	,	_	9	P
17	since	since	IN	_	9	PRP
18	only	only	RB	_	19	NMOD
19	two	two	CD	_	22	SBJ
20	of	of	IN	_	19	NMOD
21	them	them	PRP	_	20	PMOD
22	impinge	impinge	VBP	_	17	SUB
23	on	on	IN	_	22	ADV
24	the	the	DT	_	25	NMOD
25	boundary	boundary	NN	_	23	PMOD
26	of	of	IN	_	25	NMOD
27	this	this	DT	_	32	NMOD
28	highly	highly	RB	_	29	AMOD
29	conserved	conserve	VBN	_	32	NMOD
30	,	,	,	_	32	P
31	functional	functional	JJ	_	32	NMOD
32	region	region	NN	_	26	PMOD
33	.	.	.	_	6	P

1	Refinement	refinement	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	analysis	analysis	NN	_	2	CONJ
4	of	of	IN	_	1	NMOD
5	the	the	DT	_	6	NMOD
6	model	model	NN	_	4	PMOD

1	The	the	DT	_	2	NMOD
2	model	model	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	finished	finish	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	performing	perform	VBG	_	5	PMOD
7	energy	energy	NN	_	8	NMOD
8	minimization	minimization	NN	_	6	OBJ
9	in	in	FW	_	10	AMOD
10	vacuo	vacuo	FW	_	6	LOC
11	with	with	IN	_	6	MNR
12	the	the	DT	_	14	NMOD
13	computer	computer	NN	_	14	NMOD
14	program	program	NN	_	15	NMOD
15	CHARMM	charmm	NN	_	11	PMOD
16	[	[	-LRB-	_	17	P
17	31	0	CD	_	4	PRN
18	]	]	-RRB-	_	17	P
19	.	.	.	_	3	P

1	This	this	DT	_	2	SBJ
2	refined	refine	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	structure	structure	NN	_	2	OBJ
5	by	by	IN	_	2	MNR
6	bringing	bring	VBG	_	5	PMOD
7	the	the	DT	_	9	NMOD
8	covalent	covalent	JJ	_	9	NMOD
9	geometry	geometry	NN	_	6	OBJ
10	and	and	CC	_	9	COORD
11	non-bonded	non-bonded	JJ	_	12	NMOD
12	interactions	interaction	NNS	_	10	CONJ
13	into	into	IN	_	6	ADV
14	agreement	agreement	NN	_	13	PMOD
15	with	with	IN	_	14	NMOD
16	experimentally	experimentally	RB	_	17	AMOD
17	observed	observe	VBN	_	20	NMOD
18	and	and	CC	_	17	COORD
19	calculated	calculate	VBN	_	18	CONJ
20	values	value	NNS	_	15	PMOD
21	.	.	.	_	2	P

1	Such	such	JJ	_	2	NMOD
2	optimizations	optimization	NNS	_	3	SBJ
3	included	include	VBD	_	0	ROOT
4	adjusting	adjust	VBG	_	3	OPRD
5	bond	bond	NN	_	6	NMOD
6	lengths	length	NNS	_	4	OBJ
7	,	,	,	_	6	P
8	3	0	CD	_	10	NMOD
9	-	-	HYPH	_	8	P
10	point	point	NN	_	11	NMOD
11	angles	angle	NNS	_	6	CONJ
12	and	and	CC	_	11	COORD
13	4	0	CD	_	15	NMOD
14	-	-	HYPH	_	13	P
15	point	point	NN	_	17	NMOD
16	dihedral	dihedral	JJ	_	17	NMOD
17	angles	angle	NNS	_	12	CONJ
18	,	,	,	_	4	P
19	as	as	RB	_	21	ADV
20	well	well	RB	_	21	ADV
21	as	as	IN	_	4	COORD
22	eliminating	eliminate	VBG	_	21	CONJ
23	atomic	atomic	JJ	_	24	NMOD
24	overlap	overlap	NN	_	22	OBJ
25	and	and	CC	_	22	COORD
26	forming	form	VBG	_	25	CONJ
27	salt	salt	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	bridges	bridge	NNS	_	26	OBJ
30	and	and	CC	_	29	COORD
31	hydrogen	hydrogen	NN	_	32	NMOD
32	bonds	bond	NNS	_	30	CONJ
33	.	.	.	_	3	P

1	Since	since	IN	_	28	PRP
2	presently	presently	RB	_	15	TMP
3	the	the	DT	_	6	NMOD
4	potential	potential	JJ	_	6	NMOD
5	energy	energy	NN	_	6	NMOD
6	functions	function	NNS	_	15	SBJ
7	used	use	VBN	_	6	NMOD
8	to	to	TO	_	7	PRP
9	describe	describe	VB	_	8	IM
10	the	the	DT	_	14	NMOD
11	atomic	atomic	JJ	_	13	NMOD
12	-	-	HYPH	_	11	P
13	scale	scale	NN	_	14	NMOD
14	models	model	NNS	_	9	OBJ
15	are	be	VBP	_	1	SUB
16	not	not	RB	_	15	ADV
17	sufficiently	sufficiently	RB	_	18	AMOD
18	comprehensive	comprehensive	JJ	_	15	PRD
19	and	and	CC	_	18	COORD
20	accurate	accurate	JJ	_	19	CONJ
21	,	,	,	_	28	P
22	the	the	DT	_	24	NMOD
23	final	final	JJ	_	24	NMOD
24	energy	energy	NN	_	28	SBJ
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	27	NMOD
27	model	model	NN	_	25	PMOD
28	was	be	VBD	_	0	ROOT
29	not	not	RB	_	28	ADV
30	used	use	VBN	_	28	VC
31	as	as	IN	_	30	PRP
32	an	an	DT	_	33	NMOD
33	indicator	indicator	NN	_	31	PMOD
34	of	of	IN	_	33	NMOD
35	the	the	DT	_	37	NMOD
36	realistic	realistic	JJ	_	37	NMOD
37	quality	quality	NN	_	34	PMOD
38	of	of	IN	_	37	NMOD
39	the	the	DT	_	40	NMOD
40	structure	structure	NN	_	38	PMOD
41	.	.	.	_	28	P

1	The	the	DT	_	3	NMOD
2	final	final	JJ	_	3	NMOD
3	quality	quality	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	structure	structure	NN	_	4	PMOD
7	was	be	VBD	_	0	ROOT
8	analyzed	analyze	VBN	_	7	VC
9	with	with	IN	_	8	MNR
10	the	the	DT	_	12	NMOD
11	computer	computer	NN	_	12	NMOD
12	program	program	NN	_	13	NMOD
13	PROCHECK	procheck	NN	_	9	PMOD
14	[	[	-LRB-	_	15	P
15	32	0	CD	_	8	PRN
16	]	]	-RRB-	_	15	P
17	.	.	.	_	7	P

1	The	the	DT	_	2	NMOD
2	structure	structure	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	deposited	deposit	VBN	_	3	VC
5	at	at	IN	_	4	ADV
6	the	the	DT	_	7	NMOD
7	PDB	pdb	NN	_	5	PMOD
8	under	under	IN	_	4	ADV
9	accession	accession	NN	_	11	NMOD
10	code	code	NN	_	11	NMOD
11	1R60	0r0	NN	_	8	PMOD
12	.	.	.	_	3	P

1	Authors	author	NNS	_	3	NMOD
2	'	'	POS	_	1	NMOD
3	contributions	contribution	NNS	_	0	ROOT

1	AW	aw	NN	_	2	SBJ
2	initiated	initiate	VBD	_	0	ROOT
3	this	this	DT	_	4	NMOD
4	project	project	NN	_	2	OBJ
5	and	and	CC	_	2	COORD
6	analyzed	analyze	VBD	_	5	CONJ
7	the	the	DT	_	9	NMOD
8	genomic	genomic	JJ	_	9	NMOD
9	distribution	distribution	NN	_	6	OBJ
10	of	of	IN	_	9	NMOD
11	this	this	DT	_	12	NMOD
12	family	family	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	enzymes	enzyme	NNS	_	13	PMOD
15	.	.	.	_	2	P

1	SRD	srd	NN	_	2	SBJ
2	contributed	contribute	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	modeling	modeling	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	three	three	CD	_	9	AMOD
8	-	-	HYPH	_	7	P
9	dimensional	dimensional	JJ	_	10	NMOD
10	structure	structure	NN	_	5	PMOD
11	of	of	IN	_	10	NMOD
12	CLN2	cln0	NN	_	11	PMOD
13	.	.	.	_	2	P

1	ML	ml	NN	_	2	SBJ
2	analyzed	analyze	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	model	model	NN	_	2	OBJ
5	and	and	CC	_	2	COORD
6	compared	compare	VBD	_	5	CONJ
7	it	it	PRP	_	6	OBJ
8	to	to	IN	_	6	ADV
9	the	the	DT	_	11	NMOD
10	crystal	crystal	JJ	_	11	NMOD
11	structures	structure	NNS	_	8	PMOD
12	of	of	IN	_	11	NMOD
13	sedolisins	sedolisins	NNS	_	12	PMOD
14	.	.	.	_	2	P

1	HO	ho	NN	_	6	SBJ
2	,	,	,	_	1	P
3	KO	ko	NN	_	1	CONJ
4	and	and	CC	_	3	COORD
5	BMD	bmd	NN	_	4	CONJ
6	contributed	contribute	VBD	_	0	ROOT
7	their	their	PRP$	_	8	NMOD
8	experience	experience	NN	_	6	OBJ
9	gained	gain	VBN	_	8	NMOD
10	from	from	IN	_	9	ADV
11	studies	study	NNS	_	10	PMOD
12	of	of	IN	_	11	NMOD
13	serine	serine	NN	_	15	NMOD
14	-	-	HYPH	_	13	P
15	carboxyl	carboxyl	NN	_	16	NMOD
16	peptidases	peptidase	NNS	_	12	PMOD
17	and	and	CC	_	8	COORD
18	the	the	DT	_	19	NMOD
19	design	design	NN	_	17	CONJ
20	of	of	IN	_	19	NMOD
21	their	their	PRP$	_	22	NMOD
22	inhibitors	inhibitor	NNS	_	20	PMOD
23	,	,	,	_	19	P
24	aimed	aim	VBN	_	19	NMOD
25	at	at	IN	_	24	ADV
26	analysis	analysis	NN	_	25	PMOD
27	of	of	IN	_	26	NMOD
28	substrate	substrate	NN	_	30	NMOD
29	-	-	HYPH	_	28	P
30	enzyme	enzyme	NN	_	31	NMOD
31	interactions	interaction	NNS	_	27	PMOD
32	and	and	CC	_	31	COORD
33	enzyme	enzyme	NN	_	34	NMOD
34	specificity	specificity	NN	_	32	CONJ
35	.	.	.	_	6	P

1	All	all	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	read	read	VBD	_	0	ROOT
4	and	and	CC	_	3	COORD
5	approved	approve	VBD	_	4	CONJ
6	the	the	DT	_	8	NMOD
7	final	final	JJ	_	8	NMOD
8	manuscript	manuscript	NN	_	3	OBJ
9	.	.	.	_	3	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	Extensive	extensive	JJ	_	2	NMOD
2	discussions	discussion	NNS	_	17	SBJ
3	with	with	IN	_	2	NMOD
4	Dr.	dr.	NNP	_	6	NMOD
5	A.	a.	NNP	_	6	NMOD
6	Barrett	barrett	NNP	_	3	PMOD
7	(	(	-LRB-	_	11	P
8	Wellcome	wellcome	NNP	_	11	NMOD
9	Trust	trust	NNP	_	11	NMOD
10	Sanger	sanger	NNP	_	11	NMOD
11	Institute	institute	NNP	_	6	PRN
12	,	,	,	_	11	P
13	Hinxton	hinxton	NNP	_	11	APPO
14	,	,	,	_	13	P
15	UK	uk	NNP	_	13	APPO
16	)	)	-RRB-	_	11	P
17	are	be	VBP	_	0	ROOT
18	gratefully	gratefully	RB	_	17	ADV
19	acknowledged	acknowledge	VBN	_	17	VC
20	.	.	.	_	17	P

1	Modeling	model	VBG	_	2	NMOD
2	efforts	effort	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	facilitated	facilitate	VBN	_	3	VC
5	by	by	IN	_	4	LGS
6	Dr.	dr.	NNP	_	8	NMOD
7	Robert	robert	NNP	_	8	NMOD
8	Jernigan	jernigan	NNP	_	5	PMOD
9	(	(	-LRB-	_	12	P
10	Iowa	iowa	NNP	_	12	NMOD
11	State	state	NNP	_	12	NMOD
12	University	university	NNP	_	8	PRN
13	)	)	-RRB-	_	12	P
14	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	work	work	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	part	part	JJ	_	5	PMOD
7	by	by	IN	_	4	ADV
8	a	a	DT	_	9	NMOD
9	Grant	grant	NNP	_	21	NMOD
10	-	-	HYPH	_	9	P
11	in	in	IN	_	9	NMOD
12	-	-	HYPH	_	11	P
13	Aid	aid	NNP	_	11	PMOD
14	for	for	IN	_	9	NMOD
15	Scientific	scientific	NNP	_	16	NMOD
16	Research	research	NNP	_	14	PMOD
17	(	(	-LRB-	_	18	P
18	B	b	NN	_	21	PRN
19	)	)	-RRB-	_	18	P
20	,	,	,	_	21	P
21	15380072	0	CD	_	7	PMOD
22	,	,	,	_	21	P
23	from	from	IN	_	21	NMOD
24	the	the	DT	_	25	NMOD
25	Ministry	ministry	NNP	_	23	PMOD
26	of	of	IN	_	25	NMOD
27	Education	education	NNP	_	26	PMOD
28	,	,	,	_	27	P
29	Culture	culture	NNP	_	27	CONJ
30	,	,	,	_	29	P
31	Sports	sport	NNP	_	29	CONJ
32	,	,	,	_	31	P
33	Science	science	NNP	_	31	CONJ
34	and	and	CC	_	33	COORD
35	Technology	technology	NNP	_	34	CONJ
36	of	of	IN	_	25	NMOD
37	Japan	japan	NNP	_	36	PMOD
38	(	(	-LRB-	_	39	P
39	to	to	IN	_	25	PRN
40	K.O.	k.o.	NNP	_	39	PMOD
41	)	)	-RRB-	_	39	P
42	;	;	:	_	7	P
43	by	by	IN	_	7	CONJ
44	NIH	nih	NN	_	45	NMOD
45	grants	grant	NNS	_	46	NMOD
46	DK18865	dk0	NN	_	43	PMOD
47	and	and	CC	_	46	COORD
48	AI39211	ai0	NN	_	47	CONJ
49	(	(	-LRB-	_	50	P
50	to	to	IN	_	46	PRN
51	B.M.D.	b.m.d.	NNP	_	50	PMOD
52	)	)	-RRB-	_	50	P
53	;	;	:	_	43	P
54	and	and	CC	_	43	COORD
55	in	in	IN	_	57	PMOD
56	part	part	JJ	_	55	PMOD
57	with	with	IN	_	54	CONJ
58	Federal	federal	NNP	_	59	NMOD
59	funds	fund	NNS	_	57	PMOD
60	from	from	IN	_	59	NMOD
61	the	the	DT	_	64	NMOD
62	National	national	NNP	_	64	NMOD
63	Cancer	cancer	NNP	_	64	NMOD
64	Institute	institute	NNP	_	60	PMOD
65	,	,	,	_	64	P
66	National	national	NNP	_	67	NMOD
67	Institutes	institute	NNPS	_	64	APPO
68	of	of	IN	_	67	NMOD
69	Health	health	NNP	_	68	PMOD
70	,	,	,	_	60	P
71	under	under	IN	_	60	PMOD
72	contract	contract	NN	_	78	NMOD
73	No.	no.	NN	_	78	NMOD
74	NO1	no0	NN	_	78	NMOD
75	-	-	HYPH	_	74	P
76	CO	co	NN	_	78	NMOD
77	-	-	HYPH	_	76	P
78	12400	0	NN	_	71	PMOD
79	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	content	content	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	publication	publication	NN	_	3	PMOD
6	does	do	VBZ	_	24	DEP
7	not	not	RB	_	6	ADV
8	necessarily	necessarily	RB	_	6	ADV
9	reflect	reflect	VB	_	6	VC
10	the	the	DT	_	11	NMOD
11	views	view	NNS	_	9	OBJ
12	or	or	CC	_	11	COORD
13	policies	policy	NNS	_	12	CONJ
14	of	of	IN	_	11	NMOD
15	the	the	DT	_	16	NMOD
16	Department	department	NNP	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	Health	health	NNP	_	17	PMOD
19	and	and	CC	_	18	COORD
20	Human	human	NNP	_	21	NMOD
21	Services	service	NNP	_	19	CONJ
22	,	,	,	_	24	P
23	nor	nor	CC	_	24	COORD
24	does	do	VBZ	_	0	ROOT
25	the	the	DT	_	26	NMOD
26	mention	mention	NN	_	24	SBJ
27	of	of	IN	_	26	NMOD
28	trade	trade	NN	_	29	NMOD
29	names	name	NNS	_	27	PMOD
30	,	,	,	_	29	P
31	commercial	commercial	JJ	_	32	NMOD
32	products	product	NNS	_	29	CONJ
33	or	or	CC	_	32	COORD
34	organizations	organization	NNS	_	33	CONJ
35	imply	imply	VBP	_	24	VC
36	endorsement	endorsement	NN	_	35	OBJ
37	by	by	IN	_	36	NMOD
38	the	the	DT	_	41	NMOD
39	U.	u.	NNP	_	40	NMOD
40	S.	s.	NNP	_	41	NMOD
41	Government	government	NNP	_	37	PMOD
42	.	.	.	_	24	P

